Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Bladder Cancer, January 2017

Free Subscription


Abstracts

Retrieve all available abstracts of the following 1167 articles:
HTML format


 

Single Articles

  1. LI Z, Sun M, Wang F, Shi J, et al
    Association between pioglitazone use and the risk of bladder cancer among subjects with diabetes mellitus: a dose-response meta-analysis.
    Int J Clin Pharmacol Ther. 2016 Dec 27. doi: 10.5414/CP202670.
    Abstract     Related articles   

  2. ALI ZIRAKZADEH A, Kinn J, Krantz D, Rosenblatt R, et al
    Doxorubicin enhances the capacity of B cells to activate T cells in Urothelial Urinary Bladder Cancer.
    Clin Immunol. 2016 Dec 23. pii: S1521-6616(16)30197.
    Abstract     Related articles   

  3. HINSCH A, Chaker A, Burdelski C, Koop C, et al
    betaIII-tubulin overexpression is linked to agressive tumor features and genetic instability in urinary bladder cancer.
    Hum Pathol. 2016 Dec 23. pii: S0046-8177(16)30351.
    Abstract     Related articles   

  4. PAGLIARULO V, Ancona P, Petitti T, Salerno A, et al
    Detection and Clinical Significance of Circulating Tumor Cells in Patients Undergoing Radical Cystectomy for Urothelial Bladder Cancer.
    Clin Genitourin Cancer. 2016 Dec 1. pii: S1558-7673(16)30341.
    Abstract     Related articles   

  5. RAOULT D
    Is there a link between urinary microbiota and bladder cancer?
    Eur J Epidemiol. 2016 Dec 24. doi: 10.1007/s10654-016-0213.
    Abstract     Related articles   

  6. SUN X, Deng Q, Liang Z, Liu Z, et al
    Cigarette smoke extract induces epithelial-mesenchymal transition of human bladder cancer T24 cells through activation of ERK1/2 pathway.
    Biomed Pharmacother. 2016;86:457-465.
    Abstract     Related articles   

  7. GOGALIC S, Sauer U, Doppler S, Heinzel A, et al
    Validation of a protein panel for the non-invasive detection of recurrent non-muscle invasive bladder cancer.
    Biomarkers. 2016 Dec 23:1-27. doi: 10.1080/1354750X.2016.1276628.
    Abstract     Related articles   

  8. POLOM W, Markuszewski M, Cytawa W, Czapiewski P, et al
    Fluorescent Versus Radioguided Lymph Node Mapping in Bladder Cancer.
    Clin Genitourin Cancer. 2016 Nov 30. pii: S1558-7673(16)30343.
    Abstract     Related articles   

  9. LISS MA, White M, Natarajan L, Parsons JK, et al
    Exercise Decreases and Smoking Increases Bladder Cancer Mortality.
    Clin Genitourin Cancer. 2016 Dec 1. pii: S1558-7673(16)30342.
    Abstract     Related articles   

  10. PICHLER R, Gruenbacher G, Culig Z, Brunner A, et al
    Intratumoral Th2 predisposition combines with an increased Th1 functional phenotype in clinical response to intravesical BCG in bladder cancer.
    Cancer Immunol Immunother. 2016 Dec 22. doi: 10.1007/s00262-016-1945.
    Abstract     Related articles   

  11. TACHIBANA H, Gi M, Kato M, Yamano S, et al
    Carbonic anhydrase 2 is a novel invasion-associated factor in urinary bladder cancers.
    Cancer Sci. 2016 Dec 22. doi: 10.1111/cas.13143.
    Abstract     Related articles   

  12. BAI Y, Yang H, Zhang G, Hu L, et al
    Inhibitory effects of resveratrol on the adhesion, migration and invasion of human bladder cancer cells.
    Mol Med Rep. 2016 Dec 15. doi: 10.3892/mmr.2016.6051.
    Abstract     Related articles   

  13. CHENG S, Andrew AS, Andrews PC, Moore JH, et al
    Complex systems analysis of bladder cancer susceptibility reveals a role for decarboxylase activity in two genome-wide association studies.
    BioData Min. 2016;9:40.
    Abstract     Related articles   

  14. LIU D, Li Y, Luo G, Xiao X, et al
    LncRNA SPRY4-IT1 sponges miR-101-3p to promote proliferation and metastasis of bladder cancer cells through up-regulating EZH2.
    Cancer Lett. 2016 Dec 18. pii: S0304-3835(16)30750.
    Abstract     Related articles   

  15. ZARIFMAHMOUDI L, Sadeghi R
    Re: Radio-Guided Lymph Node Mapping in Bladder Cancer Using SPECT/CT and Intraoperative gamma-Probe Methods.
    Clin Nucl Med. 2016 Dec 16. doi: 10.1097/RLU.0000000000001485.
    Abstract     Related articles   

  16. SAMY MD, Tong WL, Yavorski JM, Sexton WJ, et al
    T cell receptor gene recombinations in human tumor specimen exome files: detection of T cell receptor-beta VDJ recombinations associates with a favorable oncologic outcome for bladder cancer.
    Cancer Immunol Immunother. 2016.
    Abstract     Related articles   

  17. TRETTER EM, Ebel JJ, Pohar KS, Zynger DL, et al
    Does the gross prosector impact pT3 subclassification or lymph node counts in bladder cancer?
    Hum Pathol. 2016 Dec 16. pii: S0046-8177(16)30347.
    Abstract     Related articles   

  18. ZHANG XJ, Yu HY, Cai YJ, Ke M, et al
    Lycium barbarum polysaccharides inhibit proliferation and migration of bladder cancer cell lines BIU87 by suppressing Pi3K/AKT pathway.
    Oncotarget. 2016 Dec 15. doi: 10.18632/oncotarget.13963.
    Abstract     Related articles   

  19. WANG X, Ni S, Chen Q, Ma L, et al
    Bladder cancer cells induce immunosuppression of T cells by supporting PD-L1 expression in tumor macrophages partially through interleukin 10.
    Cell Biol Int. 2016 Dec 17. doi: 10.1002/cbin.10716.
    Abstract     Related articles   

  20. ROPERTO S, Munday JS, Corrado F, Goria M, et al
    Detection of bovine papillomavirus type 14 DNA sequences in urinary bladder tumors in cattle.
    Vet Microbiol. 2016;190:1-4.
    Abstract     Related articles   

  21. HARGRAVE C, Mason N, Guidi R, Miller JA, et al
    Automated replication of cone beam CT-guided treatments in the Pinnacle(3) treatment planning system for adaptive radiotherapy.
    J Med Radiat Sci. 2016;63:48-58.
    Abstract     Related articles   

  22. TAKAYAMA T, Kubo T, Morikawa A, Morita T, et al
    Potential of sulfasalazine as a therapeutic sensitizer for CD44 splice variant 9-positive urogenital cancer.
    Med Oncol. 2016;33:45.
    Abstract     Related articles   

  23. MIKAMO H
    [Deep-seated mycosis].
    Med Mycol J. 2016;57:J33-4.
    Abstract     Related articles   

  24. CHEN L, Li H, Gu L, Ma X, et al
    Prognostic role of urinary collecting system invasion in renal cell carcinoma: a systematic review and meta-analysis.
    Sci Rep. 2016;6:21325.
    Abstract     Related articles   

  25. TAN WS, Lamb BW, Kelly JD
    Evolution of the neobladder: A critical review of open and intracorporeal neobladder reconstruction techniques.
    Scand J Urol. 2016;50:95-103.
    Abstract     Related articles   

  26. RUIZ-TAMAYO I, Franch-Nadal J, Mata-Cases M, Mauricio D, et al
    Noninsulin Antidiabetic Drugs for Patients with Type 2 Diabetes Mellitus: Are We Respecting Their Contraindications?
    J Diabetes Res. 2016;2016:7502489.
    Abstract     Related articles   

  27. LI XD, Chen SL, Dong P, Chen JW, et al
    Overexpression of RNF2 Is an Independent Predictor of Outcome in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy.
    Sci Rep. 2016;6:20894.
    Abstract     Related articles   

  28. JIANG T, Liu T, Li L, Yang Z, et al
    Knockout of phospholipase Cepsilon attenuates N-butyl-N-(4-hydroxybutyl) nitrosamine-induced bladder tumorigenesis.
    Mol Med Rep. 2016;13:2039-45.
    Abstract     Related articles   

  29. ZHANG Z, Zhang G, Kong C, Zhan B, et al
    METTL13 is downregulated in bladder carcinoma and suppresses cell proliferation, migration and invasion.
    Sci Rep. 2016;6:19261.
    Abstract     Related articles   

  30. MONTIRONI R, Santoni M, Cheng L, Lopez-Beltran A, et al
    An Overview of Emerging Immunotargets of Genitourinary Tumors.
    Curr Drug Targets. 2016;17:750-6.
    Abstract     Related articles   

  31. ROUANNE M, Loriot Y, Lebret T, Soria JC, et al
    Novel therapeutic targets in advanced urothelial carcinoma.
    Crit Rev Oncol Hematol. 2016;98:106-15.
    Abstract     Related articles   

  32. BAACK KUKREJA JE, Messing EM, Shah JB
    Are we doing "better"? The discrepancy between perception and practice of enhanced recovery after cystectomy principles among urologic oncologists.
    Urol Oncol. 2016;34:120.
    Abstract     Related articles   

  33. PARISER JJ, Anderson BB, Pearce SM, Han Z, et al
    The effect of broader, directed antimicrobial prophylaxis including fungal coverage on perioperative infectious complications after radical cystectomy.
    Urol Oncol. 2016;34:121.
    Abstract     Related articles   

  34. HOLM PS, Retz M, Gschwend JE, Nawroth R, et al
    [YB-1-based virotherapy: A new therapeutic intervention for transitional cell carcinoma of the bladder?].
    Urologe A. 2016;55:356-63.
    Abstract     Related articles   

  35. HIRNER L, Stagge E, Rubben H, Schenck M, et al
    [Narrow band imaging-assisted cystoscopy in bladder tumor follow-up: Can more tumors be identified?].
    Urologe A. 2016;55:370-5.
    Abstract     Related articles   

  36. WANG YL, Fang N, Zeng L, Wu ZJ, et al
    18F-FDG PET/CT Findings of Metastasis to Spongy Body of Penis From Urothelial Carcinoma of Bladder.
    Clin Nucl Med. 2015.
    Abstract     Related articles   

  37. COLLINS JW, Adding C, Hosseini A, Nyberg T, et al
    Introducing an enhanced recovery programme to an established totally intracorporeal robot-assisted radical cystectomy service.
    Scand J Urol. 2016;50:39-46.
    Abstract     Related articles   

  38. LIU SL, Qi L, Han WQ, Zhu BS, et al
    Shorter hemodialysis duration is a risk factor for the recurrence of urothelial carcinoma of the bladder in patients on maintenance hemodialysis.
    Clin Transl Oncol. 2016;18:304-9.
    Abstract     Related articles   

  39. WANG CT, Chen TM, Mei CT, Chang CF, et al
    The Functional Haplotypes of CHRM3 Modulate mRNA Expression and Associate with Bladder Cancer among a Chinese Han Population in Kaohsiung City.
    Biomed Res Int. 2016;2016:4052846.
    Abstract     Related articles   

  40. RAMSEY SA, Xu T, Goodall C, Rhodes AC, et al
    Cross-Species Analysis of the Canine and Human Bladder Cancer Transcriptome and Exome.
    Genes Chromosomes Cancer. 2017 Jan 3. doi: 10.1002/gcc.22441.
    Abstract     Related articles   

  41. ZIGEUNER R
    Bladder cancer in 2016: News in diagnosis, treatment, and risk group assessment.
    Nat Rev Urol. 2017 Jan 4. doi: 10.1038/nrurol.2016.
    Abstract     Related articles   

  42. WANG C, Wang Q, Li X, Jin Z, et al
    Lycorine induces apoptosis of bladder cancer T24 cells by inhibiting phospho-Akt and activating the intrinsic apoptotic cascade.
    Biochem Biophys Res Commun. 2016 Dec 29. pii: S0006-291X(16)32240.
    Abstract     Related articles   

  43. STEINBERG RL, Brooks NA, Thomas LJ, Mott SL, et al
    Bacillus Calmette-Guerin strain may not effect recurrence-free survival when used intravesically with interferon-alpha2b for non-muscle-invasive bladder cancer.
    Urol Oncol. 2016 Dec 29. pii: S1078-1439(16)30404.
    Abstract     Related articles   

  44. LUO KW, Wei Chen, Lung WY, Wei XY, et al
    EGCG inhibited bladder cancer SW780 cell proliferation and migration both in vitro and in vivo via down-regulation of NF-kappaB and MMP-9.
    J Nutr Biochem. 2016;41:56-64.
    Abstract     Related articles   

  45. MOSCHINI M, Shariat SF, Luciano R, D'Andrea D, et al
    Pure but Not Mixed Histologic Variants Are Associated With Poor Survival at Radical Cystectomy in Bladder Cancer Patients.
    Clin Genitourin Cancer. 2016 Dec 14. pii: S1558-7673(16)30352.
    Abstract     Related articles   

  46. YANG GL, Zhang LH, Liu Q, Wang ZL, et al
    A novel treatment strategy for newly diagnosed high-grade T1 bladder cancer: Gemcitabine and cisplatin adjuvant chemotherapy-A single-institution experience.
    Urol Oncol. 2016 Dec 28. pii: S1078-1439(16)30254.
    Abstract     Related articles   

  47. FENG C, Ho Y, Sun C, Xia G, et al
    TFPI-2 expression is decreased in bladder cancer and is related to apoptosis.
    J BUON. 2016;21:1518-1523.
    Abstract     Related articles   

  48. KANG M, Jeong CW, Kwak C, Kim HH, et al
    Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.
    Oncotarget. 2016 Dec 26. doi: 10.18632/oncotarget.14179.
    Abstract     Related articles   

  49. ZHEN S, Hua L, Liu YH, Sun XM, et al
    Inhibition of long non-coding RNA UCA1 by CRISPR/Cas9 attenuated malignant phenotypes of bladder cancer.
    Oncotarget. 2016 Dec 25. doi: 10.18632/oncotarget.14176.
    Abstract     Related articles   

  50. YU GQ, Dou ZL, Jia ZH
    [Corrigendum] 5bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2one induces apoptosis in T24 human bladder cancer cells through mitochondria-dependent signaling pathways.
    Mol Med Rep. 2016 Dec 27. doi: 10.3892/mmr.2016.6076.
    Abstract     Related articles   

  51. MESSING EM
    Checkpoint Inhibitors for Advanced Bladder Cancer.
    Bladder Cancer. 2016;2:473-474.
    Abstract     Related articles   

  52. SHAHAIT M, Bulbul M
    Bladder Cancer Screening in Lebanese Population: There is Nothing more Unequal than the Equal Treatment of Unequal People.
    Bladder Cancer. 2016;2:467-468.
    Abstract     Related articles   

  53. SUI W, Matulay JT, James MB, Onyeji IC, et al
    Micropapillary Bladder Cancer: Insights from the National Cancer Database.
    Bladder Cancer. 2016;2:415-423.
    Abstract     Related articles   

  54. ROSE TL, Deal AM, Ladoire S, Crehange G, et al
    Patterns of Bladder Preservation Therapy Utilization for Muscle-Invasive Bladder Cancer.
    Bladder Cancer. 2016;2:405-413.
    Abstract     Related articles   

  55. RUSSELL CM, Lebastchi AH, Borza T, Spratt DE, et al
    The Role of Transurethral Resection in Trimodal Therapy for Muscle-Invasive Bladder Cancer.
    Bladder Cancer. 2016;2:381-394.
    Abstract     Related articles   

  56. NANDAGOPAL L, Sonpavde G
    Circulating Biomarkers in Bladder Cancer.
    Bladder Cancer. 2016;2:369-379.
    Abstract     Related articles   

  57. CHIANG Y, Cheng JC, Huang CY, Tsai YC, et al
    A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvement.
    J Formos Med Assoc. 2016 Dec 26. pii: S0929-6646(16)30350.
    Abstract     Related articles   

  58. YAN X, Wu C, Chen T, Santos MM, et al
    Cathepsin S inhibition changes regulatory T-cell activity in regulating bladder cancer and immune cell proliferation and apoptosis.
    Mol Immunol. 2016;82:66-74.
    Abstract     Related articles   

  59. CHEN A, Liu A, Liu J, Tian S, et al
    Application of dual-energy spectral CT imaging in differential diagnosis of bladder cancer and benign prostate hyperplasia.
    Medicine (Baltimore). 2016;95:e5705.
    Abstract     Related articles   

  60. SIDAWAY P
    Bladder cancer: Atezolizumab: an alternative to cisplatin?
    Nat Rev Urol. 2016 Dec 29. doi: 10.1038/nrurol.2016.
    Abstract     Related articles   

  61. ELLISON LF
    Differences in cancer survival in Canada by sex.
    Health Rep. 2016;27:19-27.
    Abstract     Related articles   

  62. POURCHET A, Fuhrmann SR, Pilones KA, Demaria S, et al
    CD8(+) T-cell Immune Evasion Enables Oncolytic Virus Immunotherapy.
    EBioMedicine. 2016;5:59-67.
    Abstract     Related articles   

  63. VENKATESH K, Madhusudhan HR
    Anaplastic lymphoma kinase positive inflammatory myofibroblastic tumor of the urachus: A rare neoplasm in an unusual location.
    Indian J Pathol Microbiol. 2016;59:93-5.
    Abstract     Related articles   

  64. RALLABANDI HB, Swain M, Gowrishankar S, Sinha S, et al
    Postradiation angiosarcoma of bladder with extensive osseous metaplasia.
    Indian J Pathol Microbiol. 2016;59:78-80.
    Abstract     Related articles   

  65. SAKATA K, Fukuoka N, Tanabe K, Takenaka M, et al
    Anaphylactic shock due to intravesical administration of pirarubicin hydrochloride for the fifth time.
    J Clin Anesth. 2016;28:2-3.
    Abstract     Related articles   

  66. IWAMOTO H, Yumioka T, Yamaguchi N, Masago T, et al
    Robot-assisted radical cystectomy is a promising alternative to open surgery in the Japanese population with a high rate of octogenarians.
    Int J Clin Oncol. 2016;21:756-63.
    Abstract     Related articles   

  67. KIERAN K, Shnorhavorian M
    Current standards of care in bladder and prostate rhabdomyosarcoma.
    Urol Oncol. 2016;34:93-102.
    Abstract     Related articles   

  68. AKACHA M, Ogundimu EO
    Sensitivity analyses for partially observed recurrent event data.
    Pharm Stat. 2016;15:4-14.
    Abstract     Related articles   

  69. BAUMAN G
    Choosing Wisely? "It's Complicated!".
    Pract Radiat Oncol. 2016;6:71-3.
    Abstract     Related articles   

  70. SHIMURA H, Ihara T, Mitsui T, Takeda M, et al
    Tuberculous Granuloma in the Scrotal Skin After Intravesical Bacillus Calmette-Guerin Therapy for Bladder Cancer: A Case Report.
    Urol Case Rep. 2017;11:4-6.
    Abstract     Related articles   

  71. SONG BN, Kim SK, Chu IS
    Bioinformatic identification of prognostic signature defined by copy number alteration and expression of CCNE1 in non-muscle invasive bladder cancer.
    Exp Mol Med. 2017;49:e282.
    Abstract     Related articles   

  72. WILBORN D, Schmidt S
    [Adjuvant chemotherapy for invasive bladder cancer (individual patient data)].
    Urologe A. 2017 Jan 11. doi: 10.1007/s00120-016-0305.
    Abstract     Related articles   

  73. RINK M, Shariat SF, Soave A
    Liquid biopsies in bladder cancer-did we find the Holy Grail for biomarker analyses?
    Transl Androl Urol. 2016;5:980-983.
    Abstract     Related articles   

  74. GOPALAKRISHNA A, Fantony JJ, Longo TA, Owusu R, et al
    Anticipatory Positive Urine Tests for Bladder Cancer.
    Ann Surg Oncol. 2017 Jan 10. doi: 10.1245/s10434-016-5763.
    Abstract     Related articles   

  75. BREYER J, Wirtz RM, Otto W, Erben P, et al
    In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival.
    Virchows Arch. 2017 Jan 10. doi: 10.1007/s00428-017-2064.
    Abstract     Related articles   

  76. POLOM W, Gruszecka A, Markuszewski M, Cytawa W, et al
    Radio-Guided Lymph Node Mapping in Bladder Cancer Using SPECT/CT and Intraoperative gamma-Probe Methods: Reply.
    Clin Nucl Med. 2017 Jan 9. doi: 10.1097/RLU.0000000000001523.
    Abstract     Related articles   

  77. CRIPPA A, Larsson SC, Discacciati A, Wolk A, et al
    Red and processed meat consumption and risk of bladder cancer: a dose-response meta-analysis of epidemiological studies.
    Eur J Nutr. 2016 Dec 22. doi: 10.1007/s00394-016-1356.
    Abstract     Related articles   

  78. TAN M, Mu X, Liu Z, Tao L, et al
    microRNA-495 promotes bladder cancer cell growth and invasion by targeting phosphatase and tensin homolog.
    Biochem Biophys Res Commun. 2017 Jan 6. pii: S0006-291X(17)30019.
    Abstract     Related articles   

  79. HAMPP C, Pippins J
    Pioglitazone and bladder cancer: FDA's assessment.
    Pharmacoepidemiol Drug Saf. 2017 Jan 9. doi: 10.1002/pds.4154.
    Abstract     Related articles   

  80. EL-SIDDIG AA, Albasri AM, Hussainy AS, Alhujaily AS, et al
    Urinary bladder cancer in adults: a histopathological experience from Madinah, Saudi Arabia.
    J Pak Med Assoc. 2017;67:83-86.
    Abstract     Related articles   

  81. MATSUMOTO K, Kikuchi E, Yanai Y, Hayakawa N, et al
    Characterizing intermediate-risk non-muscle-invasive bladder cancer: Implications for the definition of intermediate risk and treatment strategy.
    Urol Oncol. 2017 Jan 3. pii: S1078-1439(16)30402.
    Abstract     Related articles   

  82. KHARE SR, Aprikian A, Black P, Blais N, et al
    Quality indicators in the management of bladder cancer: A modified Delphi study.
    Urol Oncol. 2017 Jan 3. pii: S1078-1439(16)30410.
    Abstract     Related articles   

  83. MIZUSHIMA T, Tirador KA, Miyamoto H
    Androgen receptor activation: A prospective therapeutic target for bladder cancer?
    Expert Opin Ther Targets. 2017 Jan 9. doi: 10.1080/14728222.2017.1280468.
    Abstract     Related articles   

  84. VAGO R, Bettiga A, Salonia A, Ciuffreda P, et al
    Development of new inhibitors for N-acylethanolamine-hydrolyzing acid amidase as promising tool against bladder cancer.
    Bioorg Med Chem. 2016 Dec 27. pii: S0968-0896(16)31496.
    Abstract     Related articles   

  85. SEGOVIA C, Martinez-Fernandez M, Duenas M, Rubio C, et al
    Opposing roles of PIK3CA gene alterations to EZH2 signaling in non-muscle invasive bladder cancer.
    Oncotarget. 2017 Jan 2. doi: 10.18632/oncotarget.14453.
    Abstract     Related articles   

  86. MOHAMMED AA, El-Tanni H, El-Khatib HM, Mirza AA, et al
    Urinary Bladder Cancer: Biomarkers and Target Therapy, New Era for More Attention.
    Oncol Rev. 2016;10:320.
    Abstract     Related articles   

  87. HUANG C, Zeng X, Jiang G, Liao X, et al
    XIAP BIR domain suppresses miR-200a expression and subsequently promotes EGFR protein translation and anchorage-independent growth of bladder cancer cell.
    J Hematol Oncol. 2017;10:6.
    Abstract     Related articles   

  88. NAKAMOTO R, Nakamoto Y, Ishimori T, Togashi K, et al
    Clinical Significance of Quantitative 123I-MIBG SPECT/CT Analysis of Pheochromocytoma and Paraganglioma.
    Clin Nucl Med. 2016.
    Abstract     Related articles   

  89. YOSHINO T, Wake K, Yamamoto T, Onuma H, et al
    [Liposarcoma of the Spermatic Cord : A Case Report and Review of the Literature].
    Hinyokika Kiyo. 2016;62:393-7.
    Abstract     Related articles   

  90. DE LUCA F, Zacharakis E, Shabbir M, Maurizi A, et al
    Malignant priapism due to penile metastases: Case series and literature review.
    Arch Ital Urol Androl. 2016;88:150-2.
    Abstract     Related articles   

  91. STAMATIOU K, Christopoulos G, Tsavari A, Koulia K, et al
    Lymphoepithelioma-like carcinoma of the bladder: A case report.
    Arch Ital Urol Androl. 2016;88:147-9.
    Abstract     Related articles   

  92. UN S, Turk H, Karabicak M, Divrik RT, et al
    Is a second look necessary in multiple and/or large Ta tumors?
    Arch Ital Urol Androl. 2016;88:86-8.
    Abstract     Related articles   

  93. SCHEPISI G, Santoni M, Massari F, Gurioli G, et al
    Urothelial Cancer: Inflammatory Mediators and Implications for Immunotherapy.
    BioDrugs. 2016;30:263-73.
    Abstract     Related articles   

  94. SHAW N, Marchalik D, Stamatakis L
    Incidentally discovered urachal cancer in a patient with necrotising fasciitis of the abdominal wall.
    BMJ Case Rep. 2016;2016.
    Abstract     Related articles   

  95. GOMELLA PT, Frazier H
    Takotsubo stress-induced cardiomyopathy following robotic radical cystectomy.
    Can J Urol. 2016;23:8234-6.
    Abstract     Related articles   

  96. GREGG JR, McCormick B, Wang L, Cohen P, et al
    Short term complications from transurethral resection of bladder tumor.
    Can J Urol. 2016;23:8198-203.
    Abstract     Related articles   

  97. FENG Y, Kawrakow I, Olsen J, Parikh PJ, et al
    A comparative study of automatic image segmentation algorithms for target tracking in MR-IGRT.
    J Appl Clin Med Phys. 2016;17:5820.
    Abstract     Related articles   

  98. NISHIMOTO K, Akise Y, Miyazawa M, Kutsuki S, et al
    A Case of Severe Rectal Hemorrhage Possibly Caused by Radiation Recall after Administration of Gemcitabine.
    Keio J Med. 2016;65:16-20.
    Abstract     Related articles   

  99. ELSHERIF E, Elbaky TA, Elserafy F, Elkady N, et al
    beta-catenin and SKP2 proteins as predictors of grade and stage of non-muscle invasive urothelial bladder carcinoma.
    Chin Clin Oncol. 2016;5:6.
    Abstract     Related articles   

  100. KNUCHEL-CLARKE R, Gaisa NT
    [Preneoplastic lesions and precursors of urothelial cancer].
    Pathologe. 2016;37:33-9.
    Abstract     Related articles   

  101. NAYAK JG, Gore JL, Holt SK, Wright JL, et al
    Patient-centered risk stratification of disposition outcomes following radical cystectomy.
    Urol Oncol. 2016;34:235.
    Abstract     Related articles   

  102. AGAIMY A, Hartmann A
    [Mesenchymal tumors of the urinary bladder].
    Pathologe. 2016;37:61-70.
    Abstract     Related articles   

  103. THOMAS S, Hao L, Ricke WA, Li L, et al
    Biomarker discovery in mass spectrometry-based urinary proteomics.
    Proteomics Clin Appl. 2016;10:358-70.
    Abstract     Related articles   

  104. PULLENAYEGUM EM
    Multiple outputation for the analysis of longitudinal data subject to irregular observation.
    Stat Med. 2016;35:1800-18.
    Abstract     Related articles   

  105. ABDI H, Pourmalek F, Gleave ME, So AI, et al
    Balancing risk and benefit of extended pelvic lymph node dissection in patients undergoing radical cystectomy.
    World J Urol. 2016;34:41-8.
    Abstract     Related articles   

  106. PATEL HR, Santos PB, de Oliveira MC, Muller S, et al
    Is robotic-assisted radical cystectomy (RARC) with intracorporeal diversion becoming the new gold standard of care?
    World J Urol. 2016;34:25-32.
    Abstract     Related articles   

  107. KHURRAM SA, Farthing PM, Whitworth A, McKechnie AJ, et al
    High-grade urothelial carcinoma with squamous differentiation metastasizing to the tongue.
    Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;121:e111-5.
    Abstract     Related articles   

  108. SIDDIQUI KM, Izawa JI
    Ileal conduit: standard urinary diversion for elderly patients undergoing radical cystectomy.
    World J Urol. 2016;34:19-24.
    Abstract     Related articles   

  109. HUGEN CM, Daneshmand S
    Orthotopic urinary diversion in the elderly.
    World J Urol. 2016;34:13-8.
    Abstract     Related articles   

  110. RAUP VT, Eswara JR, Geminiani J, Madison K, et al
    Gracilis muscle interposition flap repair of urinary fistulae: pelvic radiation is associated with persistent urinary incontinence and decreased quality of life.
    World J Urol. 2016;34:131-6.
    Abstract     Related articles   

  111. MOBLEY A, Zhang S, Bondaruk J, Wang Y, et al
    Aurora Kinase A is a Biomarker for Bladder Cancer Detection and Contributes to its Aggressive Behavior.
    Sci Rep. 2017;7:40714.
    Abstract     Related articles   

  112. ELSEN S, Lerut E, Van Der Aa F, Van Cleynenbreugel B, et al
    Evans blue-mediated white-light detection of non-muscle-invasive bladder cancer: A preclinical feasibility and safety study using a rat bladder urothelial cell carcinoma model.
    Mol Clin Oncol. 2016;5:678-688.
    Abstract     Related articles   

  113. CEYLAN GG, Onalan EE, Kuloglu T, Aydog G, et al
    Potential role of melastatin-related transient receptor potential cation channel subfamily M gene expression in the pathogenesis of urinary bladder cancer.
    Oncol Lett. 2016;12:5235-5239.
    Abstract     Related articles   

  114. QI P, He Z, Zhang L, Fan Y, et al
    Rottlerin-induced autophagy leads to apoptosis in bladder cancer cells.
    Oncol Lett. 2016;12:4577-4583.
    Abstract     Related articles   

  115. GONG YQ, Peng D, Ning XH, Yang XY, et al
    UBE2T silencing suppresses proliferation and induces cell cycle arrest and apoptosis in bladder cancer cells.
    Oncol Lett. 2016;12:4485-4492.
    Abstract     Related articles   

  116. WANG S, Meng Q, Xie Q, Zhang M, et al
    Effect and mechanism of resveratrol on drug resistance in human bladder cancer cells.
    Mol Med Rep. 2017 Jan 12. doi: 10.3892/mmr.2017.6111.
    Abstract     Related articles   

  117. ITAI S, Suga Y, Hara Y, Izumi K, et al
    Co-administration of dexamethasone increases severity and accelerates onset day of neutropenia in bladder cancer patients on methotrexate, vinblastine, adriamycin and cisplatin chemotherapy: a retrospective cohort study.
    J Pharm Health Care Sci. 2017;3:3.
    Abstract     Related articles   

  118. STONE L
    Bladder cancer: Genetic urinary biomarker panel is promising.
    Nat Rev Urol. 2017 Jan 17. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  119. LV D, Wu H, Xing R, Shu F, et al
    HnRNP-L mediates bladder cancer progression by inhibiting apoptotic signaling and enhancing MAPK signaling pathways.
    Oncotarget. 2017 Jan 11. doi: 10.18632/oncotarget.14600.
    Abstract     Related articles   

  120. LLORETA J, Font-Tello A, Juanpere N, Frances A, et al
    FOXO1 downregulation is associated with worse outcome in bladder cancer and adds significant prognostic information to p53 overexpression.
    Hum Pathol. 2017 Jan 10. pii: S0046-8177(17)30011.
    Abstract     Related articles   

  121. MOSCHINI M, Dell'Oglio P, Luciano' R, Gandaglia G, et al
    Incidence and effect of variant histology on oncological outcomes in patients with bladder cancer treated with radical cystectomy.
    Urol Oncol. 2017 Jan 10. pii: S1078-1439(16)30413.
    Abstract     Related articles   

  122. RIPPY SB, Gardner HL, Nguyen SM, Warry EE, et al
    A pilot study of toceranib/vinblastine therapy for canine transitional cell carcinoma.
    BMC Vet Res. 2016;12:257.
    Abstract     Related articles   

  123. SHAH BK, Rajwani T, Jha S, Fortna RR, et al
    Chronic lymphocytic leukemia presenting with hematuria.
    Acta Oncol. 2017;56:113-115.
    Abstract     Related articles   

  124. ANZIVINO E, Zingaropoli MA, Iannetta M, Pietropaolo VA, et al
    Archetype and Rearranged Non-coding Control Regions in Urothelial Bladder Carcinoma of Immunocompetent Individuals.
    Cancer Genomics Proteomics. 2016;13:499-509.
    Abstract     Related articles   

  125. ABDEL-GAWAD M, Elsobky E, Shalaby MM, Abd-Elhameed M, et al
    Quantitative Evaluation of Heavy Metals and Trace Elements in the Urinary Bladder: Comparison Between Cancerous, Adjacent Non-cancerous and Normal Cadaveric Tissue.
    Biol Trace Elem Res. 2016;174:280-286.
    Abstract     Related articles   

  126. ROPERTO S, Russo V, Leonardi L, Martano M, et al
    Bovine Papillomavirus Type 13 Expression in the Urothelial Bladder Tumours of Cattle.
    Transbound Emerg Dis. 2016;63:628-634.
    Abstract     Related articles   

  127. ZHU L, Zhou L, Wang L, Li Z, et al
    A20 SNP rs77191406 may be related to secondary cancer for rheumatoid arthritis and systemic lupus erythematosus patients.
    Asia Pac J Clin Oncol. 2016;12:409-414.
    Abstract     Related articles   

  128. FUJII T, Asano A, Shimada K, Tatsumi Y, et al
    Evaluation of RNA and DNA extraction from liquid-based cytology specimens.
    Diagn Cytopathol. 2016;44:833-40.
    Abstract     Related articles   

  129. LIN DM, Barkan GA, Chatt G, Park JW, et al
    Vaginal fine-needle aspiration: A useful alternative to biopsy.
    Diagn Cytopathol. 2016;44:665-9.
    Abstract     Related articles   

  130. CSOMA E, Bidiga L, Mehes G, Gergely L, et al
    No Evidence of Human Polyomavirus 9, WU and KI DNA in Kidney and Urinary Bladder Tumour Tissue Samples.
    Pathobiology. 2016;83:252-7.
    Abstract     Related articles   

  131. ISHIKAWA R, Kadota K, Hayashi T, Motoyama M, et al
    Cytopathological features of villous adenoma of the urinary bladder in urine: A rare case report.
    Diagn Cytopathol. 2016;44:632-5.
    Abstract     Related articles   

  132. MITRA S, Chatterjee D, Gupta K, Dass Radotra B, et al
    Urine cytology of urothelial carcinoma with villoglandular differentiation.
    Diagn Cytopathol. 2016;44:653-6.
    Abstract     Related articles   

  133. ABUSANAD OZ, Floyd MS Jr, Khattak AQ
    Acute Urinary Retention in a Female Following Bladder Tumor Resection Due To a Stone in a Urethral Diverticulum.
    Urol J. 2016;13:2656.
    Abstract     Related articles   

  134. LIANG J, Li H, Gao L, Yin L, et al
    Bladder Paraganglioma: Clinicopathology and Magnetic Resonance Imaging Study of Five Patients.
    Urol J. 2016;13:2605-11.
    Abstract     Related articles   

  135. THORNQVIST S, Hysing LB, Tuomikoski L, Vestergaard A, et al
    Adaptive radiotherapy strategies for pelvic tumors - a systematic review of clinical implementations.
    Acta Oncol. 2016;55:943-58.
    Abstract     Related articles   

  136. RUAN HJ, Huang AH, Cheng S, Fu GX, et al
    [Clinicopathologic features of solitary fibrous tumor in urogenital system].
    Zhonghua Bing Li Xue Za Zhi. 2016;45:248-51.
    Abstract     Related articles   

  137. GLASS R, Cocker R, Rosen L, Coutsouvelis C, et al
    The impact of subdividing the "atypical" category for urinary cytology on patient management.
    Diagn Cytopathol. 2016;44:477-82.
    Abstract     Related articles   

  138. YANG H, Liu ZM, Lei YH, Qin Y, et al
    [Analysis of life-threatening complications during perioperative period in patients undergoing radical cystectomy with orthotopic neobladder].
    Zhonghua Zhong Liu Za Zhi. 2016;38:236-9.
    Abstract     Related articles   

  139. SEO GH, Kim JH, Ku JH
    Clinical Practice Pattern of Immediate Intravesical Chemotherapy following Transurethral Resection of a Bladder Tumor in Korea: National Health Insurance Database Study.
    Sci Rep. 2016;6:22716.
    Abstract     Related articles   

  140. TONE K, Kojima K, Hoshiai K, Kumagai N, et al
    An ancillary method in urine cytology: Nucleolar/nuclear volume ratio for discrimination between benign and malignant urothelial cells.
    Diagn Cytopathol. 2016;44:483-91.
    Abstract     Related articles   

  141. ALME AK, Karir BS, Faltas BM, Drake CG, et al
    Blocking immune checkpoints in prostate, kidney, and urothelial cancer: An overview.
    Urol Oncol. 2016;34:171-81.
    Abstract     Related articles   

  142. GAI JW, Qin W, Liu M, Wang HF, et al
    Expression profile of hydrogen sulfide and its synthases correlates with tumor stage and grade in urothelial cell carcinoma of bladder.
    Urol Oncol. 2016;34:166.
    Abstract     Related articles   

  143. KIM HC, Hong WP, Lim YJ, Park HP, et al
    The effect of sevoflurane versus desflurane on postoperative catheter-related bladder discomfort in patients undergoing transurethral excision of a bladder tumour: a randomized controlled trial.
    Can J Anaesth. 2016;63:596-602.
    Abstract     Related articles   

  144. SAIDI S, Popov Z, Janevska V, Panov S, et al
    Overexpression of UHRF1 gene correlates with the major clinicopathological parameters in urinary bladder cancer.
    Int Braz J Urol. 2017;43.
    Abstract     Related articles   

  145. KATA SG, Zreik A, Ahmad S, Chlosta P, et al
    Concurrent bladder cancer in patients undergoing photodynamic diagnostic ureterorenoscopy: how many lesions do we miss under white light cystoscopy?
    Cent European J Urol. 2016;69:334-340.
    Abstract     Related articles   

  146. PIOTROWICZ S, Poletajew S, Czarniecki SW, Kowalski F, et al
    Extent of lymphadenectomy in patients with bladder cancer undergoing radical cystectomy - a multi-institutional analysis.
    Cent European J Urol. 2016;69:323-326.
    Abstract     Related articles   

  147. KRISHNA SR, Konety BR
    Current Concepts in the Management of Muscle Invasive Bladder Cancer.
    Indian J Surg Oncol. 2017;8:74-81.
    Abstract     Related articles   

  148. PRACK MC CORMICK B, Belgorosky D, Langle Y, Balarino N, et al
    Bacillus Calmette-Guerin improves local and systemic response to radiotherapy in invasive bladder cancer.
    Nitric Oxide. 2017 Jan 23. pii: S1089-8603(16)30143.
    Abstract     Related articles   

  149. ARRUDA RP, Mariano MB, Pereira CF, Lima GC, et al
    Laparoscopic Cystoprostatectomy for Bladder Cancer in a Male patient combined with open ileal conduit urinary diversion.
    Int Braz J Urol. 2017;43:169-170.
    Abstract     Related articles   

  150. CIMEN HI, Halis F, Saglam HS, Gokce A, et al
    Can neutrophil to lymphocyte ratio predict lamina propria invasion in patients with non muscle invasive bladder cancer?
    Int Braz J Urol. 2017;43:67-72.
    Abstract     Related articles   

  151. SO A
    Bladder cancer, ESMO 2016.
    Can Urol Assoc J. 2016;10.
    Abstract     Related articles   

  152. WANG H, Li Q, Niu X, Wang G, et al
    miR-143 inhibits bladder cancer cell proliferation and enhances their sensitivity to gemcitabine by repressing IGF-1R signaling.
    Oncol Lett. 2017;13:435-440.
    Abstract     Related articles   

  153. MATSUO T, Miyata Y, Mitsunari K, Yasuda T, et al
    Pathological significance and prognostic implications of heme oxygenase 1 expression in non-muscle-invasive bladder cancer: Correlation with cell proliferation, angiogenesis, lymphangiogenesis and expression of VEGFs and COX-2.
    Oncol Lett. 2017;13:275-280.
    Abstract     Related articles   

  154. MUKHERJEE N, Cardenas E, Bedolla R, Ghosh R, et al
    SETD6 regulates NF-kappaB signaling in urothelial cell survival: Implications for bladder cancer.
    Oncotarget. 2017 Jan 19. doi: 10.18632/oncotarget.14750.
    Abstract     Related articles   

  155. RUSSO V, Inglese C, Avallone L, Roperto F, et al
    Sigma 2 receptor expression levels in blood and bladder from healthy and bladder cancer cattle.
    Vet Comp Oncol. 2017 Jan 25. doi: 10.1111/vco.12295.
    Abstract     Related articles   

  156. WAN YP, Xi M, He HC, Wan S, et al
    Expression and Clinical Significance of SOX9 in Renal Cell Carcinoma, Bladder Cancer and Penile Cancer.
    Oncol Res Treat. 2017;40.
    Abstract     Related articles   

  157. ROBINSON AG, Wei X, Vera-Badillo FE, Mackillop WJ, et al
    Palliative Chemotherapy for Bladder Cancer: Treatment Delivery and Outcomes in the General Population.
    Clin Genitourin Cancer. 2016 Dec 29. pii: S1558-7673(16)30371.
    Abstract     Related articles   

  158. SHEPHARD RJ
    Physical activity in the prevention and management of bladder cancer.
    J Sports Med Phys Fitness. 2017 Jan 23. doi: 10.23736/S0022-4707.17.06830.
    Abstract     Related articles   

  159. ZHANG Z, Zeng S, Zhao J, Lu X, et al
    A Pilot Study of Vela Laser for En Bloc Resection of Papillary Bladder Cancer.
    Clin Genitourin Cancer. 2016 Jun 23. pii: S1558-7673(16)30150.
    Abstract     Related articles   

  160. JIANG Z, Zhang Y, Cao R, Li L, et al
    MiR-5195-3p inhibits proliferation and invasion of human bladder cancer cells by directly targeting oncogene KLF5.
    Oncol Res. 2017 Jan 20. doi: 10.3727/096504016X14831120463349.
    Abstract     Related articles   

  161. LU J, Zheng X, Li F, Yu Y, et al
    Tunneling nanotubes promote intercellular mitochondria transfer followed by increased invasiveness in bladder cancer cells.
    Oncotarget. 2017 Jan 17. doi: 10.18632/oncotarget.14695.
    Abstract     Related articles   

  162. TAKAI T, Yoshikawa Y, Inamoto T, Minami K, et al
    A Novel Combination RNAi toward Warburg Effect by Replacement with miR-145 and Silencing of PTBP1 Induces Apoptotic Cell Death in Bladder Cancer Cells.
    Int J Mol Sci. 2017;18.
    Abstract     Related articles   

  163. FANTONY JJ, Longo TA, Gopalakrishna A, Owusu R, et al
    Urinary NID2 and TWIST1 methylation to augment conventional urine cytology for the detection of bladder cancer.
    Cancer Biomark. 2017 Jan 13. doi: 10.3233/CBM-160261.
    Abstract     Related articles   

  164. CHA KH, Hadjiiski LM, Samala RK, Chan HP, et al
    Bladder Cancer Segmentation in CT for Treatment Response Assessment: Application of Deep-Learning Convolution Neural Network-A Pilot Study.
    Tomography. 2016;2:421-429.
    Abstract     Related articles   

  165. TAKEUCHI H, Tokuyama N, Kuroda I, Aoyagi T, et al
    Annular rectal constriction caused by infiltrating bladder cancer: A case report.
    Mol Clin Oncol. 2016;5:842-844.
    Abstract     Related articles   

  166. LI R, Choi W, Ferguson Rd JE, Metcalfe MJ, et al
    New discoveries in the molecular landscape of bladder cancer.
    F1000Res. 2016;5:2875.
    Abstract     Related articles   

  167. SHENG Z, Liu Y, Qin C, Liu Z, et al
    Involvement of cancer-derived IgG in the proliferation, migration and invasion of bladder cancer cells.
    Oncol Lett. 2016;12:5113-5121.
    Abstract     Related articles   

  168. FALTAS BM, Tagawa ST
    Immune-checkpoint blockade in cisplatin-ineligible patients with urothelial cancer.
    Lancet. 2017;389:6-7.
    Abstract     Related articles   

  169. LIU J, Li D, Cao L, Wang Z, et al
    Elevated preoperative plasma fibrinogen level is an independent predictor of malignancy and advanced stage disease in patients with bladder urothelial tumors.
    Int J Surg. 2016;36.
    Abstract     Related articles   

  170. DURING VA, Sole GM, Jha AK, Anderson JA, et al
    Prediction of histological stage based on cytoscopic appearances of newly diagnosed bladder tumours.
    Ann R Coll Surg Engl. 2016;98:547-551.
    Abstract     Related articles   

  171. SHARMA A, Sharma S, Patnaik N, Pradhan D, et al
    Cytomorphologic and Immunophenotypic Profile of a Cohort of Small Cell Carcinoma of the Urinary Bladder.
    Acta Cytol. 2016;60:475-480.
    Abstract     Related articles   

  172. MOROZUMI K, Namiki S, Nakamura Y
    [Inflammatory Myofibroblastic Tumor of the Bladder : A Case Report].
    Hinyokika Kiyo. 2016;62:427-30.
    Abstract     Related articles   

  173. GAYE AM, Doh K, Thiam I, Bentefouet L, et al
    [Schistosomiasis and cancer: A fortuitous association or relationships cause and effect].
    Bull Cancer. 2016;103:806-7.
    Abstract     Related articles   

  174. WASHIO M, Mori M, Mikami K, Miki T, et al
    Risk Factors for Upper and Lower Urinary Tract Cancer Death in a Japanese Population: Findings from the Japan Collaborative Cohort Study for Evaluation of Cancer Risk (JACC Study).
    Asian Pac J Cancer Prev. 2016;17:3545-9.
    Abstract     Related articles   

  175. XIN Z, Zhao C, Huang T, Zhang Z, et al
    Intestinal metaplasia of the bladder in 89 patients: a study with emphasis on long-term outcome.
    BMC Urol. 2016;16:24.
    Abstract     Related articles   

  176. ALRASHIDY M, Atef A, Baky TA
    Immunohistochemical Differentiation between Urothelial Papillomas and Papillary Neoplasms of Low Malignant Potential of the Urinary Bladder.
    Asian Pac J Cancer Prev. 2016;17:1769-72.
    Abstract     Related articles   

  177. ALBERTI C
    Whyever bladder tissue engineering clinical applications still remain unusual even though many intriguing technological advances have been reached?
    G Chir. 2016;37:6-12.
    Abstract     Related articles   

  178. ALEXANDER RE, Wang L, Lopez-Beltran A, Emerson RE, et al
    Human papillomavirus (HPV)-induced neoplasia in the urinary bladder: a missing link?
    Histol Histopathol. 2016;31:595-600.
    Abstract     Related articles   

  179. YE W, Chen C, Gao Y, Zheng ZS, et al
    Overexpression of SLC34A2 is an independent prognostic indicator in bladder cancer and its depletion suppresses tumor growth via decreasing c-Myc expression and transcriptional activity.
    Cell Death Dis. 2017;8:e2581.
    Abstract     Related articles   

  180. ZARGAR H, Almassi N, Kovac E, Ercole C, et al
    Change in Psoas Muscle Volume as a Predictor of Outcomes in Patients Treated with Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer.
    Bladder Cancer. 2017;3:57-63.
    Abstract     Related articles   

  181. MATULEWICZ RS, DeLancey JO, Pavey E, Schaeffer EM, et al
    Dipstick Urinalysis as a Test for Microhematuria and Occult Bladder Cancer.
    Bladder Cancer. 2017;3:45-49.
    Abstract     Related articles   

  182. VON RUNDSTEDT FC, Mata DA, Kryvenko ON, Shah AA, et al
    Utility of Clinical Risk Stratification in the Selection of Muscle-Invasive Bladder Cancer Patients for Neoadjuvant Chemotherapy: A Retrospective Cohort Study.
    Bladder Cancer. 2017;3:35-44.
    Abstract     Related articles   

  183. BAUMANN BC, Sargos P, Eapen LJ, Efstathiou JA, et al
    The Rationale for Post-Operative Radiation in Localized Bladder Cancer.
    Bladder Cancer. 2017;3:19-30.
    Abstract     Related articles   

  184. FRANTZI M, Vlahou A
    Ten Years of Proteomics in Bladder Cancer: Progress and Future Directions.
    Bladder Cancer. 2017;3:1-18.
    Abstract     Related articles   

  185. VERMA A, Kapoor R, Mittal RD
    Cluster of Differentiation 44 (CD44) Gene Variants: A Putative Cancer Stem Cell Marker in Risk Prediction of Bladder Cancer in North Indian Population.
    Indian J Clin Biochem. 2017;32:74-83.
    Abstract     Related articles   

  186. HADAMI K, Ameziane El Hassani R, Ameur A, Dakka N, et al
    Association between GPX1 Pro189Leu polymorphism and the occurrence of bladder cancer in Morocco.
    Cell Mol Biol (Noisy-le-grand). 2016;62:38-43.
    Abstract     Related articles   

  187. WILDE L, Ali SM, Solomides CC, Ross JS, et al
    Response to Pembrolizumab in a Patient With Chemotherapy Refractory Bladder Cancer With Small Cell Variant Histology: A Case Report and Review of the Literature.
    Clin Genitourin Cancer. 2016 Dec 22. pii: S1558-7673(16)30358.
    Abstract     Related articles   

  188. WU Y, Zhang X, Li Z, Yan H, et al
    Formononetin inhibits human bladder cancer cell proliferation and invasiveness via regulation of miR-21 and PTEN.
    Food Funct. 2017 Jan 31. doi: 10.1039/c6fo01535.
    Abstract     Related articles   

  189. CUI X, Shen D, Kong C, Zhang Z, et al
    NF-kappaB suppresses apoptosis and promotes bladder cancer cell proliferation by upregulating survivin expression in vitro and in vivo.
    Sci Rep. 2017;7:40723.
    Abstract     Related articles   

  190. LEE D, Yoo S, You D, Hong B, et al
    Lymph node density vs. the American Joint Committee on Cancer TNM nodal staging system in node-positive bladder cancer in patients undergoing extended or super-extended pelvic lymphadenectomy.
    Urol Oncol. 2017 Jan 27. pii: S1078-1439(16)30366.
    Abstract     Related articles   

  191. TAO S, Meng S, Zheng X, Xie L, et al
    ATM participates in the regulation of viability and cell cycle via ellipticine in bladder cancer.
    Mol Med Rep. 2017 Jan 24. doi: 10.3892/mmr.2017.6141.
    Abstract     Related articles   

  192. BUTTIGLIERO C, Tucci M, Vignani F, Scagliotti GV, et al
    Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancer.
    Cancer Treat Rev. 2017;54:1-9.
    Abstract     Related articles   

  193. ASAI K, Murata M, Saso K, Yamada M, et al
    [A Case of Metachronous Liver Metastases of Gall Bladder Cancer Successfully Treated by Liver Resection].
    Gan To Kagaku Ryoho. 2016;43:2092-2094.
    Abstract     Related articles   

  194. ABBAOUI B, Telu KH, Lucas CR, Thomas-Ahner JM, et al
    The impact of cruciferous vegetable isothiocyanates on histone acetylation and histone phosphorylation in bladder cancer.
    J Proteomics. 2017 Jan 26. pii: S1874-3919(17)30026.
    Abstract     Related articles   

  195. LIU D, Plimack ER, Hoffman-Censits J, Garraway LA, et al
    Clinical Validation of Chemotherapy Response Biomarker ERCC2 in Muscle-Invasive Urothelial Bladder Carcinoma.
    JAMA Oncol. 2016;2:1094-6.
    Abstract     Related articles   

  196. LI J, Wang P, Wang B
    Unique Case Report of Pineal Gland Metastasis From Bladder Carcinoma.
    Medicine (Baltimore). 2016;95:e3622.
    Abstract     Related articles   

  197. LIEDBERG F, Hoglund M
    [Not Available].
    Lakartidningen. 2016;113.
    Abstract     Related articles   

  198. OGAWA Y
    Chemical poisonings, new and old.
    Ind Health. 2016;54:99-100.
    Abstract     Related articles   

  199. ALLEEMUDDER DI, Alleemudder AI, Harry D, Fountain S, et al
    Bladder squamous cell carcinoma in pregnancy.
    J Obstet Gynaecol. 2016;36:388-9.
    Abstract     Related articles   

  200. XU WJ, Wen LP, Jiang XX, Ye LY, et al
    Association between N-Acetyltransferase 2 Polymorphism and Bladder Cancer Risk: a Meta-Analysis in a Single Ethnic Group.
    Clin Lab. 2017;63:287-293.
    Abstract     Related articles   

  201. HUI K, Gao Y, Huang J, Xu S, et al
    RASAL2, a RAS GTPase-activating protein, inhibits stemness and epithelial-mesenchymal transition via MAPK/SOX2 pathway in bladder cancer.
    Cell Death Dis. 2017;8:e2600.
    Abstract     Related articles   

  202. PANEBIANCO V, De Berardinis E, Barchetti G, Simone G, et al
    An evaluation of morphological and functional multi-parametric MRI sequences in classifying non-muscle and muscle invasive bladder cancer.
    Eur Radiol. 2017 Feb 8. doi: 10.1007/s00330-017-4758.
    Abstract     Related articles   

  203. YANG Y, Li C, Li H, Wu M, et al
    Differential sensitivities of bladder cancer cell lines to resveratol are unrelated to its metabolic profile.
    Oncotarget. 2017 Feb 2. doi: 10.18632/oncotarget.15041.
    Abstract     Related articles   

  204. DONG Q, Fu L, Zhao Y, Tan S, et al
    Derlin-1 overexpression confers poor prognosis in muscle invasive bladder cancer and contributes to chemoresistance and invasion through PI3K/AKT and ERK/MMP signaling.
    Oncotarget. 2017 Feb 2. doi: 10.18632/oncotarget.15001.
    Abstract     Related articles   


  205. Bladder cancer: Risk factors, diagnosis, and management.
    Nurse Pract. 2017;42:33-34.
    Abstract     Related articles   

  206. SHIN SS, Won SY, Noh DH, Hwang B, et al
    Morin Inhibits Proliferation, Migration, and Invasion of Bladder Cancer EJ Cells via Modulation of Signaling Pathways, Cell Cycle Regulators, and Transcription Factor-Mediated MMP-9 Expression.
    Drug Dev Res. 2017 Feb 8. doi: 10.1002/ddr.21377.
    Abstract     Related articles   

  207. FARLING KB
    Bladder cancer: Risk factors, diagnosis, and management.
    Nurse Pract. 2017;42:26-33.
    Abstract     Related articles   

  208. LEE M, Shin SJ, Oh YT, Jung DC, et al
    Non-contrast magnetic resonance imaging for bladder cancer: fused high b value diffusion-weighted imaging and T2-weighted imaging helps evaluate depth of invasion.
    Eur Radiol. 2017 Feb 6. doi: 10.1007/s00330-017-4759.
    Abstract     Related articles   

  209. PIRZADA MT, Ghauri R, Ahmed MJ, Shah MF, et al
    Outcomes of BCG Induction in High-Risk Non-Muscle-Invasive Bladder Cancer Patients (NMIBC): A Retrospective Cohort Study.
    Cureus. 2017;9:e957.
    Abstract     Related articles   

  210. WENG H, Zeng XT, Li S, Kwong JS, et al
    Tea Consumption and Risk of Bladder Cancer: A Dose-Response Meta-Analysis.
    Front Physiol. 2017;7:693.
    Abstract     Related articles   

  211. OLKHOV-MITSEL E, Savio AJ, Kron KJ, Pethe VV, et al
    Epigenome-Wide DNA Methylation Profiling Identifies Differential Methylation Biomarkers in High-Grade Bladder Cancer.
    Transl Oncol. 2017;10:168-177.
    Abstract     Related articles   

  212. KANG M, Lee KH, Lee HS, Jeong CW, et al
    Concurrent Autophagy Inhibition Overcomes the Resistance of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Human Bladder Cancer Cells.
    Int J Mol Sci. 2017;18.
    Abstract     Related articles   

  213. MANIKANDAN R, Rodriguez O, Parada R, Palou Redorta J, et al
    Nonmuscle-invasive bladder cancer: what's changing and what has changed.
    Urologia. 2017;84:1-8.
    Abstract     Related articles   

  214. YANG D, Huo Q, Luan T, Wang J, et al
    Effects of Angiotensin Inhibitor Valsartan on the Expression of the Angiotensin II 1 Receptor, Matrix Metalloproteinases -2 and -9 in Human Bladder Cancer Cell Lines.
    Clin Lab. 2016;62:1435-1442.
    Abstract     Related articles   

  215. THONG AE, Petruzella S, Orlow I, Zabor EC, et al
    Accuracy of Self-reported Smoking Exposure Among Bladder Cancer Patients Undergoing Surveillance at a Tertiary Referral Center.
    Eur Urol Focus. 2016;2:441-444.
    Abstract     Related articles   

  216. FEBER A, Dhami P, Dong L, de Winter P, et al
    UroMark-a urinary biomarker assay for the detection of bladder cancer.
    Clin Epigenetics. 2017;9:8.
    Abstract     Related articles   

  217. KANG M, Balpukov UJ, Jeong CW, Kwak C, et al
    Can the Preoperative Neutrophil-to-Lymphocyte Ratio Significantly Predict the Conditional Survival Probability in Muscle-invasive Bladder Cancer Patients Undergoing Radical Cystectomy?
    Clin Genitourin Cancer. 2017 Jan 9. pii: S1558-7673(16)30324.
    Abstract     Related articles   

  218. ZHOU Y, Song R, Ma C, Zhou L, et al
    Discovery and validation of potential urinary biomarkers for bladder cancer diagnosis using a pseudotargeted GC-MS metabolomics method.
    Oncotarget. 2017 Feb 1. doi: 10.18632/oncotarget.14988.
    Abstract     Related articles   

  219. CHEN M, Li J, Zhuang C, Cai Z, et al
    Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancer.
    Oncotarget. 2017 Feb 1. doi: 10.18632/oncotarget.14945.
    Abstract     Related articles   

  220. NAKAMURA T, Noma Y, Sakurai Y, Harashima H, et al
    Modifying Cationic Liposomes with Cholesteryl-PEG Prevents Their Aggregation in Human Urine and Enhances Cellular Uptake by Bladder Cancer Cells.
    Biol Pharm Bull. 2017;40:234-237.
    Abstract     Related articles   

  221. RAMAN SP, Fishman EK
    Upper and Lower Tract Urothelial Imaging Using Computed Tomography Urography.
    Radiol Clin North Am. 2017;55:225-241.
    Abstract     Related articles   

  222. STROJAN FLEZAR M, Srebotnik-Kirbis I, Gutnik H
    Use of vimentin immunocytochemical staining for evaluation of atypical cells in voided urine samples.
    Diagn Cytopathol. 2017;45:85-90.
    Abstract     Related articles   

  223. LI X, Liu S
    Suppression of HBXIP Reduces Cell Proliferation, Migration and Invasion In Vitro, and Tumorigenesis In Vivo in Human Urothelial Carcinoma of the Bladder.
    Cancer Biother Radiopharm. 2016;31:311-316.
    Abstract     Related articles   

  224. SHEN KH, Li CF, Chien LH, Huang CH, et al
    Role of galectin-1 in urinary bladder urothelial carcinoma cell invasion through the JNK pathway.
    Cancer Sci. 2016;107:1390-1398.
    Abstract     Related articles   

  225. DE ALMEIDA EF, Abdalla TE, Arrym TP, de Oliveira Delgado P, et al
    Plasma and urine DNA levels are related to microscopic hematuria in patients with bladder urothelial carcinoma.
    Clin Biochem. 2016;49.
    Abstract     Related articles   

  226. KURTZHALTS K, Gee ME, Feuz L, Krajewski KC, et al
    Evidence of a clinically significant interaction between warfarin and intravesical gemcitabine.
    Am J Health Syst Pharm. 2016;73:1508-11.
    Abstract     Related articles   

  227. LIN DM, Park JW, Gattuso P
    Metastatic Signet-Ring Cell Carcinoma of the Bladder in Cerebrospinal Fluid.
    Diagn Cytopathol. 2017;45:73-76.
    Abstract     Related articles   

  228. ZHAO XR, Gao C, Zhang Y, Kong L, et al
    Urachal adenocarcinoma that metastasized to breast was misinterpreted as primary breast mucinous carcinoma: A rare case report and literature review.
    Medicine (Baltimore). 2016;95:e4612.
    Abstract     Related articles   

  229. KIM TK, Xu ML, Podoltsev NA, Prebet T, et al
    Single agent blinatumumab as frontline therapy for an 85-year-old patient with B cell precursor acute lymphoblastic leukemia.
    Ann Hematol. 2016.
    Abstract     Related articles   

  230. XIN J, Lai HP, Lin SK, Zhang QQ, et al
    Bladder leiomyoma presenting as dyspareunia: Case report and literature review.
    Medicine (Baltimore). 2016;95:e3971.
    Abstract     Related articles   

  231. ALBERTI C
    Urology pertinent neuroendocrine tumors: focusing on renal pelvis, bladder, prostate located sympathetic functional paragangliomas.
    G Chir. 2016;37:55-60.
    Abstract     Related articles   

  232. GOLDMAN H, Sowter S
    Urachal adenocarcinoma incidentally discovered in a young woman at elective caesarean section.
    BMJ Case Rep. 2016;2016.
    Abstract     Related articles   

  233. KONG YG, Kim JY, Yu J, Lim J, et al
    Efficacy and Safety of Stroke Volume Variation-Guided Fluid Therapy for Reducing Blood Loss and Transfusion Requirements During Radical Cystectomy: A Randomized Clinical Trial.
    Medicine (Baltimore). 2016;95:e3685.
    Abstract     Related articles   

  234. GONZALEZ-DEL VECCHIO M, Ruiz-Serrano MJ, Gijon P, Sanchez-Somolinos M, et al
    Differences between a probable and proven BCG infection following intravesical instillations: 16 years experience in a tertiary care hospital.
    Diagn Microbiol Infect Dis. 2016;85:338-43.
    Abstract     Related articles   

  235. LI WM, Wei YC, Huang CN, Ke HL, et al
    Matrix metalloproteinase-11 as a marker of metastasis and predictor of poor survival in urothelial carcinomas.
    J Surg Oncol. 2016;113:700-7.
    Abstract     Related articles   

  236. WENG WC, Huang YH, Yang SF, Wang SS, et al
    Effect of CD44 gene polymorphisms on risk of transitional cell carcinoma of the urinary bladder in Taiwan.
    Tumour Biol. 2016;37:6971-7.
    Abstract     Related articles   

  237. SCHUBERT M, Junker K, Heinzelmann J
    Prognostic and predictive miRNA biomarkers in bladder, kidney and prostate cancer: Where do we stand in biomarker development?
    J Cancer Res Clin Oncol. 2016;142:1673-95.
    Abstract     Related articles   

  238. STEINESTEL K, Eder S, Ehinger K, Schneider J, et al
    The small conductance calcium-activated potassium channel 3 (SK3) is a molecular target for Edelfosine to reduce the invasive potential of urothelial carcinoma cells.
    Tumour Biol. 2016;37:6275-83.
    Abstract     Related articles   

  239. NOLAN CP, Forde EJ
    A review of the use of fiducial markers for image-guided bladder radiotherapy.
    Acta Oncol. 2016;55:533-8.
    Abstract     Related articles   

  240. JAEGER MT, Siemens DR, Wei X, Peng P, et al
    Association Between Anesthesiology Volumes and Early and Late Outcomes After Cystectomy for Bladder Cancer: A Population-Based Study.
    Anesth Analg. 2017 Feb 15. doi: 10.1213/ANE.0000000000001781.
    Abstract     Related articles   

  241. ZHAN L, Zhang B, Tan Y, Yang C, et al
    Quantitative assessment of the relationship between RASSF1A gene promoter methylation and bladder cancer (PRISMA).
    Medicine (Baltimore). 2017;96:e6097.
    Abstract     Related articles   

  242. SHAO YH, Kao CC, Tang SH, Cha TL, et al
    Unusual presentation of direct intraperitoneal metastases complicated with massive ascites from plasmacytoid variant of bladder cancer and adenocarcinoma of colon: A case report and literature review.
    Medicine (Baltimore). 2017;96:e5816.
    Abstract     Related articles   

  243. FU D, Li P, Cheng W, Tian F, et al
    Impact of vascular endothelial growth factor gene-gene and gene-smoking interaction and haplotype combination on bladder cancer risk in Chinese population.
    Oncotarget. 2017 Feb 11. doi: 10.18632/oncotarget.15287.
    Abstract     Related articles   

  244. KISS B, Wyatt AW, Douglas J, Skuginna V, et al
    Her2 alterations in muscle-invasive bladder cancer: Patient selection beyond protein expression for targeted therapy.
    Sci Rep. 2017;7:42713.
    Abstract     Related articles   

  245. WANG CY, Hua R, Liu L, Zhan X, et al
    Immunotherapy against metastatic bladder cancer by combined administration of granulocyte macrophage-colony stimulating factor and interleukin-2 surface modified MB49 bladder cancer stem cells vaccine.
    Cancer Med. 2017 Feb 16. doi: 10.1002/cam4.1023.
    Abstract     Related articles   

  246. MATSUDA T, Okuyama A
    Incidence rate for bladder cancer in Japanese in Japan and in the United States from the Cancer Incidence in Five Continents.
    Jpn J Clin Oncol. 2017 Feb 16:1-2. doi: 10.1093.
    Abstract     Related articles   

  247. PEI Z, Du X, Song Y, Fan L, et al
    Down-regulation of lncRNA CASC2 promotes cell proliferation and metastasis of bladder cancer by activation of the Wnt/beta-catenin signaling pathway.
    Oncotarget. 2017 Feb 9. doi: 10.18632/oncotarget.15210.
    Abstract     Related articles   

  248. ZHANG X, Xu X, Tian Q, Li B, et al
    Radiomics assessment of bladder cancer grade using texture features from diffusion-weighted imaging.
    J Magn Reson Imaging. 2017 Feb 15. doi: 10.1002/jmri.25669.
    Abstract     Related articles   

  249. DOMINGOS-PEREIRA S, Cesson V, Chevalier MF, Derre L, et al
    Preclinical efficacy and safety of the Ty21a vaccine strain for intravesical immunotherapy of non-muscle-invasive bladder cancer.
    Oncoimmunology. 2016;6:e1265720.
    Abstract     Related articles   

  250. SMITH SG, Baltz JL, Koppolu BP, Ravindranathan S, et al
    Immunological mechanisms of intravesical chitosan/interleukin-12 immunotherapy against murine bladder cancer.
    Oncoimmunology. 2016;6:e1259050.
    Abstract     Related articles   

  251. BETTIGA A, Aureli M, Colciago G, Murdica V, et al
    Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolism.
    Sci Rep. 2017;7:42157.
    Abstract     Related articles   

  252. GUPTA S, De S, Leekha N, Sahay SC, et al
    Chemoradiation for organ preservation in the treatment of muscle invasive bladder cancer: Our Institutional Experience.
    Gulf J Oncolog. 2016;1:55-60.
    Abstract     Related articles   

  253. RICHARD PO, Ahmad AE, Bashir S, Hamilton RJ, et al
    Effect of statins as a secondary chemopreventive agent among individuals with non-muscle-invasive bladder cancer: A population-based analysis.
    Urol Oncol. 2017 Feb 9. pii: S1078-1439(16)30417.
    Abstract     Related articles   

  254. TRAINOR S, Choudhury A, Huddart R, Kiltie AE, et al
    The National Institute for Health and Care Excellence (NICE) Guidance on Bladder Cancer; a Step in the Right Direction?
    Clin Oncol (R Coll Radiol). 2017 Feb 9. pii: S0936-6555(17)30068.
    Abstract     Related articles   

  255. BUSETTO GM, Ferro M, Del Giudice F, Antonini G, et al
    The Prognostic Role of Circulating Tumor Cells (CTC) in High-risk Non-muscle-invasive Bladder Cancer.
    Clin Genitourin Cancer. 2017 Jan 18. pii: S1558-7673(17)30011.
    Abstract     Related articles   

  256. SARGOS P, Larre S, Chapet O, Latorzeff I, et al
    [Adjuvant radiotherapy for bladder cancer in patients with risk of locoregional recurrence: Who, what and how?]
    Cancer Radiother. 2017 Feb 7. pii: S1278-3218(17)30004.
    Abstract     Related articles   

  257. DONG F, Xu T, Shen Y, Zhong S, et al
    Dysregulation of miRNAs in bladder cancer: altered expression with aberrant biogenesis procedure.
    Oncotarget. 2017 Feb 7. doi: 10.18632/oncotarget.15173.
    Abstract     Related articles   

  258. REZAEI G, Habibi-Anbouhi M, Mahmoudi M, Azadmanesh K, et al
    Development of anti-CD47 single-chain variable fragment targeted magnetic nanoparticles for treatment of human bladder cancer.
    Nanomedicine (Lond). 2017 Feb 10. doi: 10.2217/nnm-2016-0302.
    Abstract     Related articles   

  259. UKAI R, Hashimoto K, Nakayama H, Iwamoto T, et al
    Lymphovascular invasion predicts poor prognosis in high-grade pT1 bladder cancer patients who underwent transurethral resection in one piece.
    Jpn J Clin Oncol. 2017 Feb 10:1-6. doi: 10.1093.
    Abstract     Related articles   


  260. Nivolumab Gets FDA Nod for Bladder Cancer.
    Cancer Discov. 2017 Feb 9. doi: 10.1158/2159-8290.CD-NB2017.
    Abstract     Related articles   

  261. AOUN F, El Rassy E, Peltier A
    Bladder cancer immunotherapy: swinging for the fences.
    Future Oncol. 2017 Feb 10. doi: 10.2217/fon-2017-0013.
    Abstract     Related articles   

  262. SOLINAS C, Chanza NM, Awada A, Scartozzi M, et al
    The immune infiltrate in prostate, bladder and testicular tumors: An old friend for new challenges.
    Cancer Treat Rev. 2017;53:138-145.
    Abstract     Related articles   

  263. SU X, Fang D, Li X, Xiong G, et al
    The Influence of Tumor Size on Oncologic Outcomes for Patients with Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy.
    Biomed Res Int. 2016;2016:4368943.
    Abstract     Related articles   

  264. PATEL R, Bock M, Polotti CF, Elsamra S, et al
    Pharmacokinetic drug evaluation of atezolizumab for the treatment of locally advanced or metastatic urothelial carcinoma.
    Expert Opin Drug Metab Toxicol. 2017;13:225-232.
    Abstract     Related articles   

  265. GRAPIN-DAGORNO C, Peycelon M, Philippe-Chomette P, Berrebi D, et al
    [Urothelial tumors in children].
    Bull Cancer. 2017;104:195-201.
    Abstract     Related articles   

  266. MANLEY KV, Hubbard R, Swallow D, Finch W, et al
    Risk factors for development of primary bladder squamous cell carcinoma.
    Ann R Coll Surg Engl. 2017;99:155-160.
    Abstract     Related articles   

  267. GRANADOS R, Duarte JA, Corrales T, Camarmo E, et al
    Applying the Paris System for Reporting Urine Cytology Increases the Rate of Atypical Urothelial Cells in Benign Cases: A Need for Patient Management Recommendations.
    Acta Cytol. 2017;61:71-76.
    Abstract     Related articles   

  268. BREYER J, Wirtz RM, Laible M, Schlombs K, et al
    ESR1, ERBB2, and Ki67 mRNA expression predicts stage and grade of non-muscle-invasive bladder carcinoma (NMIBC).
    Virchows Arch. 2016;469:547-552.
    Abstract     Related articles   

  269. SHANMUGAM V, Geraghty B, DeSimone R, Hoda RS, et al
    Diagnostic value of positive urinary cytology in the detection of recurrent urothelial carcinoma: 10-Year Experience at the Papanicolaou Cytology Laboratory.
    Diagn Cytopathol. 2016 Sep 26. doi: 10.1002/dc.23598.
    Abstract     Related articles   

  270. PRABHU B, Balakrishnan D, Sundaresan S
    Antiproliferative and anti-inflammatory properties of diindolylmethane and lupeol against N-butyl-N-(4-hydroxybutyl) nitrosamine induced bladder carcinogenesis in experimental rats.
    Hum Exp Toxicol. 2016;35:685-92.
    Abstract     Related articles   

  271. DE OLIVEIRA DT, Savio AL, Marcondes JP, Barros TM, et al
    Cytotoxic and toxicogenomic effects of silibinin in bladder cancer cells with different TP53 status.
    J Biosci. 2017;42:91-101.
    Abstract     Related articles   

  272. TANG M, Zhao Y, Liu N, Chen E, et al
    Overexpression of HepaCAM inhibits bladder cancer cell proliferation and viability through the AKT/FoxO pathway.
    J Cancer Res Clin Oncol. 2017 Feb 22. doi: 10.1007/s00432-016-2333.
    Abstract     Related articles   

  273. TEKE K, Ozkan TA, Cebeci OO, Yilmaz H, et al
    Preventive effect of intravesical ozone supplementation on n-methyl-n-nitrosourea-induced non-muscle invasive bladder cancer in male rats.
    Exp Anim. 2017 Feb 22. doi: 10.1538/expanim.16-0093.
    Abstract     Related articles   

  274. LER LD, Ghosh S, Chai X, Thike AA, et al
    Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2.
    Sci Transl Med. 2017;9.
    Abstract     Related articles   

  275. JIANG G, Huang C, Li J, Huang H, et al
    Role of STAT3 and FOXO1 in the divergent therapeutic responses of non-metastatic and metastatic bladder cancer cells to miR-145.
    Mol Cancer Ther. 2017 Feb 21. pii: molcanther.0631.2016.
    Abstract     Related articles   

  276. GUO J, Cao R, Yu X, Xiao Z, et al
    MicroRNA-223-3p inhibits human bladder cancer cell migration and invasion.
    Tumour Biol. 2017;39:1010428317691678.
    Abstract     Related articles   

  277. ZHI Y, Ji H, Pan J, He P, et al
    Downregulated XPA promotes carcinogenesis of bladder cancer via impairment of DNA repair.
    Tumour Biol. 2017;39:1010428317691679.
    Abstract     Related articles   

  278. LI P, Yang X, Cheng Y, Zhang X, et al
    MicroRNA-218 Increases the Sensitivity of Bladder Cancer to Cisplatin by Targeting Glut1.
    Cell Physiol Biochem. 2017;41:921-932.
    Abstract     Related articles   

  279. POZZAR RA, Berry DL
    Gender Differences in Bladder Cancer Treatment Decision Making.
    Oncol Nurs Forum. 2017;44:204-209.
    Abstract     Related articles   


  280. Atezolizumab (Tecentriq) for bladder cancer and NSCLC.
    Med Lett Drugs Ther. 2017;59:e40-e41.
    Abstract     Related articles   

  281. SIDAWAY P
    Bladder cancer: Mutations in DNA-damage-repair pathways confer platinum sensitivity.
    Nat Rev Urol. 2017 Feb 14. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  282. DEMIRDAG C, Citgez S, Talat Z, Onal B, et al
    Management of Bladder Cancer After Renal Transplantation.
    Transplant Proc. 2017;49:293-296.
    Abstract     Related articles   

  283. EL-ASHMAWY NE, Khedr EG, El-Bahrawy HA, Al-Tantawy SM, et al
    Chemopreventive effect of omega-3 polyunsaturated fatty acids and atorvastatin in rats with bladder cancer.
    Tumour Biol. 2017;39:1010428317692254.
    Abstract     Related articles   

  284. XU X, Liu Y, Zhang X, Tian Q, et al
    Preoperative prediction of muscular invasiveness of bladder cancer with radiomic features on conventional MRI and its high-order derivative maps.
    Abdom Radiol (NY). 2017 Feb 20. doi: 10.1007/s00261-017-1079.
    Abstract     Related articles   

  285. CANYILMAZ E, Yoney A, Serdar L, Uslu GH, et al
    Corrigendum to "Long-term results of a concomitant boost radiotherapy technique for elderly patients with muscle-invasive bladder cancer" [J Geriatr Oncol6 (4) (July 2015)316-323].
    J Geriatr Oncol. 2017 Feb 16. pii: S1879-4068(17)30026.
    Abstract     Related articles   

  286. BELLMUNT J, Powles T, Vogelzang NJ
    A review on the evolution of PD-1/PD-L1 immunotherapy for bladder cancer: The future is now.
    Cancer Treat Rev. 2017;54:58-67.
    Abstract     Related articles   

  287. ABUFARAJ M, Shariat SF, Haitel A, Moschini M, et al
    Prognostic role of N-cadherin expression in patients with non-muscle-invasive bladder cancer.
    Urol Oncol. 2017 Feb 14. pii: S1078-1439(17)30014.
    Abstract     Related articles   

  288. EDMONDSON AJ, Birtwistle JC, Catto JW, Twiddy M, et al
    The patients' experience of a bladder cancer diagnosis: a systematic review of the qualitative evidence.
    J Cancer Surviv. 2017 Feb 17. doi: 10.1007/s11764-017-0603.
    Abstract     Related articles   

  289. LIN T, Yuan A, Zhao X, Lian H, et al
    Self-assembled tumor-targeting hyaluronic acid nanoparticles for photothermal ablation in orthotopic bladder cancer.
    Acta Biomater. 2017 Feb 14. pii: S1742-7061(17)30126.
    Abstract     Related articles   

  290. INGELMO-TORRES M, Lozano JJ, Izquierdo L, Carrion A, et al
    Urinary cell microRNA-based prognostic classifier for non-muscle invasive bladder cancer.
    Oncotarget. 2017 Feb 14. doi: 10.18632/oncotarget.15315.
    Abstract     Related articles   

  291. GENG J, Fan J, Wang Q, Zhang XP, et al
    Decreased REG1alpha expression suppresses growth, invasion and angiogenesis of bladder cancer.
    Eur J Surg Oncol. 2017 Feb 2. pii: S0748-7983(17)30108.
    Abstract     Related articles   

  292. PATEL S, Hafez O, Sexton WJ, Edwards DA, et al
    Perioperative Management of a Patient With an Intrathecal Drug Delivery Device Infusing Ziconotide: A Case Report.
    A A Case Rep. 2017;8:78-80.
    Abstract     Related articles   

  293. LIU Y, Bui MM, Xu B
    Urothelial Carcinoma With Squamous Differentiation Is Associated With High Tumor Stage and Pelvic Lymph-Node Metastasis.
    Cancer Control. 2017;24:78-82.
    Abstract     Related articles   

  294. COURTADE-SAIDI M, Aziza J, d'Aure D, Berard E, et al
    Immunocytochemical staining for p53 and Ki-67 helps to characterise urothelial cells in urine cytology.
    Cytopathology. 2016;27:456-464.
    Abstract     Related articles   

  295. VAN DE GOOR RM, Leunis N, van Hooren MR, Francisca E, et al
    Feasibility of electronic nose technology for discriminating between head and neck, bladder, and colon carcinomas.
    Eur Arch Otorhinolaryngol. 2017;274:1053-1060.
    Abstract     Related articles   

  296. XU X, Wei M, Liu Y, Liu X, et al
    A simple, fast, label-free colorimetric method for detection of telomerase activity in urine by using hemin-graphene conjugates.
    Biosens Bioelectron. 2017;87:600-606.
    Abstract     Related articles   

  297. KISHIMOTO N, Takao T, Kuribayashi S, Yamamichi G, et al
    The neutrophil-to-lymphocyte ratio as a predictor of intravesical recurrence in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.
    Int J Clin Oncol. 2017;22:153-158.
    Abstract     Related articles   

  298. NGUYEN D, Taheri D, Springer S, Cowan M, et al
    High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma.
    Virchows Arch. 2016;469:427-34.
    Abstract     Related articles   

  299. VOLLMER RT
    A Review of Outcomes for Stage Ta Bladder Tumors.
    Am J Clin Pathol. 2016;146:215-20.
    Abstract     Related articles   

  300. SMITH DM
    BCG-osis following intravesical BCG treatment leading to miliary pulmonary nodules, penile granulomas and a mycotic aortic aneurysm.
    BMJ Case Rep. 2016;2016.
    Abstract     Related articles   

  301. ZHOU AG, Liu Y, Cyr MS, Garver J, et al
    Role of Tetrasomy for the Diagnosis of Urothelial Carcinoma Using UroVysion Fluorescent In Situ Hybridization.
    Arch Pathol Lab Med. 2016;140:552-9.
    Abstract     Related articles   

  302. PHAM HV, Pantanowitz L, Liu Y
    Quantitative phase imaging to improve the diagnostic accuracy of urine cytology.
    Cancer Cytopathol. 2016;124:641-50.
    Abstract     Related articles   

  303. ROSENTHAL DL
    High apoptotic index in urine cytology is associated with high-grade urothelial carcinoma.
    Cancer Cytopathol. 2016;124:538-9.
    Abstract     Related articles   

  304. YANG CS, Chen S, Cramer HM, Wu HH, et al
    High apoptotic index in urine cytology is associated with high-grade urothelial carcinoma.
    Cancer Cytopathol. 2016;124:546-51.
    Abstract     Related articles   

  305. SANFRANCESCO J, McKenney JK, Leivo MZ, Gupta S, et al
    Sarcomatoid Urothelial Carcinoma of the Bladder: Analysis of 28 Cases With Emphasis on Clinicopathologic Features and Markers of Epithelial-to-Mesenchymal Transition.
    Arch Pathol Lab Med. 2016;140:543-51.
    Abstract     Related articles   

  306. ZHANG ML, Rosenthal DL, VandenBussche CJ
    The cytomorphological features of low-grade urothelial neoplasms vary by specimen type.
    Cancer Cytopathol. 2016;124:552-64.
    Abstract     Related articles   

  307. LOVDAHL S, Henriksson KM, Baghaei F, Holmstrom M, et al
    Malignancies in Swedish persons with haemophilia: a longitudinal registry study.
    Blood Coagul Fibrinolysis. 2016;27:631-6.
    Abstract     Related articles   

  308. BRIMO F, Auger M
    The atypical urothelial cell category in the Paris System: Strengthening the Achilles' heel.
    Cancer Cytopathol. 2016;124:305-6.
    Abstract     Related articles   

  309. BAGAYOGO T, Jakhal N, Slaoui A, Ziouziou I, et al
    [Neoplastic Vesico-vaginal Fistula (VVF) secondary to bladder cancer: a rare entity].
    Pan Afr Med J. 2016;25:59.
    Abstract     Related articles   

  310. KAMAT AM, Colombel M, Sundi D, Lamm D, et al
    BCG-unresponsive non-muscle-invasive bladder cancer: recommendations from the IBCG.
    Nat Rev Urol. 2017 Feb 21. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  311. YARMOSHCHUK SV, Kudryavtsev AS, Zeravin AA, Drobyazgin EA, et al
    [Robot-assisted cystprostatectomy for urinary bladder cancer (the first experience)].
    Urologiia. 2016;:132-135.
    Abstract     Related articles   

  312. PAVLOV VN, Pushkaryev AM, Safiullin RI, Kazikhinurov AA, et al
    [Experience with radical surgery for muscle-invasive bladder cancer in patients with end-stage chronic kidney disease].
    Urologiia. 2016;:124-127.
    Abstract     Related articles   

  313. ALYAEV YG, Pshikhachev AM, Perekalina AN
    [The risk of bladder cancer in patients with prostatic hyperplasia and strategies to manage this combination].
    Urologiia. 2016;:115-118.
    Abstract     Related articles   

  314. GLYBOCHKO PV, Alyaev YG, Pshikhachev AM, Sorokin NI, et al
    [Choosing treatment for patients with bladder cancer combined with prostatic hyperplasia].
    Urologiia. 2016;:92-96.
    Abstract     Related articles   

  315. ROLEVICH AI, Evmenenko AA
    [A systematic review and meta-analysis to assess the recurrence-free survival in non-muscle invasive bladder cancer after transurethral resection guided by 5-aminolevulinic acid-induced photodynamic diagnosis compared with white-light transurethral re
    Urologiia. 2016;:137-146.
    Abstract     Related articles   

  316. GLYBOCHKO PV, Alyaev JG, Potoldykova NV, Polyakovsky KA, et al
    [The role of telomerase activity in non-invasive diagnostics of bladder cancer].
    Urologiia. 2016;:76-81.
    Abstract     Related articles   

  317. MIKHAILENKO DS, Nemtsova MV
    [Point somatic mutations in bladder cancer: key carcinogenesis events, diagnostic markers and therapeutic targets].
    Urologiia. 2016;:100-105.
    Abstract     Related articles   

  318. ROLEVICH AI
    [The criteria of patient selection for repeat transurethral resection of non-muscle invasive bladder cancer].
    Urologiia. 2016;:71-76.
    Abstract     Related articles   

  319. KOSOVA IV
    [The role of viruses in the etiology of bladder cancer].
    Urologiia. 2016;:100-103.
    Abstract     Related articles   

  320. FENG S, Chen J, Zheng Y
    [Research progress on the effect of glucocorticoid receptor signaling pathways in bladder cancer].
    Zhejiang Da Xue Xue Bao Yi Xue Ban. 2016;45:655-660.
    Abstract     Related articles   

  321. YOSHIDA S, Takahara T, Kwee TC, Waseda Y, et al
    DWI as an Imaging Biomarker for Bladder Cancer.
    AJR Am J Roentgenol. 2017 Feb 28:1-11. doi: 10.2214/AJR.17.17798.
    Abstract     Related articles   

  322. REDDY AV, Christodouleas JP, Wu T, Smith ND, et al
    External Validation and Optimization of International Consensus Clinical Target Volumes for Adjuvant Radiation Therapy in Bladder Cancer.
    Int J Radiat Oncol Biol Phys. 2017;97:740-746.
    Abstract     Related articles   

  323. THOMPSON C, Joseph N, Sanderson B, Logue J, et al
    Tolerability of Concurrent Chemoradiation Therapy With Gemcitabine (GemX), With and Without Prior Neoadjuvant Chemotherapy, in Muscle Invasive Bladder Cancer.
    Int J Radiat Oncol Biol Phys. 2017;97:732-739.
    Abstract     Related articles   

  324. PARK SJ, Myung SK, Lee Y, Lee YJ, et al
    Effects of Vitamin and Antioxidant Supplements in Prevention of Bladder Cancer: a Meta-Analysis of Randomized Controlled Trials.
    J Korean Med Sci. 2017;32:628-635.
    Abstract     Related articles   

  325. SOLANKI AA, Martin B, Korpics M, Small C, et al
    Adjuvant Radiotherapy Use by US Radiation Oncologists After Radical Cystectomy for Muscle-invasive Bladder Cancer.
    Clin Oncol (R Coll Radiol). 2017 Feb 24. pii: S0936-6555(17)30080.
    Abstract     Related articles   

  326. LI P, Chen J, Miyamoto H
    Androgen Receptor Signaling in Bladder Cancer.
    Cancers (Basel). 2017;9.
    Abstract     Related articles   

  327. MIGITA T, Ueda A, Ohishi T, Hatano M, et al
    Epithelial-mesenchymal transition promotes SOX2 and NANOG expression in bladder cancer.
    Lab Invest. 2017 Feb 27. doi: 10.1038/labinvest.2017.
    Abstract     Related articles   

  328. COGORNO WASYLKOWSKI L, Rios-Gonzalez E, Linares Espinos E, Leibar Tamayo A, et al
    Indication for early cystectomy in nonmuscle-invasive bladder cancer. Literature review.
    Actas Urol Esp. 2017 Feb 18. pii: S0210-4806(17)30004.
    Abstract     Related articles   

  329. APFELTHALER C, Anzengruber M, Gabor F, Wirth M, et al
    Poly - (L) - glutamic acid drug delivery system for the intravesical therapy of bladder cancer using WGA as targeting moiety.
    Eur J Pharm Biopharm. 2017 Feb 22. pii: S0939-6411(16)30583.
    Abstract     Related articles   

  330. HENON C, Huillard O, Preta LH, Blanchet B, et al
    Cytidine Deaminase Activity Assessment to Select Perioperative Chemotherapy Regimen in Localized Bladder Cancer.
    Clin Genitourin Cancer. 2017 Feb 1. pii: S1558-7673(17)30033.
    Abstract     Related articles   

  331. ISMAIL AF, Oskay S, Babteen N, De Piano M, et al
    PAK5 mediates cell:cell adhesion integrity via interaction with E-cadherin in bladder cancer cells.
    Biochem J. 2017 Feb 23. pii: BCJ20160875. doi: 10.1042/BCJ20160875.
    Abstract     Related articles   

  332. YU HT, Kim TH, Uhm JS, Kim JY, et al
    Clinical Significance of Hematuria in Atrial Fibrillation With Oral Anticoagulation Therapy.
    Circ J. 2017;81:158-164.
    Abstract     Related articles   

  333. WU YP, Lin TT, Chen SH, Xu N, et al
    Comparison of the efficacy and feasibility of en bloc transurethral resection of bladder tumor versus conventional transurethral resection of bladder tumor: A meta-analysis.
    Medicine (Baltimore). 2016;95:e5372.
    Abstract     Related articles   

  334. KIM C, Gao J, Shannon VR, Siefker-Radtke A, et al
    Systemic sarcoidosis first manifesting in a tattoo in the setting of immune checkpoint inhibition.
    BMJ Case Rep. 2016;2016.
    Abstract     Related articles   

  335. KEHILA M, Mekni K, Abouda HS, Chtourou M, et al
    [Leiomyoma of the bladder causing the destruction of a kidney].
    Pan Afr Med J. 2016;24:10.
    Abstract     Related articles   

  336. KITAYAMA H, Yokota T, Kondo T, Sugiyama J, et al
    Unusual Development of Pulmonary Tumor Embolism from Controlled Liver Metastases of Transitional Cell Carcinoma: An Autopsy Case.
    Intern Med. 2016;55:2453-6.
    Abstract     Related articles   

  337. GUO XG, Long JJ
    Cytokeratin-19 fragment in the diagnosis of bladder carcinoma.
    Tumour Biol. 2016;37:14329-14330.
    Abstract     Related articles   

  338. KOUBA E, Cheng L
    Neuroendocrine Tumors of the Urinary Bladder According to the 2016 World Health Organization Classification: Molecular and Clinical Characteristics.
    Endocr Pathol. 2016;27:188-99.
    Abstract     Related articles   

  339. HASSAN M, Qureshi A, Nasir H
    Recurrent verrucous carcinoma of the urinary bladder after transurethral resection followed by intravesical mitomycin, and a review of the literature.
    BMJ Case Rep. 2016;2016.
    Abstract     Related articles   

  340. XING QW, Wu Y, Cai B, Ma LM, et al
    [Clinical research of second resection on early stage primary bladder adenocarcinoma and literature review].
    Zhonghua Yi Xue Za Zhi. 2016;96:1585-7.
    Abstract     Related articles   

  341. GUPTA S, Zhang J, Rivera M, Erickson LA, et al
    Urinary Bladder Paragangliomas: Analysis of Succinate Dehydrogenase and Outcome.
    Endocr Pathol. 2016;27:243-52.
    Abstract     Related articles   

  342. OU X, Hong F, Zhang Z, Cheng Y, et al
    A highly sensitive and facile graphene oxide-based nucleic acid probe: Label-free detection of telomerase activity in cancer patient's urine using AIEgens.
    Biosens Bioelectron. 2017;89.
    Abstract     Related articles   

  343. RIZOS CV, Kei A, Elisaf MS
    The current role of thiazolidinediones in diabetes management.
    Arch Toxicol. 2016;90:1861-81.
    Abstract     Related articles   

  344. KIM M, Kim YY, Jee HJ, Bae SS, et al
    Akt3 knockdown induces mitochondrial dysfunction in human cancer cells.
    Acta Biochim Biophys Sin (Shanghai). 2016;48:447-53.
    Abstract     Related articles   

  345. CANDIDO S, Di Maso M, Serraino D, McCubrey JA, et al
    Diagnostic value of neutrophil gelatinase-associated lipocalin/matrix metalloproteinase-9 pathway in transitional cell carcinoma of the bladder.
    Tumour Biol. 2016;37:9855-63.
    Abstract     Related articles   

  346. ISLAM SS, Mokhtari RB, Akbari P, Hatina J, et al
    Simultaneous Targeting of Bladder Tumor Growth, Survival, and Epithelial-to-Mesenchymal Transition with a Novel Therapeutic Combination of Acetazolamide (AZ) and Sulforaphane (SFN).
    Target Oncol. 2016;11:209-27.
    Abstract     Related articles   

  347. KAHOKEHR A, Glasson J, Studd R
    Surgical waiting time for radical cystectomy: a New Zealand experience.
    ANZ J Surg. 2016;86:1042-1045.
    Abstract     Related articles   

  348. SINGLA M, Shikha D, Lee S, Baumstein D, et al
    Ileal Neobladder With Mucous Plugs as a Cause of Obstructive Acute Kidney Injury Requiring Emergent Hemodialysis.
    Am J Ther. 2016;23:e1099-101.
    Abstract     Related articles   

  349. YAO HH, Chu K, Hallot C, Lewin J, et al
    Metachronous primary urothelial carcinoma following small cell carcinoma of the urinary bladder.
    ANZ J Surg. 2017;87.
    Abstract     Related articles   

  350. WU C, Zhou X, Miao C, Zhang J, et al
    Assessing the Feasibility of Replacing Standard-Dose Bacillus Calmette-Guerin Immunotherapy with Other Intravesical Instillation Therapies in Bladder Cancer Patients: A Network Meta-Analysis.
    Cell Physiol Biochem. 2017;41:1298-1312.
    Abstract     Related articles   

  351. QIU W, Lin J, Zhu Y, Zhang J, et al
    Kaempferol Modulates DNA Methylation and Downregulates DNMT3B in Bladder Cancer.
    Cell Physiol Biochem. 2017;41:1325-1335.
    Abstract     Related articles   

  352. ATTA MA, Kotb AF, Sharafeldeen M, Elabbady A, et al
    The value of extended good quality transurethral resection of bladder tumour in the treatment of the newly diagnosed bladder cancer.
    Arab J Urol. 2016;15:60-63.
    Abstract     Related articles   

  353. BUISAN O, Orsola A, Oliveira M, Martinez R, et al
    Role of Inflammation in the Perioperative Management of Urothelial Bladder Cancer With Squamous-Cell Features: Impact of Neutrophil-to-Lymphocyte Ratio on Outcomes and Response to Neoadjuvant Chemotherapy.
    Clin Genitourin Cancer. 2017 Feb 6. pii: S1558-7673(17)30040.
    Abstract     Related articles   

  354. YIN X, Li F, Jin Y, Yin Z, et al
    [Establishment of a human bladder cancer cell line stably co-expressing hSPRY2 and luciferase genes and its subcutaneous tumor xenograft model in nude mice].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2017;33:337-341.
    Abstract     Related articles   

  355. ISMAILI N
    Neoadjuvant Chemotherapy: A New Standard for Muscle Invasive Bladder Cancer?
    Gulf J Oncolog. 2017;1:82-85.
    Abstract     Related articles   

  356. KILINC MF, Bayar G, Dalkilic A, Sonmez NC, et al
    Applicability of the EORTC risk tables to predict outcomes in non-muscle-invasive bladder cancer in Turkish patients.
    Turk J Urol. 2017;43:48-54.
    Abstract     Related articles   

  357. KAMAT AM, Bagcioglu M, Huri E
    What is new in non-muscle-invasive bladder cancer in 2016?
    Turk J Urol. 2017;43:9-13.
    Abstract     Related articles   

  358. YUAN Q, Sun T, Ye F, Kong W, et al
    MicroRNA-124-3p affects proliferation, migration and apoptosis of bladder cancer cells through targeting AURKA.
    Cancer Biomark. 2017 Feb 27. doi: 10.3233/CBM-160427.
    Abstract     Related articles   

  359. SHEPHERD AR, Shepherd E, Brook NR
    Intravesical Bacillus Calmette-Guerin with interferon-alpha versus intravesical Bacillus Calmette-Guerin for treating non-muscle-invasive bladder cancer.
    Cochrane Database Syst Rev. 2017;3:CD012112.
    Abstract     Related articles   

  360. SHANG A, Yang M, Shen F, Wang J, et al
    MiR-1-3p Suppresses the Proliferation, Invasion and Migration of Bladder Cancer Cells by Up-Regulating SFRP1 Expression.
    Cell Physiol Biochem. 2017;41:1179-1188.
    Abstract     Related articles   

  361. HWANG EC, Jung SI, Lee HJ, Lee JJ, et al
    Generation of potent cytotoxic T lymphocytes against in male patients with non-muscle invasive bladder cancer by dendritic cells loaded with dying T24 bladder cancer cells.
    Int Braz J Urol. 2017;43.
    Abstract     Related articles   

  362. SIDAWAY P
    Bladder cancer: Pembrolizumab is superior to chemotherapy.
    Nat Rev Urol. 2017 Mar 7. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  363. TYSON MD, Chang SS, Keegan KA
    Role of consolidative surgical therapy in patients with locally advanced or regionally metastatic bladder cancer.
    Bladder (San Franc). 2016;3.
    Abstract     Related articles   

  364. YURUK E, Saitz TR, Gonultas S, Serefoglu EC, et al
    Neutrophil-to-lymphocyte ratio is elevated in recurringnonmuscle invasive bladder cancer.
    Turk J Med Sci. 2017;47:234-239.
    Abstract     Related articles   

  365. MAHDAVINEZHAD A, Yadegarazari R, Mousavi-Bahar SH, Poorolajal J, et al
    Evaluation of zinc finger E-box binding homeobox 1 and transforming growth factor-beta2 expression in bladder cancer tissue in comparison with healthy adjacent tissue.
    Investig Clin Urol. 2017;58:140-145.
    Abstract     Related articles   

  366. ZHAO ZF, Wang K, Guo FF, Lu H, et al
    Inhibition of T24 and RT4 Human Bladder Cancer Cell Lines by Heterocyclic Molecules.
    Med Sci Monit. 2017;23:1156-1164.
    Abstract     Related articles   

  367. MUPPA P, Gupta S, Frank I, Boorjian SA, et al
    Prognostic significance of lymphatic, vascular and perineural invasion for bladder cancer patients treated by radical cystectomy.
    Pathology. 2017 Mar 1. pii: S0031-3025(16)40358.
    Abstract     Related articles   

  368. YIN H, Qin C, Zhao Y, Du Y, et al
    SOX10 is over-expressed in bladder cancer and contributes to the malignant bladder cancer cell behaviors.
    Clin Transl Oncol. 2017 Mar 3. doi: 10.1007/s12094-017-1641.
    Abstract     Related articles   

  369. MIYAKE M, Hori S, Morizawa Y, Tatsumi Y, et al
    Corrigendum to "CXCL1-Mediated Interaction of Cancer Cells with Tumor-Associated Macrophages and Cancer-Associated Fibroblasts Promotes Tumor Progression in Human Bladder Cancer" [Neoplasia 18 (2016) 636-646].
    Neoplasia. 2017;19:250-251.
    Abstract     Related articles   

  370. SANGUEDOLCE F, Loizzi D, Sollitto F, Di Bisceglie M, et al
    Bladder Metastases from Lung Cancer: Clinical and Pathological Implications: A Systematic Review.
    Oncology. 2017;92:125-134.
    Abstract     Related articles   

  371. KUMAR V, Garg R, Gupta N, Bharati SJ, et al
    Cautious use and optimal dose of morphine for relieving malignant pain in a complex patient with multiple comorbidities.
    BMJ Case Rep. 2016;2016.
    Abstract     Related articles   

  372. TORRES-BLANCO A, Gomez-Palones F, Edo-Fleta G
    Arteriocutaneous Fistula Associated with Bilateral Femoral Pseudoaneurysms Caused by Bacillus Calmette-Guerin. Apropos of a Case and Review of Literature.
    Ann Vasc Surg. 2017;39:291.
    Abstract     Related articles   

  373. PIVOVARCIKOVA K, Pitra T, Vanecek T, Alaghehbandan R, et al
    Comparative study of TERT gene mutation analysis on voided liquid-based urine cytology and paraffin-embedded tumorous tissue.
    Ann Diagn Pathol. 2016;24:7-10.
    Abstract     Related articles   

  374. ALONGI P, Caobelli F, Gentile R, Stefano A, et al
    Recurrent bladder carcinoma: clinical and prognostic role of 18 F-FDG PET/CT.
    Eur J Nucl Med Mol Imaging. 2017;44:224-233.
    Abstract     Related articles   

  375. MADANCHI M, Zeitz J, Barthel C, Samaras P, et al
    Malignancies in Patients with Inflammatory Bowel Disease: A Single-Centre Experience.
    Digestion. 2016;94:1-8.
    Abstract     Related articles   

  376. YU R, Gohla G, Haider EA
    Chromophobe renal cell carcinoma mimicking cortical invasion by synchronous invasive urothelial carcinoma of the intra-renal collecting system on CT urography.
    Int Braz J Urol. 2016;42:392-4.
    Abstract     Related articles   

  377. ARISTA-NASR J, Martinez-Benitez B, Bornstein-Quevedo L, Aguilar-Ayala E, et al
    Low grade urothelial carcinoma mimicking basal cell hyperplasia and transitional metaplasia in needle prostate biopsy.
    Int Braz J Urol. 2016;42:247-52.
    Abstract     Related articles   

  378. POLAT H, Utangac MM, Gulpinar MT, Cift A, et al
    Urothelial neoplasm of the bladder in childhood and adolescence: a rare disease.
    Int Braz J Urol. 2016;42:242-6.
    Abstract     Related articles   

  379. DING XL, Yang X, Liang G, Wang K, et al
    Isoform switching and exon skipping induced by the DNA methylation inhibitor 5-Aza-2'-deoxycytidine.
    Sci Rep. 2016;6:24545.
    Abstract     Related articles   

  380. DAHM HH, von der Haar C, Rubben H
    DNA cytophotometric and histological analysis of N-butyl-N-(4-hydroxybutyl)nitrosamine-induced precancerous lesions of the bladder urothelium.
    J Cancer Res Clin Oncol. 2016;142:1253-60.
    Abstract     Related articles   

  381. TAMAS A, Javorhazy A, Reglodi D, Sarlos DP, et al
    Examination of PACAP-Like Immunoreactivity in Urogenital Tumor Samples.
    J Mol Neurosci. 2016;59:177-83.
    Abstract     Related articles   

  382. DAVARPANAH NN, Yuno A, Trepel JB, Apolo AB, et al
    Immunotherapy: a new treatment paradigm in bladder cancer.
    Curr Opin Oncol. 2017 Mar 16. doi: 10.1097/CCO.0000000000000366.
    Abstract     Related articles   

  383. LI QQ, Hao JJ, Zhang Z, Krane LS, et al
    Proteomic analysis of proteome and histone post-translational modifications in heat shock protein 90 inhibition-mediated bladder cancer therapeutics.
    Sci Rep. 2017;7:201.
    Abstract     Related articles   

  384. ROUDNICKY F, Dieterich LC, Poyet C, Buser L, et al
    High expression of insulin receptor on tumor-associated blood vessels in invasive bladder cancer predicts poor overall and progression-free survival.
    J Pathol. 2017 Mar 14. doi: 10.1002/path.4892.
    Abstract     Related articles   

  385. BOMAN K, Andersson G, Wennersten C, Nodin B, et al
    Podocalyxin-like and RNA-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer: a validatory study.
    Biomark Res. 2017;5:10.
    Abstract     Related articles   

  386. SEILER R, Black PC, Thalmann G, Stenzl A, et al
    Is The Cancer Genome Atlas (TCGA) bladder cancer cohort representative of invasive bladder cancer?
    Urol Oncol. 2017 Mar 10. pii: S1078-1439(17)30059.
    Abstract     Related articles   

  387. NGUYEN DP, Thalmann GN
    Contemporary update on neoadjuvant therapy for bladder cancer.
    Nat Rev Urol. 2017 Mar 14. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  388. POTTS KG, Irwin CR, Favis NA, Pink DB, et al
    Deletion of F4L (ribonucleotide reductase) in vaccinia virus produces a selective oncolytic virus and promotes anti-tumor immunity with superior safety in bladder cancer models.
    EMBO Mol Med. 2017 Mar 13. pii: e201607296. doi: 10.15252/emmm.201607296.
    Abstract     Related articles   


  389. Immunotherapy Beats Chemo for Bladder Cancer.
    Cancer Discov. 2017 Mar 13. doi: 10.1158/2159-8290.CD-NB2017.
    Abstract     Related articles   

  390. DURIEZ E, Masselon CD, Mesmin C, Court M, et al
    Large-Scale SRM Screen of Urothelial Bladder Cancer Candidate Biomarkers in Urine.
    J Proteome Res. 2017 Mar 13. doi: 10.1021/acs.jproteome.6b00979.
    Abstract     Related articles   

  391. TYSON MD, Lee D, Clark P
    New developments in the management of nonmuscle invasive bladder cancer.
    Curr Opin Oncol. 2017 Mar 9. doi: 10.1097/CCO.0000000000000362.
    Abstract     Related articles   

  392. LI J, Qu W, Jiang Y, Sun Y, et al
    miR-489 Suppresses Proliferation and Invasion of Human Bladder Cancer Cells.
    Oncol Res. 2016;24:391-398.
    Abstract     Related articles   

  393. CICCARESE C, Massari F, Blanca A, Tortora G, et al
    Tp53 and its potential therapeutic role as a target in bladder cancer.
    Expert Opin Ther Targets. 2017;21:401-414.
    Abstract     Related articles   

  394. AZER SA, Alghofaili MM, Alsultan RM, Alrumaih NS, et al
    Accuracy and Readability of Websites on Kidney and Bladder Cancers.
    J Cancer Educ. 2017 Mar 9. doi: 10.1007/s13187-017-1181.
    Abstract     Related articles   

  395. PARK J, Shin DW, Kim TH, Jung SI, et al
    Development and Validation of the Korean Version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for Patients with Non-muscle invasive bladder Cancer - EORTC QLQ-NMIBC24.
    Cancer Res Treat. 2017 Mar 10. doi: 10.4143/crt.2016.
    Abstract     Related articles   

  396. PATEL A, Desai P, Malczewski F, Stephens D, et al
    Mullerianosis of the urinary bladder: a rare and problematic bladder tumour.
    BMJ Case Rep. 2017;2017.
    Abstract     Related articles   

  397. ZHANG YG, Song QX, Song B, Zhang DL, et al
    Diagnosis and Treatment of Urinary Incontinence after Orthotopic Ileal Neobladder in China.
    Chin Med J (Engl). 2017;130:231-235.
    Abstract     Related articles   

  398. LIANG X, Men QL, Li YW, Li HC, et al
    Silencing of Armadillo Repeat-Containing Protein 8 (ARMc8) Inhibits TGF-beta-Induced EMT in Bladder Carcinoma UMUC3 Cells.
    Oncol Res. 2017;25:99-105.
    Abstract     Related articles   

  399. KUMAR AV, Mogili HK, Boju SL, Guptha R, et al
    Pheochromocytoma of Urinary Bladder in a Dialysis PatientPheochromocytoma of Urinary Bladder.
    Nephrology (Carlton). 2017;22:183.
    Abstract     Related articles   

  400. KIM CJ, Fujiwara R, Yamashita H
    [Modified Toyoda Method for Complete Duplex Ureters in Tubeless Cutaneous Ureterostomy : Report of a Case].
    Hinyokika Kiyo. 2016;62:591-594.
    Abstract     Related articles   

  401. OWARI T, Yamamoto T, Mizobuchi S, Itami Y, et al
    [Bladder Metastasis of Renal Cell Carcinoma 7 Years after Ex Vivo Partial Nephrectomy and Auto-Transplantation : A Case Report].
    Hinyokika Kiyo. 2016;62:575-579.
    Abstract     Related articles   

  402. TOPAL CS, Kir G, Das T, Sarbay B, et al
    Metastatic malignant melanoma of the urinary bladder: A case report and review of the literature.
    Indian J Pathol Microbiol. 2016;59:532-534.
    Abstract     Related articles   

  403. SINGH JP, Priyadarshi V, Pal DK
    A clinicoepidemiological study of young age bladder tumors: An eastern Indian scenario.
    J Cancer Res Ther. 2016;12:751-4.
    Abstract     Related articles   

  404. WANG HJ, Pui MH, Guo Y, Guan J, et al
    Preliminary study of diffusion-weighted MRI in the preoperative diagnosis of cystitis glandularis.
    Clin Radiol. 2016;71:937.
    Abstract     Related articles   

  405. SARSIK B, Doganavsargil B, Simsir A, Yazici A, et al
    P21 and p27 Immunoexpression in Upper Urinary Tract Urothelial Carcinomas.
    Pathol Oncol Res. 2016;22:839-45.
    Abstract     Related articles   

  406. VANDENBUSSCHE CJ
    A review of the Paris system for reporting urinary cytology.
    Cytopathology. 2016;27:153-6.
    Abstract     Related articles   

  407. PRABHU B, Sivakumar A, Sundaresan S
    Diindolylmethane and Lupeol Modulates Apoptosis and Cell Proliferation in N-Butyl-N-(4-Hydroxybutyl) Nitrosamine Initiated and Dimethylarsinic Acid Promoted rat Bladder Carcinogenesis.
    Pathol Oncol Res. 2016;22:747-54.
    Abstract     Related articles   

  408. WU D, Wang Y, Zhang Y, Ma H, et al
    Sensitive Electrochemical Immunosensor for Detection of Nuclear Matrix Protein-22 based on NH2-SAPO-34 Supported Pd/Co Nanoparticles.
    Sci Rep. 2016;6:24551.
    Abstract     Related articles   

  409. ROSS EM, Markowetz F
    OncoNEM: inferring tumor evolution from single-cell sequencing data.
    Genome Biol. 2016;17:69.
    Abstract     Related articles   

  410. WU CL, Svendsen SG, Riviere A, Desgrandchamps F, et al
    Multiplex bead-based immunoassay for the free soluble forms of the HLA-G receptors, ILT2 and ILT4.
    Hum Immunol. 2016;77:720-6.
    Abstract     Related articles   

  411. FUJII N, Hoshii Y, Hirata H, Mori J, et al
    Impact of divergent differentiation in urothelial carcinoma on oncological outcome in patients with T1 high-grade bladder cancer.
    Jpn J Clin Oncol. 2017 Mar 8:1-8. doi: 10.1093.
    Abstract     Related articles   

  412. ASCHENBRENNER DS
    Updated Review Confirms Potential Risk of Bladder Cancer with Pioglitazone.
    Am J Nurs. 2017;117:25.
    Abstract     Related articles   

  413. MICHAELSON MD, Hu C, Pham HT, Dahl DM, et al
    A Phase 1/2 Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation After Transurethral Surgery for Noncystectomy Candidates With Muscle-Invasive Bladder Cancer (Trial NRG Oncology RTOG 05
    Int J Radiat Oncol Biol Phys. 2017;97:995-1001.
    Abstract     Related articles   

  414. VASHISTHA V, Wang H, Mazzone A, Liss MA, et al
    Radical Cystectomy Compared to Combined Modality Treatment for Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.
    Int J Radiat Oncol Biol Phys. 2017;97:1002-1020.
    Abstract     Related articles   

  415. CHEN W, Zhao K, Miao C, Xu A, et al
    Silencing Trim59 inhibits invasion/migration and epithelial-to-mesenchymal transition via TGF-beta/Smad2/3 signaling pathway in bladder cancer cells.
    Onco Targets Ther. 2017;10:1503-1512.
    Abstract     Related articles   

  416. AYDIN AM, Woldu SL, Hutchinson RC, Boegemann M, et al
    Spotlight on atezolizumab and its potential in the treatment of advanced urothelial bladder cancer.
    Onco Targets Ther. 2017;10:1487-1502.
    Abstract     Related articles   

  417. MITIN T
    Radical Cystectomy is the best choice for most patients with muscle-invasive bladder cancer? | Opinion: No.
    Int Braz J Urol. 2017;43:188-191.
    Abstract     Related articles   

  418. MONTEIRO LL, Kassouf W
    Radical Cystectomy is the best choice for most patients with muscle-invasive bladder cancer? | Opinion: Yes.
    Int Braz J Urol. 2017;43:184-187.
    Abstract     Related articles   

  419. MURPHY DR, Meyer AN, Vaghani V, Russo E, et al
    Application of Electronic Algorithms to Improve Diagnostic Evaluation for Bladder Cancer.
    Appl Clin Inform. 2017;8:279-290.
    Abstract     Related articles   

  420. GEE JR, Saltzstein DR, Kim K, Kolesar JM, et al
    A phase II randomized, double-blind, presurgical trial of Polyphenon E in bladder cancer patients to evaluate pharmacodynamics and bladder tissue biomarkers.
    Cancer Prev Res (Phila). 2017 Mar 21. pii: canprevres.0167.2016.
    Abstract     Related articles   

  421. PIETZAK EJ
    The Impact of Blue Light Cystoscopy on the Diagnosis and Treatment of Bladder Cancer.
    Curr Urol Rep. 2017;18:39.
    Abstract     Related articles   

  422. SUN X, Hoadley KA, Kim WY, Furberg H, et al
    Age at diagnosis, obesity, smoking, and molecular subtypes in muscle-invasive bladder cancer.
    Cancer Causes Control. 2017 Mar 20. doi: 10.1007/s10552-017-0885.
    Abstract     Related articles   

  423. CAO W, Ma E, Zhou L, Yuan T, et al
    Exploring the FGFR3-related oncogenic mechanism in bladder cancer using bioinformatics strategy.
    World J Surg Oncol. 2017;15:66.
    Abstract     Related articles   

  424. YASUI M, Morikawa T, Nakagawa T, Miyakawa J, et al
    Urinary bladder carcinoma with divergent differentiation featuring small cell carcinoma, sarcomatoid carcinoma, and liposarcomatous component.
    Pathol Res Pract. 2016;212:833-7.
    Abstract     Related articles   

  425. NIKOLEISHVILI D, Tchanturaia Z, Managadze G, Koberidze G, et al
    THE FIRST REPORT OF LAPAROSCOPIC RADICAL CYSTECTOMY IN GEORGIA.
    Georgian Med News. 2016;:7-11.
    Abstract     Related articles   

  426. NIU HT, Dong P, Wang JN, Huang J, et al
    [Analysis of treatment and prognosis in post-operative patients with urachal carcinoma].
    Zhonghua Yi Xue Za Zhi. 2016;96:1923-5.
    Abstract     Related articles   

  427. MAKBOUL R, Refaiy A, Abdelkawi IF, Hameed DA, et al
    Alterations of mTOR and PTEN protein expression in schistosomal squamous cell carcinoma and urothelial carcinoma.
    Pathol Res Pract. 2016;212:385-92.
    Abstract     Related articles   

  428. PYUN JH, Kim HK, Cho S, Kang SG, et al
    Robot-Assisted Radical Cystectomy with Total Intracorporeal Urinary Diversion: Comparative Analysis with Extracorporeal Urinary Diversion.
    J Laparoendosc Adv Surg Tech A. 2016;26:349-55.
    Abstract     Related articles   

  429. TURATI F, Bosetti C, Polesel J, Serraino D, et al
    Family history of cancer and the risk of bladder cancer: A case-control study from Italy.
    Cancer Epidemiol. 2017;48:29-35.
    Abstract     Related articles   

  430. WOLDU SL, Sanli O, Lotan Y
    Tackling Non-Muscle Invasive Bladder Cancer in the Clinic.
    Expert Rev Anticancer Ther. 2017 Mar 31. doi: 10.1080/14737140.2017.1313119.
    Abstract     Related articles   

  431. KASMANN L, Manig L, Janssen S, Rades D, et al
    Chemoradiation Including Paclitaxel for Locally Recurrent Muscle-invasive Bladder Cancer in Elderly Patients.
    In Vivo. 2017;31:239-241.
    Abstract     Related articles   

  432. AOUN F, Rassy EE, Assi T, Albisinni S, et al
    Advances in urothelial bladder cancer immunotherapy, dawn of a new age of treatment.
    Immunotherapy. 2017;9:451-460.
    Abstract     Related articles   

  433. CHENG N, Xu Y, Luo Y, Zhu L, et al
    Specific and relative detection of urinary microRNA signatures in bladder cancer for point-of-care diagnostics.
    Chem Commun (Camb). 2017 Mar 30. doi: 10.1039/c7cc01007.
    Abstract     Related articles   

  434. WANG H, Zuo Y, Ding M, Ke C, et al
    LASS2 inhibits growth and invasion of bladder cancer by regulating ATPase activity.
    Oncol Lett. 2017;13:661-668.
    Abstract     Related articles   

  435. TSAI JL, Tsai SF
    Calcium oxalate crystal related kidney injury in a patient receiving Roux-en Y hepaticojejunostomy due to gall bladder cancer.
    BMC Nephrol. 2017;18:106.
    Abstract     Related articles   

  436. SUNDAR RAJAN V, Laurent VM, Verdier C, Duperray A, et al
    Unraveling the Receptor-Ligand Interactions between Bladder Cancer Cells and the Endothelium Using AFM.
    Biophys J. 2017;112:1246-1257.
    Abstract     Related articles   

  437. SIDAWAY P
    Bladder cancer: TCGA cohort is representative of invasive disease.
    Nat Rev Urol. 2017 Mar 29. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  438. SON SK, Lee NR, Kang SH, Lee SH, et al
    Safety and Effectiveness of Robot-Assisted Versus Open Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis.
    J Laparoendosc Adv Surg Tech A. 2017 Mar 28. doi: 10.1089/lap.2016.0437.
    Abstract     Related articles   

  439. CHIU M, McBeth L, Sindhwani P, Hinds TD, et al
    Deciphering the Roles of Thiazolidinediones and PPARgamma in Bladder Cancer.
    PPAR Res. 2017;2017:4810672.
    Abstract     Related articles   

  440. OLIVEIRA MB, Villa Nova M, Bruschi ML
    A review of recent developments on micro/nanostructured pharmaceutical systems for intravesical therapy of the bladder cancer.
    Pharm Dev Technol. 2017 Mar 27:1-43. doi: 10.1080/10837450.2017.1312441.
    Abstract     Related articles   

  441. MOUW KW
    DNA Repair Pathway Alterations in Bladder Cancer.
    Cancers (Basel). 2017;9.
    Abstract     Related articles   

  442. VALE N, Gouveia MJ, Rinaldi G, Santos J, et al
    The role of estradiol metabolism in urogenital schistosomiasis-induced bladder cancer.
    Tumour Biol. 2017;39:1010428317692247.
    Abstract     Related articles   

  443. ZHANG H, Fan Y, Xia L, Gao C, et al
    The impact of advanced proteomics in the search for markers and therapeutic targets of bladder cancer.
    Tumour Biol. 2017;39:1010428317691183.
    Abstract     Related articles   

  444. QU K, Gu J, Ye Y, Williams SB, et al
    High baseline levels of interleukin-8 in leukocytes and urine predict tumor recurrence in non-muscle invasive bladder cancer patients receiving bacillus Calmette-Guerin therapy: A long-term survival analysis.
    Oncoimmunology. 2017;6:e1265719.
    Abstract     Related articles   

  445. SORIA F, Lucca I, Moschini M, Mathieu R, et al
    Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer.
    Urol Oncol. 2017 Mar 22. pii: S1078-1439(17)30093.
    Abstract     Related articles   

  446. SIKIC D, Breyer J, Hartmann A, Burger M, et al
    High Androgen Receptor mRNA Expression Is Independently Associated with Prolonged Cancer-Specific and Recurrence-Free Survival in Stage T1 Bladder Cancer.
    Transl Oncol. 2017;10:340-345.
    Abstract     Related articles   

  447. SATO A, Asano T, Okubo K, Isono M, et al
    Ritonavir and ixazomib kill bladder cancer cells by causing ubiquitinated protein accumulation.
    Cancer Sci. 2017 Mar 25. doi: 10.1111/cas.13242.
    Abstract     Related articles   

  448. SEITZ AK, Christensen LL, Christensen E, Faarkrog K, et al
    Profiling of long non-coding RNAs identifies LINC00958 and LINC01296 as candidate oncogenes in bladder cancer.
    Sci Rep. 2017;7:395.
    Abstract     Related articles   

  449. DONIN NM, Chamie K, Lenis AT, Pantuck AJ, et al
    A phase 2 study of TMX-101, intravesical imiquimod, for the treatment of carcinoma in situ bladder cancer.
    Urol Oncol. 2017;35:39.
    Abstract     Related articles   

  450. MENG FM, Meng FM, Song XL
    MiR-576-3p is a novel marker correlated with poor clinical outcome in bladder cancer.
    Eur Rev Med Pharmacol Sci. 2017;21:973-977.
    Abstract     Related articles   

  451. WANG R, Wu Y, Huang W, Chen W, et al
    MicroRNA-940 Targets INPP4A or GSK3beta and Activates the Wnt/beta-Catenin Pathway to Regulate the Malignant Behavior of Bladder Cancer Cells.
    Oncol Res. 2017 Mar 23. doi: 10.3727/096504017X14902261600566.
    Abstract     Related articles   

  452. FINA E, Necchi A, Bottelli S, Reduzzi C, et al
    Detection of Circulating Tumour Cells in Urothelial Cancers and Clinical Correlations: Comparison of Two Methods.
    Dis Markers. 2017;2017:3414910.
    Abstract     Related articles   

  453. MD NOH MS, Abdul Aziz AF, Mohd Ghani KA, Lee Kheng Siang C, et al
    Giant Intradiverticular Bladder Tumor.
    Am J Case Rep. 2017;18:212-216.
    Abstract     Related articles   

  454. CHO A, Lee SM, Noh JW, Choi DK, et al
    Acid-base disorders after orthotopic bladder replacement: comparison of an ileal neobladder and an ileal conduit.
    Ren Fail. 2017;39:379-384.
    Abstract     Related articles   

  455. LOBO J, Henrique R, Monteiro P, Lobo C, et al
    ALK-negative anaplastic large cell lymphoma with urinary bladder involvement diagnosed in urine cytology: A case report and literature review.
    Diagn Cytopathol. 2017;45:354-358.
    Abstract     Related articles   

  456. ISHIBASHI N, Maebayashi T, Aizawa T, Sakaguchi M, et al
    Refractory Haematuria Resulting From Peritoneal Dissemination of Metastatic Gastric Cancer: Radiation Therapy For A Nodule Infiltrating The Urinary Bladder.
    Urol J. 2017;14:2982-2984.
    Abstract     Related articles   

  457. LEE J, Park S, Cho MS, Sung SH, et al
    Urine cytology findings of primary paraganglioma of the urinary bladder: Case report.
    Diagn Cytopathol. 2017;45:350-353.
    Abstract     Related articles   

  458. LIU X, Wei M, Xu E, Yang H, et al
    A sensitive, label-free electrochemical detection of telomerase activity without modification or immobilization.
    Biosens Bioelectron. 2017;91:347-353.
    Abstract     Related articles   

  459. LV M, Zhong Z, Chi H, Huang M, et al
    Genome-Wide Screen of miRNAs and Targeting mRNAs Reveals the Negatively Regulatory Effect of miR-130b-3p on PTEN by PI3K and Integrin beta1 Signaling Pathways in Bladder Carcinoma.
    Int J Mol Sci. 2016;18.
    Abstract     Related articles   

  460. POLLARD RE, Watson KD, Hu X, Ingham E, et al
    Feasibility of quantitative contrast ultrasound imaging of bladder tumors in dogs.
    Can Vet J. 2017;58:70-72.
    Abstract     Related articles   

  461. BROWN KG, Solomon MJ, Latif ER, Koh CE, et al
    Urological complications after cystectomy as part of pelvic exenteration are higher than that after cystectomy for primary bladder malignancy.
    J Surg Oncol. 2017;115:307-311.
    Abstract     Related articles   

  462. WANG ZY, Zhang W, Yang JJ, Song DK, et al
    Expression of miRNA-630 in bladder urothelial carcinoma and its clinical significance.
    J Huazhong Univ Sci Technolog Med Sci. 2016;36:705-709.
    Abstract     Related articles   

  463. ARAKAWA K, Ishihara S, Kawai K, Shibata J, et al
    Asynchronous bilateral anastomosis site sigmoid colon cancer after ureterosigmoidostomy: a case report.
    World J Surg Oncol. 2016;14:180.
    Abstract     Related articles   

  464. HEDEGAARD J, Lamy P, Nordentoft I, Algaba F, et al
    Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma.
    Cancer Cell. 2016;30:27-42.
    Abstract     Related articles   

  465. SAUER M, Degen O, Beyersdorff D
    [Not Available].
    Rofo. 2016;188:782-3.
    Abstract     Related articles   

  466. PANG C, Guan Y, Li H, Chen W, et al
    Urologic cancer in China.
    Jpn J Clin Oncol. 2016;46:497-501.
    Abstract     Related articles   

  467. ISMAILI N
    External beam radiation therapy for small cell carcinoma of the bladder.
    Pract Radiat Oncol. 2016;6:e215-6.
    Abstract     Related articles   

  468. KONG V, Kwan M, Chen S, Moseley J, et al
    Impact of image registration surrogates on the planning target volume geometry for bladder radiation therapy.
    Pract Radiat Oncol. 2016;6:e187-94.
    Abstract     Related articles   

  469. SALAH S, Lee JL, Rozzi A, Kitamura H, et al
    Second-Line Chemotherapy for Metastatic Urothelial Carcinoma: Importance of Lymph Node-Only Metastasis as a Prognostic Factor and Construction of a Prognostic Model.
    Clin Genitourin Cancer. 2016;14:255-60.
    Abstract     Related articles   

  470. JAN AS, Dolan DE, Lombardi K, Gupta S, et al
    Tolerability of Gemcitabine Plus Cisplatin for Treatment of Urothelial Cancer in the Elderly Population.
    Clin Genitourin Cancer. 2016;14:e257-63.
    Abstract     Related articles   

  471. ANTONELLI A, Belotti S, Cristinelli L, De Luca V, et al
    Comparison of Perioperative Morbidity of Radical Cystectomy With Neobladder Versus Ileal Conduit: A Matched Pair Analysis of 170 Patients.
    Clin Genitourin Cancer. 2016;14:244-8.
    Abstract     Related articles   

  472. TAGUCHI S, Akamatsu N, Nakagawa T, Gonoi W, et al
    Sarcopenia Evaluated Using the Skeletal Muscle Index Is a Significant Prognostic Factor for Metastatic Urothelial Carcinoma.
    Clin Genitourin Cancer. 2016;14:237-43.
    Abstract     Related articles   

  473. TAJIMA S, Suzuki T, Yamada Y, Morikawa T, et al
    Invasive urothelial carcinoma with chordoid features may be an ominous sign predicting sarcomatoid change: a case report of a bladder carcinoma.
    Med Mol Morphol. 2016;49:182-7.
    Abstract     Related articles   

  474. DU L, Jiang X, Duan W, Wang R, et al
    Cell-free microRNA expression signatures in urine serve as novel noninvasive biomarkers for diagnosis and recurrence prediction of bladder cancer.
    Oncotarget. 2017 Mar 28. doi: 10.18632/oncotarget.16586.
    Abstract     Related articles   

  475. KIM YJ, Byun SJ, Ahn H, Kim CS, et al
    Comparison of outcomes between trimodal therapy and radical cystectomy in muscle-invasive bladder cancer: a propensity score matching analysis.
    Oncotarget. 2017 Mar 25. doi: 10.18632/oncotarget.16576.
    Abstract     Related articles   

  476. CHLOSTA PL, Golabek T, Nyirady P
    New Insights into Diagnosis and Treatment of Renal Cell Carcinoma, Bladder Cancer, and Prostate Cancer.
    Biomed Res Int. 2017;2017:6467072.
    Abstract     Related articles   

  477. YU H, Duan P, Zhu H, Rao D, et al
    miR-613 inhibits bladder cancer proliferation and migration through targeting SphK1.
    Am J Transl Res. 2017;9:1213-1221.
    Abstract     Related articles   

  478. TAN G, Wang H, Yuan J, Qin W, et al
    Three serum metabolite signatures for diagnosing low-grade and high-grade bladder cancer.
    Sci Rep. 2017;7:46176.
    Abstract     Related articles   

  479. WU J, Wan F, Sheng H, Shi G, et al
    NR1H3 Expression is a Prognostic Factor of Overall Survival for Patients with Muscle-Invasive Bladder Cancer.
    J Cancer. 2017;8:852-860.
    Abstract     Related articles   

  480. LI Y, Guo G, Song J, Cai Z, et al
    B7-H3 Promotes the Migration and Invasion of Human Bladder Cancer Cells via the PI3K/Akt/STAT3 Signaling Pathway.
    J Cancer. 2017;8:816-824.
    Abstract     Related articles   

  481. EISSA S, Matboli M, Awad N, Kotb Y, et al
    Identification and validation of a novel autophagy gene expression signature for human bladder cancer patients.
    Tumour Biol. 2017;39:1010428317698360.
    Abstract     Related articles   

  482. MINAMI K, Taniguchi K, Sugito N, Kuranaga Y, et al
    MiR-145 negatively regulates Warburg effect by silencing KLF4 and PTBP1 in bladder cancer cells.
    Oncotarget. 2017 Mar 23. doi: 10.18632/oncotarget.16524.
    Abstract     Related articles   

  483. WANG X, Zhang F, Wu XR
    Inhibition of Pyruvate Kinase M2 Markedly Reduces Chemoresistance of Advanced Bladder Cancer to Cisplatin.
    Sci Rep. 2017;7:45983.
    Abstract     Related articles   

  484. KUMARI N, Agrawal U, Mishra AK, Kumar A, et al
    Predictive role of serum and urinary cytokines in invasion and recurrence of bladder cancer.
    Tumour Biol. 2017;39:1010428317697552.
    Abstract     Related articles   

  485. JIANG H, Hu X, Zhang H, Li W, et al
    Down-regulation of LncRNA TUG1 enhances radiosensitivity in bladder cancer via suppressing HMGB1 expression.
    Radiat Oncol. 2017;12:65.
    Abstract     Related articles   

  486. EL-ARABEY AA
    New insight for metformin against bladder cancer.
    Genes Environ. 2017;39:13.
    Abstract     Related articles   

  487. LEVINE JJ, Somer RA, Hosoya H, Squillante C, et al
    Atezolizumab-induced Encephalitis in Metastatic Bladder Cancer: A Case Report and Review of the Literature.
    Clin Genitourin Cancer. 2017 Mar 16. pii: S1558-7673(17)30063.
    Abstract     Related articles   

  488. LI Y, Shan Z, Liu C, Yang D, et al
    MicroRNA-294 Promotes Cellular Proliferation and Motility through the PI3K/AKT and JAK/STAT Pathways by Upregulation of NRAS in Bladder Cancer.
    Biochemistry (Mosc). 2017;82:474-482.
    Abstract     Related articles   

  489. KLUMPER N, Syring I, Vogel W, Schmidt D, et al
    Mediator Complex Subunit MED1 Protein Expression Is Decreased during Bladder Cancer Progression.
    Front Med (Lausanne). 2017;4:30.
    Abstract     Related articles   

  490. KONG DB, Chen F, Sima N
    Focal adhesion kinases crucially regulate TGFbeta-induced migration and invasion of bladder cancer cells via Src kinase and E-cadherin.
    Onco Targets Ther. 2017;10:1783-1792.
    Abstract     Related articles   

  491. LUO F, Wang YS, Su YH, Zhang ZH, et al
    Prognostic impact of preoperative anemia on non-muscle-invasive bladder carcinoma treated with GreenLight laser vaporization.
    Lasers Med Sci. 2017;32:397-403.
    Abstract     Related articles   

  492. KHACHATRYAN A
    [THE EARLY DIAGNOSTICS OF MULTIPLE PRIMARY TUMORS OF MALE UROGENITAL TRACT (REVIEW OF CLINICAL CASES)].
    Georgian Med News. 2016;.
    Abstract     Related articles   

  493. FAGHIH Z, Shobeiri SS, Ariafar A, Sarkarian M, et al
    CD8+ T Lymphocyte Subsets in Bladder Tumor Draining Lymph Nodes.
    Iran J Immunol. 2016;13:237-248.
    Abstract     Related articles   

  494. LENOS M, Katafigiotis I, Vrettou K, Papaioannou D, et al
    Evaluation of double immunocytochemical staining for CK20 and P53 as a potential adjunct to cytology for urothelial cancer diagnosis.
    Cytopathology. 2017;28:96-102.
    Abstract     Related articles   

  495. NAKAMURA T
    Development of a Drug Delivery System for Cancer Immunotherapy.
    Yakugaku Zasshi. 2016;136:1477-1484.
    Abstract     Related articles   

  496. MIKI Y, Neat M, Chandra A
    Application of The Paris System to atypical urine cytology samples: correlation with histology and UroVysion(R) FISH.
    Cytopathology. 2017;28:88-95.
    Abstract     Related articles   

  497. LEIVO MZ, Elson PJ, Tacha DE, Delahunt B, et al
    A combination of p40, GATA-3 and uroplakin II shows utility in the diagnosis and prognosis of muscle-invasive urothelial carcinoma.
    Pathology. 2016;48:543-9.
    Abstract     Related articles   

  498. TIAN DW, Hu HL, Sun Y, Tang Y, et al
    Biological effects of eukaryotic recombinant plasmid pReceiver-M61-BAI-1 transfection on T24 cells and HUVECs.
    Mol Med Rep. 2016;14:1553-9.
    Abstract     Related articles   

  499. HINRICHSEN S, Planer-Friedrich B
    Cytotoxic activity of selenosulfate versus selenite in tumor cells depends on cell line and presence of amino acids.
    Environ Sci Pollut Res Int. 2016;23:8349-57.
    Abstract     Related articles   

  500. SANLI O, Dobruch J, Knowles MA, Burger M, et al
    Bladder cancer.
    Nat Rev Dis Primers. 2017;3:17022.
    Abstract     Related articles   


  501. Bladder cancer.
    Nat Rev Dis Primers. 2017;3:17023.
    Abstract     Related articles   

  502. DAVIES BJ, Hwang TJ, Kesselheim AS
    Ensuring Access to Injectable Generic Drugs - The Case of Intravesical BCG for Bladder Cancer.
    N Engl J Med. 2017;376:1401-1403.
    Abstract     Related articles   

  503. WANG LH, Lei S, Dong Yuan S, Che X, et al
    Long-term floating control-released intravesical preparation of 5-fluorouracil for the local treatment of bladder cancer.
    Drug Dev Ind Pharm. 2017 Apr 12:1-21. doi: 10.1080/03639045.2017.1318898.
    Abstract     Related articles   

  504. NIEDERSUSS-BEKE D, Puntus T, Kunit T, Grunberger B, et al
    Neoadjuvant Chemotherapy with Gemcitabine plus Cisplatin in Patients with Locally Advanced Bladder Cancer.
    Oncology. 2017 Apr 12. doi: 10.1159/000463389.
    Abstract     Related articles   

  505. PANER GP, Montironi R, Amin MB
    Challenges in Pathologic Staging of Bladder Cancer: Proposals for Fresh Approaches of Assessing Pathologic Stage in Light of Recent Studies and Observations Pertaining to Bladder Histoanatomic Variances.
    Adv Anat Pathol. 2017;24:113-127.
    Abstract     Related articles   

  506. PATSCHAN O, Holmang S, Hosseini A, Jancke G, et al
    Second-look resection for primary stage T1 bladder cancer: a population-based study.
    Scand J Urol. 2017 Apr 11:1-7. doi: 10.1080/21681805.2017.1303846.
    Abstract     Related articles   

  507. KUSAKA A, Hatakeyama S, Hosogoe S, Hamano I, et al
    Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer.
    Med Oncol. 2017;34:90.
    Abstract     Related articles   

  508. ZHAO L, Tian X, Duan X, Ye Y, et al
    Association of body mass index with bladder cancer risk: a dose-response meta-analysis of prospective cohort studies.
    Oncotarget. 2017 Mar 30. doi: 10.18632/oncotarget.16722.
    Abstract     Related articles   

  509. LI Y, Wen JM, Du CJ, Hu SM, et al
    Thymol inhibits bladder cancer cell proliferation via inducing cell cycle arrest and apoptosis.
    Biochem Biophys Res Commun. 2017 Apr 4. pii: S0006-291X(17)30666.
    Abstract     Related articles   

  510. MALMSTROM PU, Hemdan T, Segersten U
    Validation of the ezrin, CK20, and Ki-67 as potential predictive markers for BCG instillation therapy of non-muscle-invasive bladder cancer.
    Urol Oncol. 2017 Apr 4. pii: S1078-1439(17)30110.
    Abstract     Related articles   

  511. CHALA B, Choi MH, Moon KC, Kim HS, et al
    Development of Urinary Bladder Pre-Neoplasia by Schistosoma haematobium Eggs and Chemical Carcinogen in Mice.
    Korean J Parasitol. 2017;55:21-29.
    Abstract     Related articles   

  512. SHARMA A, Mete UK, Sood A, Kakkar N, et al
    Utility of early dynamic and delayed post-diuretic 18F-FDG PET/CT SUVmax in predicting tumor grade and T-stage of urinary bladder carcinoma: Results from a prospective single center study.
    Br J Radiol. 2017 Mar 3:20160787. doi: 10.1259/bjr.20160787.
    Abstract     Related articles   

  513. AI XL, Chi Q, Qiu Y, Li HY, et al
    Gap junction protein connexin43 deregulation contributes to bladder carcinogenesis via targeting MAPK pathway.
    Mol Cell Biochem. 2017;428.
    Abstract     Related articles   

  514. LEMBO F, Subba E, Lagana AS, Vitale SG, et al
    Intradiverticular Sarcomatoid Carcinoma of The Bladder: An Overview Starting From A Peculiar Case.
    Urol J. 2016;13:2800-2.
    Abstract     Related articles   

  515. WU SW, Liou JH, Yeh KT, Hung TW, et al
    The Prevalence and Prognostic Significance of Polyomavirus Infection in Patients with Urothelial Carcinoma of the Bladder.
    Urol J. 2016;13:2773-8.
    Abstract     Related articles   

  516. BARNES SC, Shepherd DE, Espino DM, Bryan RT, et al
    Design of an improved surgical instrument for the removal of bladder tumours.
    Proc Inst Mech Eng H. 2016;230:579-87.
    Abstract     Related articles   

  517. SHRADER S, Lauridson J, King Z, Loch J, et al
    Urachal Adenocarcinoma in a Dog.
    J Comp Pathol. 2016;154:304-8.
    Abstract     Related articles   

  518. GUO S, Fan C, Rohr J, Fan L, et al
    A clinicopathologic study of paragangliomas of the urinary bladder: can the clinical behavior of the tumor be predicted?
    Histol Histopathol. 2016;31:785-91.
    Abstract     Related articles   

  519. NOVOTNY V, Froehner M, Koch R, Zastrow S, et al
    Age, American Society of Anesthesiologists physical status classification and Charlson score are independent predictors of 90-day mortality after radical cystectomy.
    World J Urol. 2016;34:1123-9.
    Abstract     Related articles   

  520. COMBERG D, Gauer A, Tschernig T
    First findings of gap junction proteins in human urothelial carcinoma.
    World J Urol. 2016;34:145-7.
    Abstract     Related articles   

  521. HUANG XL, Zhang H, Yang XY, Dong XY, et al
    Activation of a c-Jun N-terminal kinase-mediated autophagy pathway attenuates the anticancer activity of gemcitabine in human bladder cancer cells.
    Anticancer Drugs. 2017 Apr 20. doi: 10.1097/CAD.0000000000000499.
    Abstract     Related articles   

  522. BACCHETTI T, Sartini D, Pozzi V, Cacciamani T, et al
    Exploring the role of paraoxonase-2 in bladder cancer: analyses performed on tissue samples, urines and cell cultures.
    Oncotarget. 2017 Feb 24. doi: 10.18632/oncotarget.15674.
    Abstract     Related articles   

  523. EICH ML, Dyrskjot L, Netto GJ
    Toward personalized management in bladder cancer: the promise of novel molecular taxonomy.
    Virchows Arch. 2017 Apr 21. doi: 10.1007/s00428-017-2119.
    Abstract     Related articles   

  524. HAU AM, Nakasaki M, Nakashima K, Krish G, et al
    Differential mTOR pathway profiles in bladder cancer cell line subtypes to predict sensitivity to mTOR inhibition.
    Urol Oncol. 2017 Apr 18. pii: S1078-1439(17)30134.
    Abstract     Related articles   

  525. YANG LL, Wang XY, Zheng LY, Fang SJ, et al
    [The role of FOXO3a-Bim signaling in triptolide induced bladder cancer T24 cells apoptosis].
    Zhonghua Yi Xue Za Zhi. 2017;97:1187-1190.
    Abstract     Related articles   

  526. OZGOZ A, Samli M, Dincel D, Sahin A, et al
    Association of B7-H4 gene polymorphisms in urothelial bladder cancer.
    Turk J Med Sci. 2017;47:443-446.
    Abstract     Related articles   

  527. LIU X, Liu X, Wu Y, Wu Q, et al
    MicroRNAs in biofluids are novel tools for bladder cancer screening.
    Oncotarget. 2017 Mar 8. doi: 10.18632/oncotarget.16026.
    Abstract     Related articles   

  528. LEONE A, Diorio G, Sexton W, Schell M, et al
    Sulforaphane for the chemoprevention of bladder cancer: molecular mechanism targeted approach.
    Oncotarget. 2017 Mar 8. doi: 10.18632/oncotarget.16015.
    Abstract     Related articles   

  529. POYET C, Thomas L, Benoit TM, Delmo DA, et al
    Implication of vascular endothelial growth factor A and C in revealing diagnostic lymphangiogenic markers in node-positive bladder cancer.
    Oncotarget. 2017;8:21871-21883.
    Abstract     Related articles   

  530. CHEN L, Pan XW, Huang H, Gao Y, et al
    Epithelial-mesenchymal transition induced by GRO-alpha-CXCR2 promotes bladder cancer recurrence after intravesical chemotherapy.
    Oncotarget. 2017 Apr 3. doi: 10.18632/oncotarget.16786.
    Abstract     Related articles   

  531. STYRKE J, Henriksson H, Ljungberg B, Hasan M, et al
    Evaluation of the diagnostic accuracy of UBC(R) Rapid in bladder cancer: a Swedish multicentre study.
    Scand J Urol. 2017 Apr 19:1-8. doi: 10.1080/21681805.2017.1313309.
    Abstract     Related articles   

  532. SUN F, Zhao R, Zhu Y, Cui D, et al
    A prospective comparison of intra-arterial chemotherapy combined with intravesical chemotherapy and intravesical chemotherapy alone after transurethral resection with a thulium laser in high-risk non-muscle invasive bladder cancer.
    Cancer Chemother Pharmacol. 2017 Apr 18. doi: 10.1007/s00280-017-3305.
    Abstract     Related articles   

  533. D'ANDREA D, Moschini M, Gust K, Abufaraj M, et al
    Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Primary Non-muscle-invasive Bladder Cancer.
    Clin Genitourin Cancer. 2017 Mar 27. pii: S1558-7673(17)30069.
    Abstract     Related articles   

  534. YANG G, Shen W, Zhang Y, Liu M, et al
    Accumulation of myeloid-derived suppressor cells (MDSCs) induced by low levels of IL-6 correlates with poor prognosis in bladder cancer.
    Oncotarget. 2017 Mar 20. doi: 10.18632/oncotarget.16386.
    Abstract     Related articles   

  535. DUDEK AM, Boer SJ, Boon N, Witjes JA, et al
    Identification of long non-coding RNAs that stimulate cell survival in bladder cancer.
    Oncotarget. 2017 Mar 16. doi: 10.18632/oncotarget.16284.
    Abstract     Related articles   

  536. CHEN C, Hu L, Chen Y, Hou J, et al
    The prognostic value of histological subtype in patients with metastatic bladder cancer.
    Oncotarget. 2017 Mar 10. doi: 10.18632/oncotarget.16083.
    Abstract     Related articles   

  537. CUI X, Jing X, Long C, Yi Q, et al
    Accuracy of the urine UCA1 for diagnosis of bladder cancer: a meta-analysis.
    Oncotarget. 2017 Mar 22. doi: 10.18632/oncotarget.16473.
    Abstract     Related articles   

  538. SHAO CH, Chen CL, Lin JY, Chen CJ, et al
    Metabolite marker discovery for the detection of bladder cancer by comparative metabolomics.
    Oncotarget. 2017 Mar 21. doi: 10.18632/oncotarget.16393.
    Abstract     Related articles   

  539. WEI Y, Gao L, Wang L, Shi L, et al
    Polydopamine and peptide decorated doxorubicin-loaded mesoporous silica nanoparticles as a targeted drug delivery system for bladder cancer therapy.
    Drug Deliv. 2017;24:681-691.
    Abstract     Related articles   

  540. LEONE AR, Zargar-Shoshtari K, Diorio GJ, Sharma P, et al
    Neoadjuvant Chemotherapy in Elderly Patients With Bladder Cancer: Oncologic Outcomes From a Single Institution Experience.
    Clin Genitourin Cancer. 2017 Feb 1. pii: S1558-7673(17)30030.
    Abstract     Related articles   

  541. SURYAVANSHI M, Sanz-Ortega J, Sirohi D, Divatia MK, et al
    S100P as a Marker for Urothelial Histogenesis: A Critical Review and Comparison With Novel and Traditional Urothelial Immunohistochemical Markers.
    Adv Anat Pathol. 2017;24:151-160.
    Abstract     Related articles   

  542. ELHAWARY NA, Nassir A, Saada H, Dannoun A, et al
    Combined Genetic Biomarkers Confer Susceptibility to Risk of Urothelial Bladder Carcinoma in a Saudi Population.
    Dis Markers. 2017;2017:1474560.
    Abstract     Related articles   

  543. AMAYA CN, Wians FH Jr, Bryan BA, Torabi A, et al
    Enhanced expression of Programmed cell death 1 (PD-1) protein in benign vascular anomalies.
    Pathology. 2017;49:292-296.
    Abstract     Related articles   

  544. BIGOT F, Bonnet C, Massard C
    [Immunotherapy for the treatment of patients with genitourinary cancers: Review and perspectives].
    Bull Cancer. 2017;104:370-379.
    Abstract     Related articles   

  545. FUKUSHIMA K, Hirosako S, Tenjin Y, Mukasa Y, et al
    Pulmonary Mucosa-associated Lymphoid Tissue Lymphoma with Spontaneous Regression after Computed Tomography-guided Needle Biopsy: A Case Report and Summary of 8 Reported Cases.
    Intern Med. 2016;55:3655-3660.
    Abstract     Related articles   

  546. WANG H, Yuan G, Zhao B, Zhao Y, et al
    High expression of B23 is associated with tumorigenesis and poor prognosis in bladder urothelial carcinoma.
    Mol Med Rep. 2017;15:743-749.
    Abstract     Related articles   

  547. PASCHKE L, Juszczak M, Slupski M
    Surgical treatment of recurrent urachal carcinoma with liver metastasis: a case report and literature review.
    World J Surg Oncol. 2016;14:296.
    Abstract     Related articles   

  548. CHO MH, Kim SH, Park WS, Joung JY, et al
    Bladder chondrosarcoma plus urothelial carcinoma in recurred transitional cell carcinoma of the upper urinary tract: a case report and literature review.
    World J Surg Oncol. 2016;14:270.
    Abstract     Related articles   

  549. SEVINC C, Ozkaptan O, Balaban M, Yucetas U, et al
    Radical Cystoprostatectomy in Patients with Behcet's Disease: The Report of Four Cases and Review of The Literature.
    Urol J. 2016;13:2871-2875.
    Abstract     Related articles   

  550. MAI KT, Bateman J, Djordjevic B, Flood TA, et al
    Clear Cell Urothelial Carcinoma.
    Int J Surg Pathol. 2017;25:18-25.
    Abstract     Related articles   

  551. RAIS-BAHRAMI S, Tracht JP, McIntosh ER, Lai WS, et al
    Complete Tissue Submission to Increase Lymph Node Detection in Pelvic Lymph Node Packets Submitted for Patients Undergoing Radical Prostatectomy and Radical Cystectomy.
    Int J Surg Pathol. 2017;25:12-17.
    Abstract     Related articles   

  552. YIKILMAZ TN, Dirim A, Ayva ES, Ozdemir H, et al
    Clinical Use of Tumor Markers for the Detection and Prognosis of Bladder Carcinoma: A Comparison of CD44, Cytokeratin 20 and Survivin.
    Urol J. 2016;13:2677-83.
    Abstract     Related articles   

  553. GOTO K
    CD138 Expression Is Observed in the Urothelial Epithelium and in Various Urothelial Carcinomas, and Cannot Be Evidence for Plasmacytoid Urothelial Carcinoma.
    Int J Surg Pathol. 2016;24:614-9.
    Abstract     Related articles   

  554. MAY M, Fritsche HM, Vetterlein MW, Bastian PJ, et al
    Impact of photodynamic diagnosis-assisted transurethral resection of bladder tumors on the prognostic outcome after radical cystectomy: results from PROMETRICS 2011.
    World J Urol. 2017;35:245-250.
    Abstract     Related articles   

  555. GOLABEK T, Palou J, Rodriguez O, Gaya JM, et al
    Is it possible to stop follow-up of patients with primary T1G3 urothelial carcinoma of the bladder managed with intravesical bacille Calmette-Guerin immunotherapy?
    World J Urol. 2017;35:237-243.
    Abstract     Related articles   

  556. LIU CW, Wu YT, Lin KJ, Yu TJ, et al
    A Hydrogel-Based Epirubicin Delivery System for Intravesical Chemotherapy.
    Molecules. 2016;21.
    Abstract     Related articles   

  557. ANGELINI L, Bisogno G, Alaggio R, Scarzello G, et al
    Prognostic factors in children undergoing salvage surgery for bladder/prostate rhabdomyosarcoma.
    J Pediatr Urol. 2016;12:265.
    Abstract     Related articles   

  558. SHAO IH, Chang YH, Yu KJ, Lin PH, et al
    Outcomes and prognostic factors of simple partial cystectomy for localized bladder urothelial cell carcinoma.
    Kaohsiung J Med Sci. 2016;32:191-5.
    Abstract     Related articles   

  559. LODH B, Sinam RS, Singh KA
    Adenocarcinoma of urinary bladder in patient with primary gastric cancer: An unusual synchronous distant metastasis.
    Indian J Cancer. 2016;53:53-5.
    Abstract     Related articles   

  560. DOGANTEKIN E, Girgin C, Gorgel SN, Soylemez H, et al
    Can immediate second resection be an alternative to standardized second transurethral resection of bladder tumors?
    Kaohsiung J Med Sci. 2016;32:147-51.
    Abstract     Related articles   

  561. KURTIS B, Zhuge J, Ojaimi C, Ye F, et al
    Recurrent TERT promoter mutations in urothelial carcinoma and potential clinical applications.
    Ann Diagn Pathol. 2016;21:7-11.
    Abstract     Related articles   

  562. MITRA S, Sundaram AK, Gupta K, Devana SK, et al
    Urothelial Carcinoma With Villoglandular Differentiation: A Rare Entity.
    Int J Surg Pathol. 2016;24:356-9.
    Abstract     Related articles   

  563. VILLA L, Cloutier J, Letendre J, Ploumidis A, et al
    Early repeated ureteroscopy within 6-8 weeks after a primary endoscopic treatment in patients with upper tract urothelial cell carcinoma: preliminary findings.
    World J Urol. 2016;34:1201-6.
    Abstract     Related articles   

  564. BREYER J, Gierth M, Shalekenov S, Aziz A, et al
    Epithelial-mesenchymal transformation markers E-cadherin and survivin predict progression of stage pTa urothelial bladder carcinoma.
    World J Urol. 2016;34:709-16.
    Abstract     Related articles   

  565. GRIMM T, Buchner A, Schneevoigt B, Kretschmer A, et al
    Impact of preoperative hemoglobin and CRP levels on cancer-specific survival in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: results of a single-center study.
    World J Urol. 2016;34:703-8.
    Abstract     Related articles   

  566. ZARGAR-SHOSHTARI K, Zargar H, Dinney CP, Ercole CE, et al
    Clinical and therapeutic factors associated with adverse pathological outcomes in clinically node-negative patients treated with neoadjuvant cisplatin-based chemotherapy and radical cystectomy.
    World J Urol. 2016;34:695-701.
    Abstract     Related articles   

  567. MATEU L, Garcia-Cruz E, Asiain I, Castaneda R, et al
    A higher Charlson comorbidity index is related to more aggressive characteristics in de novo vesical tumours.
    Actas Urol Esp. 2016;40:23-8.
    Abstract     Related articles   

  568. HANAZONO K, Nishimori T, Fukumoto S, Kawamura Y, et al
    Immunohistochemical expression of p63, Ki67 and beta-catenin in canine transitional cell carcinoma and polypoid cystitis of the urinary bladder.
    Vet Comp Oncol. 2016;14:263-9.
    Abstract     Related articles   

  569. LI G, Niu HM, Wu HT, Lei BY, et al
    Effect of cisplatin-based neoadjuvant chemotherapy on survival in patients with bladder cancer: a meta-analysis.
    Clin Invest Med. 2017;40:E81-E94.
    Abstract     Related articles   


  570. Nod for Atezolizumab in Advanced Bladder Cancer.
    Cancer Discov. 2017 Apr 26. doi: 10.1158/2159-8290.CD-NB2017.
    Abstract     Related articles   

  571. CORMIO L, Sanguedolce F, Cormio A, Massenio P, et al
    Human epidermal growth factor receptor 2 expression is more important than Bacillus Calmette Guerin treatment in predicting the outcome of T1G3 bladder cancer.
    Oncotarget. 2017;8:25433-25441.
    Abstract     Related articles   

  572. LIN J, Zhan Y, Liu Y, Chen Z, et al
    Increased expression of ZEB1-AS1 correlates with higher histopathological grade and promotes tumorigenesis in bladder cancer.
    Oncotarget. 2017;8:24202-24212.
    Abstract     Related articles   

  573. ZHU XX, Yan YW, Ai CZ, Jiang S, et al
    Jarid2 is essential for the maintenance of tumor initiating cells in bladder cancer.
    Oncotarget. 2017;8:24483-24490.
    Abstract     Related articles   

  574. KIM TS, Chung JI, Noh GH, Hwang H, et al
    Toward Better Predictions of Chemosensitivity: Comparative Study of Conventional and Simulated Chemosensitivity Tests for Bladder Cancer Cell Lines.
    Ann Lab Med. 2017;37:343-345.
    Abstract     Related articles   

  575. ZHANG YX, Qin CP, Zhang XQ, Wang QR, et al
    Knocking down glycoprotein nonmetastatic melanoma protein B suppresses the proliferation, migration, and invasion in bladder cancer cells.
    Tumour Biol. 2017;39:1010428317699119.
    Abstract     Related articles   

  576. MCPHERSON VA, Rodrigues G, Bauman G, Winquist E, et al
    Supplementary data: Chemoradiotherapy in octogenarians as primary treatment for muscle-invasive bladder cancer.
    Can Urol Assoc J. 2017;11.
    Abstract     Related articles   

  577. MCPHERSON VA, Rodrigues G, Bauman G, Winquist E, et al
    Chemoradiotherapy in octogenarians as primary treatment for muscle-invasive bladder cancer.
    Can Urol Assoc J. 2017;11.
    Abstract     Related articles   

  578. SIDAWAY P
    Bladder cancer: Targeting oncofetal glycosaminoglycans.
    Nat Rev Urol. 2017 Apr 25. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  579. TERRACCIANO D, Ferro M, Terreri S, Lucarelli G, et al
    Urinary long noncoding RNAs in nonmuscle-invasive bladder cancer: new architects in cancer prognostic biomarkers.
    Transl Res. 2017 Apr 7. pii: S1931-5244(16)30227.
    Abstract     Related articles   

  580. LIANG LG, Kong MQ, Zhou S, Sheng YF, et al
    An integrated double-filtration microfluidic device for isolation, enrichment and quantification of urinary extracellular vesicles for detection of bladder cancer.
    Sci Rep. 2017;7:46224.
    Abstract     Related articles   

  581. ZHOU Q, Song W, Xiao W
    Dioscin induces demethylation of DAPK-1 and RASSF-1alpha genes via the antioxidant capacity, resulting in apoptosis of bladder cancer T24 cells.
    EXCLI J. 2017;16:101-112.
    Abstract     Related articles   

  582. LIN YC, Lin JF, Wen SI, Yang SC, et al
    Chloroquine and hydroxychloroquine inhibit bladder cancer cell growth by targeting basal autophagy and enhancing apoptosis.
    Kaohsiung J Med Sci. 2017;33:215-223.
    Abstract     Related articles   

  583. LI Z, Liao H, Tan Z, Mao D, et al
    Micropapillary bladder cancer: a clinico-pathological characterization and treatment analysis.
    Clin Transl Oncol. 2017 Apr 21. doi: 10.1007/s12094-017-1658.
    Abstract     Related articles   

  584. HOY NY, Cohn JA, Kowalik CG, Kaufman MR, et al
    Management of Voiding Dysfunction After Female Neobladder Creation.
    Curr Urol Rep. 2017;18:33.
    Abstract     Related articles   

  585. ZAINFELD D, Daneshmand S
    Transurethral Resection of Bladder Tumors: Improving Quality Through New Techniques and Technologies.
    Curr Urol Rep. 2017;18:34.
    Abstract     Related articles   

  586. AUTORINO R, Porpiglia F, Dasgupta P, Rassweiler J, et al
    Precision surgery and genitourinary cancers.
    Eur J Surg Oncol. 2017;43:893-908.
    Abstract     Related articles   

  587. TSUKADA H, Miyakawa H
    Henoch Schonlein Purpura Nephritis Associated with Intravesical Bacillus Calmette-Guerin (BCG) Therapy.
    Intern Med. 2017;56:541-544.
    Abstract     Related articles   

  588. XU A, Ahsanul Kabir Khan M, Chen F, Zhong Z, et al
    Overexpression of autotaxin is associated with human renal cell carcinoma and bladder carcinoma and their progression.
    Med Oncol. 2016;33:131.
    Abstract     Related articles   

  589. GAJASINGHE DG, Nazeer I, Maddumage HP, Perera C, et al
    Metachronous bladder metastases of a type 2 papillary renal cell carcinoma: a case report and review of the literature.
    World J Surg Oncol. 2016;14:219.
    Abstract     Related articles   

  590. LI AY, Filson CP, Hollingsworth JM, He C, et al
    Patient-Reported Convalescence and Quality of Life Recovery: A Comparison of Open and Robotic-Assisted Radical Cystectomy.
    Surg Innov. 2016;23:598-605.
    Abstract     Related articles   

  591. BEQUET E, Stiennon L, Lhomme A, Piette C, et al
    [Rectal prolapse revealing a tumor: The role of abdominal ultrasound].
    Arch Pediatr. 2016 Jun 2. pii: S0929-693X(16)30200.
    Abstract     Related articles   

  592. ZARGAR-SHOSHTARI K, Kongnyuy M, Sharma P, Fishman MN, et al
    Clinical role of additional adjuvant chemotherapy in patients with locally advanced urothelial carcinoma following neoadjuvant chemotherapy and cystectomy.
    World J Urol. 2016;34:1567-1573.
    Abstract     Related articles   

  593. GOONEWARDENE SS, Persad R, Gillatt D
    Robotic radical cystectomy and enhanced recovery: a new pathway.
    World J Urol. 2016;34:1599-1600.
    Abstract     Related articles   

  594. PARKER WP, Ho PL, Boorjian SA, Melquist JJ, et al
    The importance of clinical stage among patients with a complete pathologic response at radical cystectomy after neoadjuvant chemotherapy.
    World J Urol. 2016;34:1561-1566.
    Abstract     Related articles   

  595. SONG YP, Ma JB, Wang L, Chen EC, et al
    Efficacy and safety of late-course hypofractionated radiation therapy for muscle-invasive bladder carcinoma after bladder-conserving surgery.
    Asia Pac J Clin Oncol. 2017;13:e111-e116.
    Abstract     Related articles   

  596. HUANG Z, Liu H, Wang Y, Zhang C, et al
    Determining the optimal maintenance schedules for adjuvant intravesical bacillus Calmette-Guerin immunotherapy in non-muscle-invasive bladder cancer: a systematic review and network meta-analysis.
    Curr Med Res Opin. 2017 May 4:1-19. doi: 10.1080/03007995.2017.1326889.
    Abstract     Related articles   

  597. NAN YH, Wang Y, Sun PH, Han Y, et al
    MiR-6838 Promotes Growth and Invasion in Bladder Cancer Via Suppression of Rb.
    Oncol Res. 2017 May 4. doi: 10.3727/096504017X14928634401169.
    Abstract     Related articles   

  598. ZHANG Q, Huang S, Luo H, Zhao X, et al
    Eight-plex iTRAQ labeling and quantitative proteomic analysis for human bladder cancer.
    Am J Cancer Res. 2017;7:935-945.
    Abstract     Related articles   

  599. NAN YH, Wang J, Wang Y, Sun PH, et al
    Erratum: MiR-4295 promotes cell growth in bladder cancer by targeting BTG1.
    Am J Transl Res. 2017;9:1960.
    Abstract     Related articles   

  600. BIJALWAN P, Pooleri GK, Thomas A
    Comparison of sterile water irrigation versus intravesical mitomycin C in preventing recurrence of nonmuscle invasive bladder cancer after transurethral resection.
    Indian J Urol. 2017;33:144-148.
    Abstract     Related articles   

  601. MITASH N, Tiwari S, Agnihotri S, Mandhani A, et al
    Bladder cancer: Micro RNAs as biomolecules for prognostication and surveillance.
    Indian J Urol. 2017;33:127-133.
    Abstract     Related articles   

  602. PINTO IG
    Systemic therapy in bladder cancer.
    Indian J Urol. 2017;33:118-126.
    Abstract     Related articles   

  603. SMELSER WW, Austenfeld MA, Holzbeierlein JM, Lee EK, et al
    Where are we with bladder preservation for muscle-invasive bladder cancer in 2017?
    Indian J Urol. 2017;33:111-117.
    Abstract     Related articles   

  604. KUKREJA JB, Shah JB
    Advances in surgical management of muscle invasive bladder cancer.
    Indian J Urol. 2017;33:106-110.
    Abstract     Related articles   

  605. KAMAT AM
    Bladder cancer: 2017 and beyond.
    Indian J Urol. 2017;33:104-105.
    Abstract     Related articles   

  606. TAE BS, Kim JK, Kang M, Jeong CW, et al
    Prognostic value of impaired estimated glomerular filtration rate in intravesical BCG-treated non-muscle-invasive bladder cancer patients.
    Sci Rep. 2017;7:1380.
    Abstract     Related articles   

  607. ECKE TH, Weiss S, Stephan C, Hallmann S, et al
    UBC(R) Rapid Test for detection of carcinoma in situ for bladder cancer.
    Tumour Biol. 2017;39:1010428317701624.
    Abstract     Related articles   

  608. SEVERINO PF, Silva M, Carrascal M, Malagolini N, et al
    Expression of sialyl-Tn sugar antigen in bladder cancer cells affects response to Bacillus Calmette Guerin (BCG) and to oxidative damage.
    Oncotarget. 2017 Apr 17. doi: 10.18632/oncotarget.17138.
    Abstract     Related articles   

  609. POLETAJEW S, Radziszewski P
    Endoscopic appearance of a tumor can predict the stage of bladder cancer.
    Cent European J Urol. 2017;70:27-28.
    Abstract     Related articles   

  610. SCHULZ WA, Kramer MW, Fuessel S, Stohr R, et al
    [The 6th symposium of the German Association for Bladder Cancer Research].
    Urologe A. 2017 May 2. doi: 10.1007/s00120-017-0405.
    Abstract     Related articles   

  611. CHEN Y, Peng Y, Xu Z, Ge B, et al
    LncROR Promotes Bladder Cancer Cell Proliferation, Migration, and Epithelial-Mesenchymal Transition.
    Cell Physiol Biochem. 2017;41:2399-2410.
    Abstract     Related articles   

  612. OMAR NN, Tash RF, Shoukry Y, ElSaeed KO, et al
    Breaking the ritual metabolic cycle in order to save acetyl CoA: A potential role for mitochondrial humanin in T2 bladder cancer aggressiveness.
    J Egypt Natl Canc Inst. 2017 Apr 24. pii: S1110-0362(17)30028.
    Abstract     Related articles   

  613. GRZEGOLKOWSKI P, Kaczmarek K, Leminski A, Soczawa M, et al
    Assessment of the infiltrative character of bladder cancer at the time of transurethral resection: a single center study.
    Cent European J Urol. 2017;70:22-26.
    Abstract     Related articles   

  614. CAMPODONICO F, Di Stasi S, Lev GM, Terrone C, et al
    Intravesical chemotherapy and chemohypherthermia in non-muscle-invasive bladder cancer; an overview on drug administration technologies and pharmacokinetics.
    Curr Drug Metab. 2017 Apr 26. doi: 10.2174/1389200218666170427092421.
    Abstract     Related articles   

  615. YONG C, Daihui C, Bo Z
    Laparoscopic versus open radical cystectomy for patients with bladder cancer over 75-year-old: a prospective randomized controlled trial.
    Oncotarget. 2017;8:26565-26572.
    Abstract     Related articles   

  616. GUERRERO-RAMOS F, Lara-Isla A, Justo-Quintas J, Duarte-Ojeda JM, et al
    Adjuvant intravesical treatment for nonmuscle invasive bladder cancer: The importance of the strain and maintenance.
    Actas Urol Esp. 2017 Apr 27. pii: S0210-4806(17)30062.
    Abstract     Related articles   

  617. WU J, Yu C, Cai L, Lu Y, et al
    Effects of increased Kindlin-2 expression in bladder cancer stromal fibroblasts.
    Oncotarget. 2017 Apr 10. doi: 10.18632/oncotarget.17021.
    Abstract     Related articles   

  618. RUTHERFORD C, Costa DSJ, King MT, Smith DP, et al
    A conceptual framework for patient-reported outcomes in non-muscle invasive bladder cancer.
    Support Care Cancer. 2017 Apr 27. doi: 10.1007/s00520-017-3717.
    Abstract     Related articles   

  619. DROCAS AI, Tomescu PI, Mitroi G, Dragoescu PO, et al
    The cadherin switch assessment in the epithelial-mesenchymal transition of urothelial bladder carcinomas.
    Rom J Morphol Embryol. 2016;57:1037-1044.
    Abstract     Related articles   

  620. OBARA W, Eto M, Mimata H, Kohri K, et al
    A phase I/II study of cancer peptide vaccine S-288310 in patients with advanced urothelial carcinoma of the bladder.
    Ann Oncol. 2017;28:798-803.
    Abstract     Related articles   

  621. FINKEL ML
    Shale gas development and cancer incidence in southwest Pennsylvania.
    Public Health. 2016;141:198-206.
    Abstract     Related articles   

  622. DUVNJAK P, Laguna M
    Left Anterior Descending Coronary Artery and Multiple Peripheral Mycotic Aneurysms Due to Mycobacterium Bovis Following Intravesical Bacillus Calmette-Guerin Therapy: A Case Report.
    J Radiol Case Rep. 2016;10:12-27.
    Abstract     Related articles   

  623. ROSATI Y, Fabiani A, Taccari T, Ranaldi R, et al
    Intravesical BCG therapy as cause of miliary pulmonary tuberculosis.
    Urologia. 2016;83:49-53.
    Abstract     Related articles   

  624. RINALDETTI S, Wirtz RM, Worst TS, Eckstein M, et al
    FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypes.
    Oncotarget. 2017 Apr 24. doi: 10.18632/oncotarget.17394.
    Abstract     Related articles   

  625. KASAHARA R, Kawahara T, Ohtake S, Saitoh Y, et al
    A Low Psoas Muscle Index before Treatment Can Predict a Poorer Prognosis in Advanced Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy.
    Biomed Res Int. 2017;2017:7981549.
    Abstract     Related articles   

  626. SANKIN A, Narasimhulu D, John P, Gartrell B, et al
    The expanding repertoire of targets for immune checkpoint inhibition in bladder cancer: What lies beneath the tip of the iceberg, PD-L1.
    Urol Oncol. 2017 May 8. pii: S1078-1439(17)30176.
    Abstract     Related articles   

  627. RAGHAVAN D
    No Bridge Over Troubled Water: Slow Progress in Bladder Cancer.
    J Oncol Pract. 2017;13:317-318.
    Abstract     Related articles   

  628. WU Z, Wang S, Xue P, Wang S, et al
    Inhibitory member of the apoptosis-stimulating protein of p53 is overexpressed in bladder cancer and correlated to its progression.
    Medicine (Baltimore). 2017;96:e6640.
    Abstract     Related articles   

  629. YEH HL, Hsu SW, Chang YC, Chan TC, et al
    Spatial Analysis of Ambient PM2.5 Exposure and Bladder Cancer Mortality in Taiwan.
    Int J Environ Res Public Health. 2017;14.
    Abstract     Related articles   

  630. PAPARO SR, Fallahi P
    Bladder cancer and Th1 chemokines
    Clin Ter. 2017;168:e59-e63.
    Abstract     Related articles   

  631. LATOSINSKA A, Mokou M, Makridakis M, Mullen W, et al
    Proteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention.
    Oncotarget. 2017 Apr 20. doi: 10.18632/oncotarget.17279.
    Abstract     Related articles   

  632. FULKERSON CM, Dhawan D, Ratliff TL, Hahn NM, et al
    Naturally Occurring Canine Invasive Urinary Bladder Cancer: A Complementary Animal Model to Improve the Success Rate in Human Clinical Trials of New Cancer Drugs.
    Int J Genomics. 2017;2017:6589529.
    Abstract     Related articles   

  633. PRADO K, Zhang KX, Pellegrini M, Chin AI, et al
    Sequencing of cancer cell subpopulations identifies micrometastases in a bladder cancer patient.
    Oncotarget. 2017 Apr 21. doi: 10.18632/oncotarget.17312.
    Abstract     Related articles   

  634. SALOMO K, Huebner D, Boehme MU, Herr A, et al
    Urinary transcript quantitation of CK20 and IGF2 for the non-invasive bladder cancer detection.
    J Cancer Res Clin Oncol. 2017 May 8. doi: 10.1007/s00432-017-2433.
    Abstract     Related articles   

  635. OSTWAL V, Pinninti R, Ramaswamy A, Shetty N, et al
    Treatment of advanced Gall bladder cancer in the real world-can continuation chemotherapy improve outcomes?
    J Gastrointest Oncol. 2017;8:368-376.
    Abstract     Related articles   

  636. MOWLDS DS, Foster CE, Ichii H
    Invasive squamous cell bladder cancer of the ureterovesical junction in a renal transplant patient: a case report.
    J Surg Case Rep. 2017;2017:rjx066.
    Abstract     Related articles   

  637. XIA L, Taylor BL, Guzzo TJ
    Characteristics and Associated Factors of Postoperative Pulmonary Complications in Patients Undergoing Radical Cystectomy for Bladder Cancer: A National Surgical Quality Improvement Program Study.
    Clin Genitourin Cancer. 2017 Apr 13. pii: S1558-7673(17)30093.
    Abstract     Related articles   

  638. ZAKARIA AS, Santos F, Dragomir A, Kassouf W, et al
    Health care services utilization during the last 6 months of life among patients with bladder cancer who underwent radical cystectomy in Quebec, Canada.
    Urol Oncol. 2017 May 4. pii: S1078-1439(17)30174.
    Abstract     Related articles   

  639. NECCHI A, Raggi D, Giannatempo P, Sonpavde G, et al
    From the Uncertainties to the Evidence: A Brief History of Immunotherapy as Salvage Therapy for Advanced Bladder Cancer Through a Meta-analysis.
    Clin Genitourin Cancer. 2017 Apr 13. pii: S1558-7673(17)30092.
    Abstract     Related articles   

  640. WILLIAMS SB, Huo J, Kosarek CD, Chamie K, et al
    Population-based assessment of racial/ethnic differences in utilization of radical cystectomy for patients diagnosed with bladder cancer.
    Cancer Causes Control. 2017 May 5. doi: 10.1007/s10552-017-0902.
    Abstract     Related articles   

  641. SRINIVASAN A, Apostolov R, Leong A, Johnson D, et al
    Atraumatic chylous ascites: an unusual presentation of bladder cancer.
    BMJ Case Rep. 2017;2017.
    Abstract     Related articles   

  642. GILL DM, Sonpavde G, Pal SK, Agarwal N, et al
    Which checkpoint inhibitor? An embarrassment of riches for bladder cancer.
    Immunotherapy. 2017;9:463-466.
    Abstract     Related articles   

  643. MITHQAL A, Darvishi P, Rehm P
    MIBG Localization of a Subclinical Paraganglioma of the Bladder.
    Clin Nucl Med. 2017;42:e196-e198.
    Abstract     Related articles   

  644. SJODAHL G, Eriksson P, Liedberg F, Hoglund M, et al
    Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification.
    J Pathol. 2017;242:113-125.
    Abstract     Related articles   

  645. CHEN Z, Liu Q, Chen R, Liu Z, et al
    Clinical analysis of small cell carcinoma of the bladder in Chinese: nine case reports and literature reviews.
    World J Surg Oncol. 2017;15:33.
    Abstract     Related articles   

  646. BLANCA A, Cheng L, Montironi R, Moch H, et al
    Mirna Expression in Bladder Cancer and Their Potential Role in Clinical Practice.
    Curr Drug Metab. 2017 May 18. doi: 10.2174/1389200218666170518164507.
    Abstract     Related articles   

  647. COHEN T, Ricchiuti D, Memo M
    Bladder cancer that metastasized to the skin: A unique presentation that signifies poor prognosis.
    Rev Urol. 2017;19:67-71.
    Abstract     Related articles   

  648. GAO F, Xu T, Wang X, Zhong S, et al
    CIP2A mediates fibronectin-induced bladder cancer cell proliferation by stabilizing beta-catenin.
    J Exp Clin Cancer Res. 2017;36:70.
    Abstract     Related articles   

  649. HAO L, Zhao Y, Li ZG, He HG, et al
    Tumor necrosis factor-related apoptosis-inducing ligand inhibits proliferation and induces apoptosis of prostate and bladder cancer cells.
    Oncol Lett. 2017;13:3638-3640.
    Abstract     Related articles   

  650. CHEN J, Zhang N, Wen J, Zhang Z, et al
    Silencing TAK1 alters gene expression signatures in bladder cancer cells.
    Oncol Lett. 2017;13:2975-2981.
    Abstract     Related articles   

  651. YAN L, Wang Y, Liang J, Liu Z, et al
    MiR-301b Promotes the Proliferation, Mobility and Epithelial-to-Mesenchymal Transition of Bladder Cancer Cells by Targeting EGR1.
    Biochem Cell Biol. 2017 May 18. doi: 10.1139/bcb-2016-0232.
    Abstract     Related articles   

  652. BACHIR BG, Souhami L, Mansure JJ, Cury F, et al
    Phase I Clinical Trial of Everolimus Combined with Trimodality Therapy in Patients with Muscle-Invasive Bladder Cancer.
    Bladder Cancer. 2017;3:105-112.
    Abstract     Related articles   

  653. PAN Q, Sathe A, Black PC, Goebell PJ, et al
    CDK4/6 Inhibitors in Cancer Therapy: A Novel Treatement Strategy for Bladder Cancer.
    Bladder Cancer. 2017;3:79-88.
    Abstract     Related articles   

  654. ZHOU L, Xu L, Chen L, Fu Q, et al
    Tumor-infiltrating neutrophils predict benefit from adjuvant chemotherapy in patients with muscle invasive bladder cancer.
    Oncoimmunology. 2017;6:e1293211.
    Abstract     Related articles   

  655. ANIL H, Karamik K, Ates M, Yuksel M, et al
    A Rare Clinical Entity in Bladder Cancer: Paraneoplastic Cerebellar Degeneration.
    Clin Genitourin Cancer. 2017 Apr 26. pii: S1558-7673(17)30110.
    Abstract     Related articles   

  656. NISHIZAWA T, Yoshida S, Koga F, Tanaka H, et al
    Standardization of the apparent diffusion coefficient value of bladder cancer across different centers: Applicability in predicting aggressive pathologic phenotypes.
    Clin Imaging. 2017;44:121-126.
    Abstract     Related articles   

  657. LIU Q, Liu H, Cheng H, Li Y, et al
    Downregulation of long noncoding RNA TUG1 inhibits proliferation and induces apoptosis through the TUG1/miR-142/ZEB2 axis in bladder cancer cells.
    Onco Targets Ther. 2017;10:2461-2471.
    Abstract     Related articles   

  658. ZHANG K, Wang W, Wu K, Ding C, et al
    [Knock-down of DAB2 interacting protein (DAB2IP) promotes proliferation and inhibits apoptosis of bladder cancer cells].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2017;33:668-676.
    Abstract     Related articles   

  659. SCHMID SC, Sathe A, Guerth F, Seitz AK, et al
    Wntless promotes bladder cancer growth and acts synergistically as a molecular target in combination with cisplatin.
    Urol Oncol. 2017 May 10. pii: S1078-1439(17)30187.
    Abstract     Related articles   

  660. IBANEZ MUNOZ D, Quintana Martinez I, Fernandez Militino A, Sanchez Zalabardo D, et al
    Virtual cystoscopy, computed tomography urography and optical cystoscopy for the detection and follow-up for bladder cancer.
    Radiologia. 2017 May 10. pii: S0033-8338(17)30054.
    Abstract     Related articles   

  661. AVELLINI C, Licini C, Lazzarini R, Gesuita R, et al
    The trophoblast cell surface antigen 2 and miR-125b axis in urothelial bladder cancer.
    Oncotarget. 2017 Apr 25. doi: 10.18632/oncotarget.17407.
    Abstract     Related articles   

  662. NORO D, Hatakeyama S, Yoneyama T, Hashimoto Y, et al
    Post-chemotherapy PD-L1 expression correlates with clinical outcomes in Japanese bladder cancer patients treated with total cystectomy.
    Med Oncol. 2017;34:117.
    Abstract     Related articles   

  663. SROUGI V, Gallucci FP, Mattedi RL, Srougi M, et al
    Carcinosarcoma of the bladder following local schistosomiasis infection.
    BMJ Case Rep. 2017;2017.
    Abstract     Related articles   

  664. ERBAY G, Akyol F, Karabakan M, Celebi B, et al
    Effect of obturator nerve block during transurethral resection of lateral bladder wall tumors on the presence of detrusor muscle in tumor specimens and recurrence of the disease.
    Kaohsiung J Med Sci. 2017;33:86-90.
    Abstract     Related articles   

  665. TAO T, He C, Deng J, Huang Y, et al
    A novel synthetic derivative of quercetin, 8-trifluoromethyl- 3,5,7,3',4'-O-pentamethyl-quercetin, inhibits bladder cancer growth by targeting the AMPK/mTOR signaling pathway.
    Oncotarget. 2017 May 11. doi: 10.18632/oncotarget.17799.
    Abstract     Related articles   

  666. YIN H, Yang X, Gu W, Liu Y, et al
    HMGB1-mediated autophagy attenuates gemcitabine-induced apoptosis in bladder cancer cells involving JNK and ERK activation.
    Oncotarget. 2017 May 11. doi: 10.18632/oncotarget.17796.
    Abstract     Related articles   

  667. WANG YN, Wang FD, Zhu L
    [Ileo-vaginal fistula caused by bladder cancer recurrence after posterior colporrhaphy: a case report].
    Zhonghua Fu Chan Ke Za Zhi. 2017;52:343.
    Abstract     Related articles   

  668. MIKHAIL AS, Negussie AH, Pritchard WF, Haemmerich D, et al
    Lyso-thermosensitive liposomal doxorubicin for treatment of bladder cancer.
    Int J Hyperthermia. 2017 May 10:1-8. doi: 10.1080/02656736.2017.1315459.
    Abstract     Related articles   

  669. WARD DG, Bryan RT
    Liquid biopsies for bladder cancer.
    Transl Androl Urol. 2017;6:331-335.
    Abstract     Related articles   

  670. EL SAYED I, Elkhwsky F, La Vecchia C, Alicandro G, et al
    The frequency of bladder cancer in Alexandria, Egypt, over the last two decades.
    Eur J Cancer Prev. 2017 May 19. doi: 10.1097/CEJ.0000000000000368.
    Abstract     Related articles   

  671. KUTWIN P, Konecki T, Cichocki M, Falkowski P, et al
    Photodynamic Diagnosis and Narrow-Band Imaging in the Management of Bladder Cancer: A Review.
    Photomed Laser Surg. 2017 May 22. doi: 10.1089/pho.2016.4217.
    Abstract     Related articles   

  672. YURUK E, Tuken M, Colakerol A, Serefoglu EC, et al
    The awareness of patients with non - muscle invasive bladder cancer regarding the importance of smoking cessation and their access to smoking cessation programs.
    Int Braz J Urol. 2017;43.
    Abstract     Related articles   

  673. MALMSTROM PU, Agrawal S, Blackberg M, Bostrom PJ, et al
    Non-muscle-invasive bladder cancer: a vision for the future.
    Scand J Urol. 2017 Feb 7:1-8. doi: 10.1080/21681805.2017.1283359.
    Abstract     Related articles   

  674. JOHN BA, Said N
    Insights from animal models of bladder cancer: recent advances, challenges, and opportunities.
    Oncotarget. 2017 May 9. doi: 10.18632/oncotarget.17714.
    Abstract     Related articles   

  675. KOLLBERG P, Almquist H, Blackberg M, Cwikiel M, et al
    [18F]Fluorodeoxyglucose-positron emission tomography/computed tomography response evaluation can predict histological response at surgery after induction chemotherapy for oligometastatic bladder cancer.
    Scand J Urol. 2017 May 22:1-6. doi: 10.1080/21681805.2017.1321579.
    Abstract     Related articles   

  676. GOPALAKRISHNA A, Longo TA, Fantony JJ, Harrison MR, et al
    Physical activity patterns and associations with health-related quality of life in bladder cancer survivors.
    Urol Oncol. 2017 May 17. pii: S1078-1439(17)30188.
    Abstract     Related articles   

  677. PARIDA GK, Tripathy S, Roy SG, Singhal A, et al
    Incidentally Detected Penile Metastases in a Patient of Carcinoma Urinary Bladder on Follow-up FDG PET/CT.
    Clin Nucl Med. 2017 Mar 10. doi: 10.1097/RLU.0000000000001607.
    Abstract     Related articles   

  678. RICARDO HUPPES R, Crivellenti LZ, Barboza De Nardi A, Roque Lima B, et al
    Radical Cystectomy and Cutaneous Ureterostomy in 4 Dogs with Trigonal Transitional Cell Carcinoma: Description of Technique and Case Series.
    Vet Surg. 2017;46:111-119.
    Abstract     Related articles   


  679. This Month in AJP.
    Am J Pathol. 2017;187:1.
    Abstract     Related articles   

  680. MAKINO K, Nakagawa T, Kanatani A, Kawai T, et al
    Biphasic decline in renal function after radical cystectomy with urinary diversion.
    Int J Clin Oncol. 2017;22:359-365.
    Abstract     Related articles   

  681. NGUYEN HT, Shah ZK, Mortazavi A, Pohar KS, et al
    Non-invasive quantification of tumour heterogeneity in water diffusivity to differentiate malignant from benign tissues of urinary bladder: a phase I study.
    Eur Radiol. 2017;27:2146-2152.
    Abstract     Related articles   

  682. TAN M, Zhang D, Zhang E, Xu D, et al
    SENP2 suppresses epithelial-mesenchymal transition of bladder cancer cells through deSUMOylation of TGF-betaRI.
    Mol Carcinog. 2017 Jun 2. doi: 10.1002/mc.22687.
    Abstract     Related articles   

  683. AYATI M, Nowroozi MR, Mortazavi A, Ohadian Moghadam S, et al
    Management of Hepatic Granulomatous Tuberculosis After BCG Therapy for Bladder Cancer.
    Urol Case Rep. 2017;13:158-159.
    Abstract     Related articles   

  684. ARAGON-CHING JB, Pagliaro LC
    New Developments and Challenges in Rare Genitourinary Tumors: Non-Urothelial Bladder Cancers and Squamous Cell Cancers of the Penis.
    Am Soc Clin Oncol Educ Book. 2017;37:330-336.
    Abstract     Related articles   

  685. SATO A, Asano T, Okubo K, Isono M, et al
    Nelfinavir and Ritonavir Kill Bladder Cancer Cells Synergistically By Inducing Endoplasmic Reticulum Stress.
    Oncol Res. 2017 May 26. doi: 10.3727/096504017X14957929842972.
    Abstract     Related articles   

  686. KIM JK, Jeong CW, Kwak C, Kim HH, et al
    Progression to T1 High Grade (T1HG) from a Lower Stage/Grade is Associated with Poorer Survival Outcomes than Initial Diagnosis with T1HG Bladder Cancer.
    Ann Surg Oncol. 2017 May 30. doi: 10.1245/s10434-017-5902.
    Abstract     Related articles   

  687. XIE X, Rui W, He W, Shao Y, et al
    Discoidin domain receptor 1 activity drives an aggressive phenotype in bladder cancer.
    Am J Transl Res. 2017;9:2500-2507.
    Abstract     Related articles   

  688. MULLARD A
    Immuno-oncology upset in bladder cancer.
    Nat Rev Drug Discov. 2017;16:375.
    Abstract     Related articles   

  689. CUMBERBATCH K, He T, Thorogood Z, Gartrell BA, et al
    Emerging Drugs for Urothelial (Bladder) Cancer.
    Expert Opin Emerg Drugs. 2017 May 30. doi: 10.1080/14728214.2017.1336536.
    Abstract     Related articles   

  690. NICOLAZZO C, Busetto GM, Del Giudice F, Sperduti I, et al
    The long-term prognostic value of survivin expressing circulating tumor cells in patients with high-risk non-muscle invasive bladder cancer (NMIBC).
    J Cancer Res Clin Oncol. 2017 May 29. doi: 10.1007/s00432-017-2449.
    Abstract     Related articles   

  691. WANG Y, Kang XL, Zeng FC, Xu CJ, et al
    Correlations of Foxo3 and Foxo4 expressions with clinicopathological features and prognosis of bladder cancer.
    Pathol Res Pract. 2017 Apr 20. pii: S0344-0338(16)30606.
    Abstract     Related articles   

  692. YU D, Zhang C, Gui J
    RNA-binding protein HuR promotes bladder cancer progression by competitively binding to the long noncoding HOTAIR with miR-1.
    Onco Targets Ther. 2017;10:2609-2619.
    Abstract     Related articles   

  693. LIN JF, Lin YC, Tsai TF, Chen HE, et al
    Cisplatin induces protective autophagy through activation of BECN1 in human bladder cancer cells.
    Drug Des Devel Ther. 2017;11:1517-1533.
    Abstract     Related articles   

  694. WU Z, Wang S, Jiang F, Li Q, et al
    Mass spectrometric detection combined with bioinformatic analysis identified possible protein markers and key pathways associated with bladder cancer.
    Gene. 2017 May 25. pii: S0378-1119(17)30411-0. doi: 10.1016/j.gene.2017.
    Abstract     Related articles   

  695. VETTERLEIN MW, Meyer CP, Leyh-Bannurah SR, Mayr R, et al
    Effect of Hospital and Surgeon Case Volume on Perioperative Quality of Care and Short-term Outcomes After Radical Cystectomy for Muscle-invasive Bladder Cancer: Results From a European Tertiary Care Center Cohort.
    Clin Genitourin Cancer. 2017 Apr 26. pii: S1558-7673(17)30105.
    Abstract     Related articles   

  696. LIANG Z, Wang X, Xu X, Xie B, et al
    MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway.
    Mol Cancer. 2017;16:96.
    Abstract     Related articles   

  697. MALVIYA K, Fernandes G, Naik L, Kothari K, et al
    Utility of the Paris System in Reporting Urine Cytology.
    Acta Cytol. 2017;61:145-152.
    Abstract     Related articles   

  698. PAGLIARULO V, Alba S, Gallone MF, Di Stasi S, et al
    Diagnostic Accuracy of Hexaminolevulinate in a Cohort of Patients Undergoing Radical Cystectomy.
    J Endourol. 2017;31:405-411.
    Abstract     Related articles   

  699. XU X, Zhang X, Tian Q, Zhang G, et al
    Three-dimensional texture features from intensity and high-order derivative maps for the discrimination between bladder tumors and wall tissues via MRI.
    Int J Comput Assist Radiol Surg. 2017;12:645-656.
    Abstract     Related articles   

  700. LADURNER C, Comploj E, Trenti E, Palermo S, et al
    Radical cystectomy: do we need standardization?
    Expert Rev Anticancer Ther. 2017;17:101-107.
    Abstract     Related articles   

  701. ZHANG H, Guo Y, Song Y, Shang C, et al
    Long noncoding RNA GAS5 inhibits malignant proliferation and chemotherapy resistance to doxorubicin in bladder transitional cell carcinoma.
    Cancer Chemother Pharmacol. 2017;79:49-55.
    Abstract     Related articles   

  702. DENG T, Liu B, Duan X, Zhang T, et al
    Systematic Review and Cumulative Analysis of the Combination of Mitomycin C plus Bacillus Calmette-Guerin (BCG) for Non-Muscle-Invasive Bladder Cancer.
    Sci Rep. 2017;7:3172.
    Abstract     Related articles   

  703. PEI N, Mao Y, Wan P, Chen X, et al
    Angiotensin II type 2 receptor promotes apoptosis and inhibits angiogenesis in bladder cancer.
    J Exp Clin Cancer Res. 2017;36:77.
    Abstract     Related articles   

  704. LIU ZH, Zheng FF, Mao YL, Ye LF, et al
    Effects of programmed death-ligand 1 expression on OK-432 immunotherapy following transurethral resection in non-muscle invasive bladder cancer.
    Oncol Lett. 2017;13:4818-4824.
    Abstract     Related articles   

  705. KIM CJ, Tambe Y, Mukaisho KI, Sugihara H, et al
    Periostin suppresses in vivo invasiveness via PDK1/Akt/mTOR signaling pathway in a mouse orthotopic model of bladder cancer.
    Oncol Lett. 2017;13:4276-4284.
    Abstract     Related articles   

  706. LIU S, Liang B, Jia H, Jiao Y, et al
    Evaluation of cell death pathways initiated by antitumor drugs melatonin and valproic acid in bladder cancer cells.
    FEBS Open Bio. 2017;7:798-810.
    Abstract     Related articles   

  707. RAMMANT E, Bultijnck R, Sundahl N, Ost P, et al
    Rehabilitation interventions to improve patient-reported outcomes and physical fitness in survivors of muscle invasive bladder cancer: a systematic review protocol.
    BMJ Open. 2017;7:e016054.
    Abstract     Related articles   

  708. GU W, Lin Y, Gou X, He W, et al
    Tea Polyphenol inhibits autophagy to sensitize Epirubicin-induced apoptosis in human bladder cancer cells.
    Neoplasma. 2017 Jun 8. doi: 10.4149/neo_2017.
    Abstract     Related articles   

  709. WANG M, Teng XD
    [Research progress in molecular classification of muscle invasive bladder cancer].
    Zhonghua Bing Li Xue Za Zhi. 2017;46:439-442.
    Abstract     Related articles   

  710. HUANG Y, Fang C, Shi JW, Wen Y, et al
    Identification of hMex-3A and its effect on human bladder cancer cell proliferation.
    Oncotarget. 2017 May 22. doi: 10.18632/oncotarget.18050.
    Abstract     Related articles   

  711. WANG XC, Wang J, Tao HH, Zhang C, et al
    Combined effects of NQO1 Pro187Ser or SULT1A1 Arg213His polymorphism and smoking on bladder cancer risk: Two meta-analyses.
    Int J Occup Med Environ Health. 2017 Jun 7. pii: 65296.
    Abstract     Related articles   

  712. SHIVAKUMAR M, Lee Y, Bang L, Garg T, et al
    Identification of epigenetic interactions between miRNA and DNA methylation associated with gene expression as potential prognostic markers in bladder cancer.
    BMC Med Genomics. 2017;10.
    Abstract     Related articles   

  713. SUZUKI K, Hanashima F, Shirotake S, Kodaira K, et al
    Determining the optimum way to maintain quality of life for very elderly patients with advanced bladder cancer and poor performance status: A case report.
    Mol Clin Oncol. 2017;6:968-970.
    Abstract     Related articles   

  714. LI S, Zhang Y, Liu Q, Zhao Q, et al
    Oxymatrine inhibits proliferation of human bladder cancer T24 cells by inducing apoptosis and cell cycle arrest.
    Oncol Lett. 2017;13:4453-4458.
    Abstract     Related articles   

  715. KATES M, Nirschl T, Sopko NA, Matsui H, et al
    Intravesical BCG induces CD4+ T-Cell Expansion in an Immune Competent Model of Bladder Cancer.
    Cancer Immunol Res. 2017 Jun 6. pii: canimm.0267.2016.
    Abstract     Related articles   

  716. SCHULZ GB, Grimm T, Buchner A, Jokisch F, et al
    Prognostic Value of the Preoperative Platelet-to-leukocyte Ratio for Oncologic Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer.
    Clin Genitourin Cancer. 2017 May 10. pii: S1558-7673(17)30133.
    Abstract     Related articles   

  717. HAFEEZ S, McDonald F, Lalondrelle S, McNair H, et al
    Clinical Outcomes of Image Guided Adaptive Hypofractionated Weekly Radiation Therapy for Bladder Cancer in Patients Unsuitable for Radical Treatment.
    Int J Radiat Oncol Biol Phys. 2017;98:115-122.
    Abstract     Related articles   

  718. LOPEZ JI, Angulo JC, Martin A, Sanchez-Chapado M, et al
    A DNA hypermethylation profile reveals new potential biomarkers for the evaluation of prognosis in urothelial bladder cancer.
    APMIS. 2017 Jun 6. doi: 10.1111/apm.12719.
    Abstract     Related articles   

  719. HE H, Chang R, Zhang T, Yang C, et al
    ATM mediates DAB2IP-deficient bladder cancer cell resistance to ionizing radiation through the p38MAPK and NF-kappaB signaling pathway.
    Mol Med Rep. 2017 Jun 6. doi: 10.3892/mmr.2017.6689.
    Abstract     Related articles   

  720. SHEN M, Zhou L, Zhou P, Zhou W, et al
    Lymphotoxin beta receptor activation promotes mRNA expression of RelA and pro-inflammatory cytokines TNFalpha and IL-1beta in bladder cancer cells.
    Mol Med Rep. 2017 Jun 1. doi: 10.3892/mmr.2017.6676.
    Abstract     Related articles   

  721. WEINHAUS B, Guin S
    Involvement of glycogen debranching enzyme in bladder cancer.
    Biomed Rep. 2017;6:595-598.
    Abstract     Related articles   

  722. CHOE J, Braschi-Amirfarzan M, Tirumani SH, Shinagare AB, et al
    Updates for the radiologist in non-muscle-invasive, muscle-invasive, and metastatic bladder cancer.
    Abdom Radiol (NY). 2017 Jun 3. doi: 10.1007/s00261-017-1195.
    Abstract     Related articles   

  723. SHAO Y, Zhu W, Da J, Xu M, et al
    Bisdemethoxycurcumin in combination with alpha-PD-L1 antibody boosts immune response against bladder cancer.
    Onco Targets Ther. 2017;10:2675-2683.
    Abstract     Related articles   

  724. MEARINI E, Poli G, Cochetti G, Boni A, et al
    Expression of urinary miRNAs targeting NLRs inflammasomes in bladder cancer.
    Onco Targets Ther. 2017;10:2665-2673.
    Abstract     Related articles   

  725. MOKHTAR A, Al MM, Al WM, Othman KA, et al
    Is survival after radical cystectomy for bladder cancer in Saudi patients different from that of Western patients?
    Ann Saudi Med. 2017;37:194-200.
    Abstract     Related articles   

  726. DA SILVA GN, Filoni LT, Salvadori MC, Salvadori DMF, et al
    Gemcitabine/Cisplatin Treatment Induces Concomitant SERTAD1, CDKN2B and GADD45A Modulation and Cellular Changes in Bladder Cancer Cells Regardless of the Site of TP53 Mutation.
    Pathol Oncol Res. 2017 Jun 2. doi: 10.1007/s12253-017-0255.
    Abstract     Related articles   

  727. BLASZKEWICZ M
    Highlight report: N-acetyltransferase 2 and urinary bladder cancer risk.
    Arch Toxicol. 2017 Jun 2. doi: 10.1007/s00204-017-2001.
    Abstract     Related articles   

  728. APPUNNI S, Anand V, Khandelwal M, Seth A, et al
    Altered expression of small leucine-rich proteoglycans (Decorin, Biglycan and Lumican): Plausible diagnostic marker in urothelial carcinoma of bladder.
    Tumour Biol. 2017;39:1010428317699112.
    Abstract     Related articles   

  729. LHUNGAY TP, Colvin A, Warncke J, Somerset H, et al
    Seventy-Year-Old Man With Large Bladder Mass: Diagnostic and Clinical Challenges of an Uncommon Neoplasm.
    Oncology (Williston Park). 2017;31:210-2.
    Abstract     Related articles   

  730. AKINGBOYE A, Schultz H, Taylor GA
    Papillary transitional cell bladder carcinoma and systematized epidermal nevus syndrome.
    Cutis. 2017;99:61-64.
    Abstract     Related articles   

  731. NASELLI A, Puppo P
    En Bloc Transurethral Resection of Bladder Tumors: A New Standard?
    J Endourol. 2017;31.
    Abstract     Related articles   

  732. BLACK PC, Sridhar S
    New research in bladder cancer, ASCO-GU 2017.
    Can Urol Assoc J. 2017;11.
    Abstract     Related articles   

  733. HAMANO I, Hatakeyama S, Iwamura H, Fujita N, et al
    Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer.
    Oncotarget. 2017 May 29. doi: 10.18632/oncotarget.18248.
    Abstract     Related articles   

  734. POLO A, Crispo A, Cerino P, Falzone L, et al
    Environment and bladder cancer: molecular analysis by interaction networks.
    Oncotarget. 2017 May 26. doi: 10.18632/oncotarget.18222.
    Abstract     Related articles   

  735. LIU Q, Liao B, Tian Y, Chen Y, et al
    Total fluid consumption and risk of bladder cancer: a meta-analysis with updated data.
    Oncotarget. 2017 May 23. doi: 10.18632/oncotarget.18100.
    Abstract     Related articles   

  736. GU W, Yin H, Liu Y, Gou X, et al
    [The mechanism underlying the effects of tea polyphenol on epirubicin-induced autophagy and apoptosis in T24 bladder cancer cells].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2017;33:772-777.
    Abstract     Related articles   

  737. RAEISI SHAHRAKI H, Bemani P, Jalali M
    Classification of Bladder Cancer Patients via Penalized Linear Discriminant Analysis
    Asian Pac J Cancer Prev. 2017;18:1453-1457.
    Abstract     Related articles   

  738. MARTINI T, Wezel F, Lobig N, Mitterberger MJ, et al
    [Systematic review on conservative treatment options in non-muscle-invasive bladder cancer patients refractory to Bacillus Calmette-Guerin instillation therapy].
    Aktuelle Urol. 2017 Jun 13. doi: 10.1055/s-0043-108944.
    Abstract     Related articles   

  739. YASAR O, Akcay T, Obek C, Turegun FA, et al
    Significance of S100A8, S100A9 and calprotectin levels in bladder cancer.
    Scand J Clin Lab Invest. 2017 Jun 13:1-5. doi: 10.1080/00365513.2017.1336567.
    Abstract     Related articles   

  740. HUANG J, Schisler J, Wong HC, Rosser CJ, et al
    Intravesical ALT-803 for BCG-unresponsive Bladder Cancer - A Case Report.
    Urol Case Rep. 2017;14:15-17.
    Abstract     Related articles   

  741. WU CT, Lin WY, Chang YH, Chen WC, et al
    Impact of CD44 expression on radiation response for bladder cancer.
    J Cancer. 2017;8:1137-1144.
    Abstract     Related articles   

  742. XU Z, Li X, Qin Z, Xue J, et al
    Association of N-acetyltransferase 1 polymorphism and bladder cancer risk: an updated meta-analysis and trial sequential analysis.
    Int J Biol Markers. 2017 Jun 7:0. doi: 10.5301/ijbm.5000269.
    Abstract     Related articles   

  743. MERTENS LS, Horenblas S
    Related to: [18F]Fluorodeoxyglucose-positron emission tomography/computed tomography response evaluation can predict histological response at surgery after induction chemotherapy for oligometastatic bladder cancer.
    Scand J Urol. 2017 Jun 12:1-2. doi: 10.1080/21681805.2017.1329229.
    Abstract     Related articles   

  744. BOTE HE, Alaoui AE, Oussama Z, Sayegh HE, et al
    [Neuroendocrine carcinoma of the bladder: about 5 cases].
    Pan Afr Med J. 2017;26:92.
    Abstract     Related articles   

  745. MBETHE D, Moudouni S, Dahami Z, Lakmichi MA, et al
    [Leiomyosarcoma of the urinary bladder treated using laparoscopic cystectomy and bladder replacement by enterocystoplasty: about a case].
    Pan Afr Med J. 2017;26:26.
    Abstract     Related articles   

  746. KONDO M, Hotta Y, Ando R, Yasui T, et al
    The impact of a solitary kidney on tolerability to gemcitabine plus cisplatin chemotherapy in urothelial carcinoma patients: a retrospective study.
    Cancer Chemother Pharmacol. 2017;79:995-1001.
    Abstract     Related articles   

  747. BONIOL M, Koechlin A, Sorahan T, Jakobsson K, et al
    Cancer incidence in cohorts of workers in the rubber manufacturing industry first employed since 1975 in the UK and Sweden.
    Occup Environ Med. 2017;74:417-421.
    Abstract     Related articles   

  748. NAITO A, Taguchi S, Nakagawa T, Matsumoto A, et al
    Prognostic significance of serum neuron-specific enolase in small cell carcinoma of the urinary bladder.
    World J Urol. 2017;35:97-103.
    Abstract     Related articles   

  749. PINEDA S, Van Steen K, Malats N
    Integrative eQTL analysis of tumor and host omics data in individuals with bladder cancer.
    Genet Epidemiol. 2017 Jun 23. doi: 10.1002/gepi.22053.
    Abstract     Related articles   

  750. LI T, Sun X, Jiang X
    UCA1 involved in the metformin-regulated bladder cancer cell proliferation and glycolysis.
    Tumour Biol. 2017;39:1010428317710823.
    Abstract     Related articles   

  751. WANG Z, Wang X, Zhang D, Yu Y, et al
    Long non-coding RNA urothelial carcinoma-associated 1 as a tumor biomarker for the diagnosis of urinary bladder cancer.
    Tumour Biol. 2017;39:1010428317709990.
    Abstract     Related articles   

  752. PHILLIPS RM, Hendriks HR, Sweeney JB, Reddy G, et al
    Efficacy, pharmacokinetic and pharmacodynamic evaluation of Apaziquone in the treatment of non-muscle invasive bladder cancer.
    Expert Opin Drug Metab Toxicol. 2017 Jun 21. doi: 10.1080/17425255.2017.1341490.
    Abstract     Related articles   

  753. ZHANG Z, Fan W, Deng Q, Tang S, et al
    The prognostic and diagnostic value of circulating tumor cells in bladder cancer and upper tract urothelial carcinoma: a meta-analysis of 30 published studies.
    Oncotarget. 2017 Jun 16. doi: 10.18632/oncotarget.18521.
    Abstract     Related articles   

  754. BEANE FREEMAN LE, Cantor KP, Baris D, Nuckols JR, et al
    Bladder Cancer and Water Disinfection By-product Exposures through Multiple Routes: A Population-Based Case-Control Study (New England, USA).
    Environ Health Perspect. 2017;125:067010.
    Abstract     Related articles   

  755. DUAN R, Zhang Z, Zheng F, Wang L, et al
    Combining protein and miRNA quantification for bladder cancer analysis.
    ACS Appl Mater Interfaces. 2017 Jun 21. doi: 10.1021/acsami.7b05639.
    Abstract     Related articles   

  756. WU JH, Deng YL, Liu Q, Yu JC, et al
    Induction of apoptosis and autophagy by calcifying nanoparticles in human bladder cancer cells.
    Tumour Biol. 2017;39:1010428317707688.
    Abstract     Related articles   

  757. KHETRAPAL P, Tan WS, Lamb B, Tan M, et al
    The Role of Robotics in the Invasive Management of Bladder Cancer.
    Curr Urol Rep. 2017;18:57.
    Abstract     Related articles   


  758. Targeting Nectin-4 in Bladder Cancer.
    Cancer Discov. 2017 Jun 20. doi: 10.1158/2159-8290.CD-NB2017.
    Abstract     Related articles   

  759. PETRYLAK DP
    Immunotherapy: The Wave of the Future in Bladder Cancer?
    Clin Genitourin Cancer. 2017;15.
    Abstract     Related articles   

  760. VOELKER R
    Immunotherapy for Bladder Cancer.
    JAMA. 2017;317:2363.
    Abstract     Related articles   

  761. MERTENS LS, Horenblas S
    Bladder cancer: oligometastases and imaging.
    Nat Rev Urol. 2017 Jun 20. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  762. YUAN H, Yu S, Cui Y, Men C, et al
    Knockdown of mediator subunit Med19 suppresses bladder cancer cell proliferation and migration by downregulating Wnt/beta-catenin signalling pathway.
    J Cell Mol Med. 2017 Jun 19. doi: 10.1111/jcmm.13229.
    Abstract     Related articles   

  763. LIBERAL J, Carmo A, Gomes C, Cruz MT, et al
    Urolithins impair cell proliferation, arrest the cell cycle and induce apoptosis in UMUC3 bladder cancer cells.
    Invest New Drugs. 2017 Jun 20. doi: 10.1007/s10637-017-0483.
    Abstract     Related articles   

  764. ZHONGBO L, U-Syn H, Ke Y, Chunli W, et al
    Kavalactone yangonin induces autophagy and sensitizes bladder cancer cells to flavokawain A and docetaxel via inhibition of the mTOR pathway.
    J Biomed Res. 2017 Jun 20. doi: 10.7555/JBR.31.20160160.
    Abstract     Related articles   

  765. SLAVYANSKAYA T, -Salnikova S, Sepiashvili R
    [CRITERIA FOR SELECTION OF TUMOR CELLS AND PROSPECTS FOR SPECIFIC IMMUNOTHERAPY FOR BLADDER CANCER].
    Georgian Med News. 2017;:26-34.
    Abstract     Related articles   

  766. SLAVYANSKAYA T, -Salnikova S
    [THE MAIN STAGES OF THE PREPARATION OF VIABLE TUMOR CELLS OF BLADDER CANCER: FROM ISOLATION OF THE TUMOR MATERIAL TILL CRYOPRESERVATION OF CELL LINES].
    Georgian Med News. 2017;:19-26.
    Abstract     Related articles   

  767. DETTLAFF K, Stawny M, Ogrodowczyk M, Jelinska A, et al
    Formulation and characterization of EGCG for the treatment of superficial bladder cancer.
    Int J Mol Med. 2017 Jun 14. doi: 10.3892/ijmm.2017.3024.
    Abstract     Related articles   

  768. LIN Y, Ge Y, Wang Y, Ma G, et al
    The association of rs710886 in lncRNA PCAT1 with bladder cancer risk in a Chinese population.
    Gene. 2017 Jun 13. pii: S0378-1119(17)30473-0. doi: 10.1016/j.gene.2017.
    Abstract     Related articles   

  769. LYNCH HN, Zu K, Kennedy EM, Lam T, et al
    Quantitative assessment of lung and bladder cancer risk and oral exposure to inorganic arsenic: Meta-regression analyses of epidemiological data.
    Environ Int. 2017 Jun 16. pii: S0160-4120(16)30336.
    Abstract     Related articles   

  770. SUGIURA S, Noto N, Koizumi M, Takamoto D, et al
    [Post-Operative Single Immediate Intravesical Instillation Chemotherapy as Prophylaxis for Reccurence after Transurethral Resection of Low Risk Non-Muscle-Invasive Bladder Cancer].
    Hinyokika Kiyo. 2017;63:183-187.
    Abstract     Related articles   

  771. ZHU J, Li Y, Tian Z, Hua X, et al
    ATG7 Overexpression Is Crucial for Tumorigenic Growth of Bladder Cancer In Vitro and In Vivo by Targeting the ETS2/miRNA196b/FOXO1/p27 Axis.
    Mol Ther Nucleic Acids. 2017;7:299-313.
    Abstract     Related articles   

  772. DEL BENE G, Sternberg CN
    Systemic chemotherapy in muscle invasive and metastatic bladder cancer: present and future.
    Urologia. 2017 Jun 14:0. doi: 10.5301/uj.5000230.
    Abstract     Related articles   

  773. FILIPOVA E, Uzunova K, Kalinov K, Vekov T, et al
    Pioglitazone and the Risk of Bladder Cancer: A Meta-Analysis.
    Diabetes Ther. 2017 Jun 16. doi: 10.1007/s13300-017-0273.
    Abstract     Related articles   

  774. ZHANG S, Zhang G, Guo H
    DCAMKL1 is associated with the malignant status and poor outcome in bladder cancer.
    Tumour Biol. 2017;39:1010428317703822.
    Abstract     Related articles   

  775. RAILKAR R, Krane LS, Li QQ, Sanford T, et al
    Epidermal Growth Factor Receptor (EGFR) Targeted Photoimmunotherapy (PIT) for the Treatment of EGFR expressing Bladder Cancer.
    Mol Cancer Ther. 2017 Jun 15. pii: molcanther.0924.2016.
    Abstract     Related articles   

  776. WANG W, Shen F, Wang C, Lu W, et al
    MiR-1-3p inhibits the proliferation and invasion of bladder cancer cells by suppressing CCL2 expression.
    Tumour Biol. 2017;39:1010428317698383.
    Abstract     Related articles   

  777. DA COSTA E, Melo T, Moreira AS, Bernardo C, et al
    Valorization of Lipids from Gracilaria sp. through Lipidomics and Decoding of Antiproliferative and Anti-Inflammatory Activity.
    Mar Drugs. 2017;15.
    Abstract     Related articles   

  778. HIGASHINO T, Nakatsuji H, Fukuda R, Okamoto H, et al
    Hexaphyrin as a Potential Theranostic Dye for Photothermal Therapy and 19 F Magnetic Resonance Imaging.
    Chembiochem. 2017;18:951-959.
    Abstract     Related articles   

  779. PATEL R, Barker HE, Kyula J, McLaughlin M, et al
    An orally bioavailable Chk1 inhibitor, CCT244747, sensitizes bladder and head and neck cancer cell lines to radiation.
    Radiother Oncol. 2017 Jan 25. pii: S0167-8140(16)34478.
    Abstract     Related articles   

  780. DOWNES MR, Weening B, van Rhijn BW, Have CL, et al
    Analysis of papillary urothelial carcinomas of the bladder with grade heterogeneity: supportive evidence for an early role of CDKN2A deletions in the FGFR3 pathway.
    Histopathology. 2017;70:281-289.
    Abstract     Related articles   

  781. APFELBECK M, Grimm T, Kretschmer A, Buchner A, et al
    Follow-up of high-risk bladder cancer-Is it safe to perform fluorescence endoscopy multiple times in the same patient?
    Urol Oncol. 2017 Jun 27. pii: S1078-1439(17)30262.
    Abstract     Related articles   

  782. GARRY EM, Buse JB, Lund JL, Pate V, et al
    Comparative Safety of Pioglitazone versus Clinically Meaningful Treatment Alternatives on the Risk of Bladder Cancer in Older US Adults with Type 2 Diabetes.
    Diabetes Obes Metab. 2017 Jun 29. doi: 10.1111/dom.13049.
    Abstract     Related articles   

  783. NOROHEIMER S, Ozalvo R, Abramovich A, Fenig E, et al
    [THE MULTIDISCIPLINARY MUSCLE INVASIVE BLADDER CANCER CLINIC AT THE RABIN MEDICAL CENTER].
    Harefuah. 2017;:349-352.
    Abstract     Related articles   

  784. WANG SC, Sung WW, Kao YL, Hsieh TY, et al
    The gender difference and mortality-to-incidence ratio relate to health care disparities in bladder cancer: National estimates from 33 countries.
    Sci Rep. 2017;7:4360.
    Abstract     Related articles   

  785. SOMASEKAR R, Naganathbabu O, Prabhakaran R, Gnanasekar M, et al
    Salvage Surgery for Metastatic Gall Bladder Cancer with Vanishing Liver Metastasis Following Palliative 5-Fluorouracil Metronomic Chemotherapy.
    J Clin Diagn Res. 2017;11:XD03-XD05.
    Abstract     Related articles   

  786. WEI Z, Hu X, Liu J, Zhu W, et al
    MicroRNA-497 upregulation inhibits cell invasion and metastasis in T24 and BIU-87 bladder cancer cells.
    Mol Med Rep. 2017 Jun 19. doi: 10.3892/mmr.2017.6805.
    Abstract     Related articles   

  787. MENG XY, Shi MJ, Chen JF, Liao Y, et al
    Association between the TACC3 rs798766 Polymorphism and Risk of Urinary Bladder Cancer: A Synthesis Based on Current Evidence.
    Dis Markers. 2017;2017:7850708.
    Abstract     Related articles   

  788. WHANG YM, Jin SB, Park SI, Chang IH, et al
    MEK inhibition enhances efficacy of bacillus Calmette-Guerin on bladder cancer cells by reducing release of toll-like receptor 2-activated antimicrobial peptides.
    Oncotarget. 2017 May 26. doi: 10.18632/oncotarget.18230.
    Abstract     Related articles   

  789. KUNATH F
    [Intravesical Bacillus Calmette-Guerin with interferon-alpha versus intravesical Bacillus Calmette-Guerin for treating non-muscle-invasive bladder cancer : Comment on a recently published Cochrane Review].
    Urologe A. 2017 Jun 26. doi: 10.1007/s00120-017-0436.
    Abstract     Related articles   

  790. TRABOULSI SL, Brimo F, Yang Y, Maedler C, et al
    Pathology review impacts clinical management of patients with T1-T2 bladder cancer.
    Can Urol Assoc J. 2017;11:188-193.
    Abstract     Related articles   

  791. KLAASSEN Z, Li K, Kassouf W, Black PC, et al
    Contemporary cost-consequence analysis of blue light cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer.
    Can Urol Assoc J. 2017;11:173-181.
    Abstract     Related articles   

  792. MANIG L, Janssen S, Schild SE, Rades D, et al
    A New Prognostic Tool for Patients Undergoing Radiotherapy plus Upfront Transurethral Resection for Bladder Cancer.
    In Vivo. 2017;31:745-748.
    Abstract     Related articles   

  793. CHEVALIER MF, Trabanelli S, Racle J, Salome B, et al
    ILC2-modulated T cell-to-MDSC balance is associated with bladder cancer recurrence.
    J Clin Invest. 2017 Jun 26. pii: 89717. doi: 10.1172/JCI89717.
    Abstract     Related articles   

  794. ATTALLA K, Kent M, Waingankar N, Mehrazin R, et al
    Robotic-assisted radical cystectomy versus open radical cystectomy for management of bladder cancer: review of literature and randomized trials.
    Future Oncol. 2017;13:1195-1204.
    Abstract     Related articles   

  795. LI C, Cui Y, Liu LF, Ren WB, et al
    High Expression of Long Noncoding RNA MALAT1 Indicates a Poor Prognosis and Promotes Clinical Progression and Metastasis in Bladder Cancer.
    Clin Genitourin Cancer. 2017 May 10. pii: S1558-7673(17)30125.
    Abstract     Related articles   

  796. MIYAKE M, Morizawa Y, Hori S, Marugami N, et al
    Integrative Assessment of Pretreatment Inflammation-, Nutrition-, and Muscle-Based Prognostic Markers in Patients with Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy.
    Oncology. 2017 Jun 24. doi: 10.1159/000477405.
    Abstract     Related articles   

  797. WILLIAMS SB, Huo J, Dafashy TJ, Ghaffary CK, et al
    Survival differences among patients with bladder cancer according to sex: Critical evaluation of radical cystectomy use and delay to treatment.
    Urol Oncol. 2017 Jun 21. pii: S1078-1439(17)30252.
    Abstract     Related articles   

  798. YANG Y, Guo JX, Shao ZQ, Gao JP, et al
    Matrine inhibits bladder cancer cell growth and invasion in vitro through PI3K/AKT signaling pathway: An experimental study.
    Asian Pac J Trop Med. 2017;10:515-519.
    Abstract     Related articles   

  799. FITZPATRICK R, Paterson NR, Belanger EC, McCurdy A, et al
    Primary amyloidosis of the bladder; a mimicker of bladder cancer.
    Can J Urol. 2017;24:8868-8870.
    Abstract     Related articles   

  800. MORALES A
    BCG: A throwback from the stone age of vaccines opened the path for bladder cancer immunotherapy.
    Can J Urol. 2017;24:8788-8793.
    Abstract     Related articles   

  801. CAKIR E, Kucuk U, Pala EE, Sezer O, et al
    Cytopathologic differential diagnosis of low-grade urothelial carcinoma and reactive urothelial proliferation in bladder washings: a logistic regression analysis.
    APMIS. 2017;125:431-436.
    Abstract     Related articles   

  802. ESKAROS AR, Egloff SA, Boyd KL, Richardson JE, et al
    Larger core size has superior technical and analytical accuracy in bladder tissue microarray.
    Lab Invest. 2017;97:335-342.
    Abstract     Related articles   

  803. ZIMMERMANN M, Wang SS, Zhang H, Lin TY, et al
    Microdose-Induced Drug-DNA Adducts as Biomarkers of Chemotherapy Resistance in Humans and Mice.
    Mol Cancer Ther. 2017;16:376-387.
    Abstract     Related articles   

  804. BI H, Zhang Z, Guo L, Fu C, et al
    Effect of wound fluid on chemotherapy sensitivity of T24 bladder cancer cells with different enhancer of zeste homolog 2 status.
    Oncotarget. 2017 Jun 28. doi: 10.18632/oncotarget.18791.
    Abstract     Related articles   

  805. VAN OSCH FHM, Pauwels CGGM, Jochems SHJ, Fayokun R, et al
    Tar, nicotine and carbon monoxide yield of UK cigarettes and the risk of non-muscle-invasive and muscle-invasive bladder cancer.
    Eur J Cancer Prev. 2017 Jul 4. doi: 10.1097/CEJ.0000000000000404.
    Abstract     Related articles   

  806. SHIN SS, Song JH, Hwang B, Park SL, et al
    Angiopoietin-like protein 4 potentiates DATS-induced inhibition of proliferation, migration, and invasion of bladder cancer EJ cells; involvement of G2/M-phase cell cycle arrest, signaling pathways, and transcription factors-mediated MMP-9 expression.
    Food Nutr Res. 2017;61:1338918.
    Abstract     Related articles   

  807. KIKUCHI K, Shigihara T, Hashimoto Y, Miyajima M, et al
    Apparent diffusion coefficient on magnetic resonance imaging (MRI) in bladder cancer: relations with recurrence/progression risk.
    Fukushima J Med Sci. 2017 Jul 5. doi: 10.5387/fms.2017.
    Abstract     Related articles   

  808. LIU Q, Diao R, Feng G, Mu X, et al
    Risk score based on three mRNA expression predicts the survival of bladder cancer.
    Oncotarget. 2017 Jun 27. doi: 10.18632/oncotarget.18642.
    Abstract     Related articles   

  809. GOZEN AS, Umari P, Scheitlin W, Su FE, et al
    Effectivity of intravescical thermo-chemotherapy prophylaxis for patients with high recurrence and progression risk for non-muscle invasive bladder cancer.
    Arch Ital Urol Androl. 2017;89:102-105.
    Abstract     Related articles   

  810. ROBINSON ARL, Radhakrishnan R, Horvath R, Pandey S, et al
    A case of disseminated Mycobacterium bovis 2 years post-intravesicular Bacillus Calmette-Guerin therapy for superficial urinary bladder cancer.
    Intern Med J. 2017;47:820-823.
    Abstract     Related articles   

  811. TRINH TW, Glazer DI, Sadow CA, Sahni VA, et al
    Bladder cancer diagnosis with CT urography: test characteristics and reasons for false-positive and false-negative results.
    Abdom Radiol (NY). 2017 Jul 4. doi: 10.1007/s00261-017-1249.
    Abstract     Related articles   

  812. MBATCHI LC, Gassiot M, Pourquier P, Goberna A, et al
    Association of NR1I2, CYP3A5 and ABCB1 genetic polymorphisms with variability of temsirolimus pharmacokinetics and toxicity in patients with metastatic bladder cancer.
    Cancer Chemother Pharmacol. 2017 Jul 4. doi: 10.1007/s00280-017-3379.
    Abstract     Related articles   

  813. LOBO N, Mount C, Omar K, Nair R, et al
    Landmarks in the treatment of muscle-invasive bladder cancer.
    Nat Rev Urol. 2017 Jul 4. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  814. DAVIS RL 3RD, Le W, Cui Z
    Granulocytes as an effector mechanism of BCG therapy for bladder cancer.
    Med Hypotheses. 2017;104:166-169.
    Abstract     Related articles   

  815. CHEN Y, Xie H, Zou Y, Lai X, et al
    Tetracycline-controllable artificial microRNA-HOTAIR + EZH2 suppressed the progression of bladder cancer cells.
    Mol Biosyst. 2017 Jul 3. doi: 10.1039/c7mb00202.
    Abstract     Related articles   

  816. FARINA MS, Lundgren KT, Bellmunt J
    Immunotherapy in Urothelial Cancer: Recent Results and Future Perspectives.
    Drugs. 2017;77:1077-1089.
    Abstract     Related articles   

  817. KE K, Li H, Yao H, Shi XN, et al
    In silico prediction and in vitro and in vivo validation of acaricide fluazuron as a potential inhibitor of FGFR3 and a candidate anticancer drug for bladder carcinoma.
    Chem Biol Drug Des. 2017;89:505-513.
    Abstract     Related articles   

  818. CHEN MC, Hsu WL, Chang WL, Chou TC, et al
    Antiangiogenic activity of phthalides-enriched Angelica Sinensis extract by suppressing WSB-1/pVHL/HIF-1alpha/VEGF signaling in bladder cancer.
    Sci Rep. 2017;7:5376.
    Abstract     Related articles   

  819. CORFIELD JM, Lawrentschuk N
    Health information quality on the internet for bladder cancer and urinary diversion: a multi-lingual analysis.
    Minerva Urol Nefrol. 2017 Jul 12. doi: 10.23736/S0393-2249.17.02952.
    Abstract     Related articles   

  820. POURSANI EM, Mehravar M, Mohammad Soltani B, Mowla SJ, et al
    A Novel Variant of OCT4 Entitled OCT4B3 is Expressed in Human Bladder Cancer and Astrocytoma Cell Lines.
    Avicenna J Med Biotechnol. 2017;9:142-145.
    Abstract     Related articles   

  821. YE T, Ding W, Wang N, Huang H, et al
    Long noncoding RNA linc00346 promotes the malignant phenotypes of bladder cancer.
    Biochem Biophys Res Commun. 2017 Jul 10. pii: S0006-291X(17)31387.
    Abstract     Related articles   

  822. SHI J, Wang Y, Jia Z, Gao Y, et al
    Curcumin inhibits bladder cancer progression via regulation of beta-catenin expression.
    Tumour Biol. 2017;39:1010428317702548.
    Abstract     Related articles   

  823. POP-BICA C, Gulei D, Cojocneanu-Petric R, Braicu C, et al
    Understanding the Role of Non-Coding RNAs in Bladder Cancer: From Dark Matter to Valuable Therapeutic Targets.
    Int J Mol Sci. 2017;18.
    Abstract     Related articles   

  824. HUANG X, Zhuang C, Zhuang C, Xiong T, et al
    An enhanced hTERT promoter-driven CRISPR/Cas9 system selectively inhibits the progression of bladder cancer cells.
    Mol Biosyst. 2017 Jul 12. doi: 10.1039/c7mb00354.
    Abstract     Related articles   

  825. SONG Y, Zhang P, Sun Y, Li X, et al
    AMPK activation-dependent autophagy compromises oleanolic acid-induced cytotoxicity in human bladder cancer cells.
    Oncotarget. 2017 Jul 4. doi: 10.18632/oncotarget.18980.
    Abstract     Related articles   

  826. HOHNE S, Gerullis H, Blaszkewicz M, Selinski S, et al
    N-acetyltransferase 1*10 genotype in bladder cancer patients.
    J Toxicol Environ Health A. 2017 Jul 11:1-6. doi: 10.1080/10937404.2017.1304727.
    Abstract     Related articles   

  827. EBBINGHAUS D, Banfi G, Selinski S, Blaszkewicz M, et al
    Polymorphisms of xenobiotic metabolizing enzymes in bladder cancer patients of the Semmelweis University Budapest, Hungary.
    J Toxicol Environ Health A. 2017 Jul 11:1-7. doi: 10.1080/10937404.2017.1304736.
    Abstract     Related articles   

  828. KRECH E, Selinski S, Blaszkewicz M, Burger H, et al
    Urinary bladder cancer risk factors in an area of former coal, iron, and steel industries in Germany.
    J Toxicol Environ Health A. 2017 Jul 11:1-9. doi: 10.1080/10937404.2017.1304719.
    Abstract     Related articles   

  829. LUKAS C, Selinski S, Prager HM, Blaszkewicz M, et al
    Occupational bladder cancer: Polymorphisms of xenobiotic metabolizing enzymes, exposures, and prognosis.
    J Toxicol Environ Health A. 2017 Jul 11:1-14. doi: 10.1080/10937404.2017.1304731
    Abstract     Related articles   

  830. YAMAMOTO Y, Suehiro Y, Suzuki A, Nawata R, et al
    Germline DNA copy number variations as potential prognostic markers for non-muscle invasive bladder cancer progression.
    Oncol Lett. 2017;14:1193-1199.
    Abstract     Related articles   

  831. SHI J, Zhang X, Shi T, Li H, et al
    Antitumor effects of curcumin in human bladder cancer in vitro.
    Oncol Lett. 2017;14:1157-1161.
    Abstract     Related articles   

  832. ZHANG DQ, Zhou CK, Chen SZ, Yang Y, et al
    Identification of hub genes and pathways associated with bladder cancer based on co-expression network analysis.
    Oncol Lett. 2017;14:1115-1122.
    Abstract     Related articles   

  833. SHIGEMATSU Y, Oue N, Nishioka Y, Sakamoto N, et al
    Overexpression of the transmembrane protein BST-2 induces Akt and Erk phosphorylation in bladder cancer.
    Oncol Lett. 2017;14:999-1004.
    Abstract     Related articles   

  834. SI L, Yang X, Yan X, Wang Y, et al
    Isoliquiritigenin induces apoptosis of human bladder cancer T24 cells via a cyclin-dependent kinase-independent mechanism.
    Oncol Lett. 2017;14:241-249.
    Abstract     Related articles   

  835. AUDENET F, Retinger C, Chien C, Benfante NE, et al
    Is restaging transurethral resection necessary in patients with non-muscle invasive bladder cancer and limited lamina propria invasion?
    Urol Oncol. 2017 Jul 6. pii: S1078-1439(17)30302.
    Abstract     Related articles   

  836. ROVE KO, Husmann DA, Wilcox DT, Vricella GJ, et al
    Systematic review of bladder cancer outcomes in patients with spina bifida.
    J Pediatr Urol. 2017 Jun 1. pii: S1477-5131(17)30234.
    Abstract     Related articles   

  837. ZHONG Z, Huang M, Lv M, He Y, et al
    Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA/VEGFR2 signaling pathway.
    Cancer Lett. 2017 Jul 4. pii: S0304-3835(17)30409.
    Abstract     Related articles   

  838. VALVERDE MARTINEZ S, Salcedo Mercado W, Rodriguez Cruz I, Prieto Nogal SB, et al
    [Urinary tract lymphoepithelial carcinoma. Report of two cases and bibliographic review.]
    Arch Esp Urol. 2017;70:361-366.
    Abstract     Related articles   

  839. ORTIZ SANCHEZ L, Alonso Prieto MA, Campanario Perez F, Alvarez-Silva I, et al
    Treatment of urachal disorders: The open and laparoscopic surgery approach.
    Arch Esp Urol. 2017;70:357-360.
    Abstract     Related articles   

  840. BALSARA ZR, Li X
    Sleeping beauty: awakening urothelium from its slumber.
    Am J Physiol Renal Physiol. 2017;312:F732-F743.
    Abstract     Related articles   

  841. NAKAI Y, Ozawa T, Mizuno F, Onishi S, et al
    Spectrophotometric photodynamic detection involving extracorporeal treatment with hexaminolevulinate for bladder cancer cells in voided urine.
    J Cancer Res Clin Oncol. 2017 Jul 19. doi: 10.1007/s00432-017-2476.
    Abstract     Related articles   

  842. KANG M, Ku JH
    Emerging role of liquid biopsy of cell-free tumor DNA for bladder cancer surveillance.
    Transl Androl Urol. 2017;6:590-592.
    Abstract     Related articles   

  843. CHEN C, Hu L, Li X, Hou J, et al
    Preoperative Anemia as a Simple Prognostic Factor in Patients with Urinary Bladder Cancer.
    Med Sci Monit. 2017;23:3528-3535.
    Abstract     Related articles   

  844. WARRICK JI, Kaag M, Raman JD, Chan W, et al
    FOXA1 and CK14 as markers of luminal and basal subtypes in histologic variants of bladder cancer and their associated conventional urothelial carcinoma.
    Virchows Arch. 2017 Jul 18. doi: 10.1007/s00428-017-2190.
    Abstract     Related articles   

  845. SMITH AB, Crowell K, Woods ME, Wallen EM, et al
    Functional Outcomes Following Radical Cystectomy in Women with Bladder Cancer: A Systematic Review.
    Eur Urol Focus. 2017;3:136-143.
    Abstract     Related articles   

  846. PAL SK, Pham A, Vuong W, Liu X, et al
    Prognostic Significance of Neutrophilic Infiltration in Benign Lymph Nodes in Patients with Muscle-invasive Bladder Cancer.
    Eur Urol Focus. 2017;3:130-135.
    Abstract     Related articles   

  847. LUO H, Yang R, Li C, Tong Y, et al
    MicroRNA-139-5p inhibits bladder cancer proliferation and self-renewal by targeting the Bmi1 oncogene.
    Tumour Biol. 2017;39:1010428317718414.
    Abstract     Related articles   

  848. EL HAMDANI W, Hadami K, Bensaid M, El Ahanidi H, et al
    Identification of G2607A mutation in EGFR gene with a significative rate in Moroccan patients with Bladder Cancer.
    Cell Mol Biol (Noisy-le-grand). 2017;63:75-81.
    Abstract     Related articles   

  849. SRIVASTAVA A, Douglass LM, Chernyak V, Watts KL, et al
    Advances in Imaging in Prostate and Bladder Cancer.
    Curr Urol Rep. 2017;18:69.
    Abstract     Related articles   

  850. UTANGAC MM, Yeni E, Savas M, Altunkol A, et al
    Paraoxonase and arylesterase activity in bladder cancer.
    Turk J Urol. 2017;43:147-151.
    Abstract     Related articles   

  851. PATEL KM, van der Vos KE, Smith CG, Mouliere F, et al
    Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer.
    Sci Rep. 2017;7:5554.
    Abstract     Related articles   

  852. XIE Y, Ma X, Chen L, Li H, et al
    MicroRNAs with prognostic significance in bladder cancer: a systematic review and meta-analysis.
    Sci Rep. 2017;7:5619.
    Abstract     Related articles   

  853. LAURIDSEN SV, Thomsen T, Thind P, Tonnesen H, et al
    STOP smoking and alcohol drinking before OPeration for bladder cancer (the STOP-OP study), perioperative smoking and alcohol cessation intervention in relation to radical cystectomy: study protocol for a randomised controlled trial.
    Trials. 2017;18:329.
    Abstract     Related articles   

  854. LIU T, Li L, Yin L, Yu H, et al
    Superantigen staphylococcal enterotoxin C1 inhibits the growth of bladder cancer.
    Biosci Biotechnol Biochem. 2017 Jul 17:1-6. doi: 10.1080/09168451.2017.1350564.
    Abstract     Related articles   

  855. CAO HL, Liu ZJ, Chang Z
    Cordycepin induces apoptosis in human bladder cancer cells via activation of A3 adenosine receptors.
    Tumour Biol. 2017;39:1010428317706915.
    Abstract     Related articles   

  856. GOURD E
    TERT mutations in urine could predict bladder cancer recurrence.
    Lancet Oncol. 2017 Jul 13. pii: S1470-2045(17)30538.
    Abstract     Related articles   

  857. MONTANO R, Khan N, Hou H, Seigne J, et al
    Cell cycle perturbation induced by gemcitabine in human tumor cells in cell culture, xenografts and bladder cancer patients: implications for clinical trial designs combining gemcitabine with a Chk1 inhibitor.
    Oncotarget. 2017 Jun 28. doi: 10.18632/oncotarget.18834.
    Abstract     Related articles   

  858. YUAN D, Zheng S, Wang L, Li J, et al
    MiR-200c inhibits bladder cancer progression by targeting lactate dehydrogenase A.
    Oncotarget. 2017 Jun 28. doi: 10.18632/oncotarget.18801.
    Abstract     Related articles   

  859. KUSAKA A, Hatakeyama S, Hosogoe S, Hamano I, et al
    Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer.
    Oncotarget. 2017 Jul 6. doi: 10.18632/oncotarget.19043.
    Abstract     Related articles   

  860. LI C, Ge Q, Liu J, Zhang Q, et al
    Effects of miR-1236-3p and miR-370-5p on activation of p21 in various tumors and its inhibition on the growth of lung cancer cells.
    Tumour Biol. 2017;39:1010428317710824.
    Abstract     Related articles   

  861. NAGAI T, Kamimura T, Itou K, Fujii M, et al
    Myopericytoma in urinary bladder: a case report.
    J Med Case Rep. 2017;11:46.
    Abstract     Related articles   

  862. JORGENSEN KR, Hoyer S, Sorensen MM, Jensen JB, et al
    Human papillomavirus types 44, 52, 66 and 67 detected in a woman with squamous cell carcinoma of the urinary bladder.
    Scand J Urol. 2017;51:85-86.
    Abstract     Related articles   

  863. ANDREASSEN BK, Myklebust TA, Haug ES
    Crude mortality and loss of life expectancy of patients diagnosed with urothelial carcinoma of the urinary bladder in Norway.
    Scand J Urol. 2017;51:38-43.
    Abstract     Related articles   

  864. LIEDBERG F, Ahlgren G, Baseckas G, Gudjonsson S, et al
    Long-term functional outcomes after radical cystectomy with ileal bladder substitute: does the definition of continence matter?
    Scand J Urol. 2017;51:44-49.
    Abstract     Related articles   

  865. YANG YB, Bai YJ, Tang Y, Liu ZH, et al
    [Detection of Circulating Tumor Cells in Bladder Cancer by Subtraction Enrichment and Immunostaining-fluorescence in situ Hybridization].
    Sichuan Da Xue Xue Bao Yi Xue Ban. 2017;48:605-609.
    Abstract     Related articles   

  866. TANG X, Du P, Yang Y
    The clinical use of neutrophil-to-lymphocyte ratio in bladder cancer patients: a systematic review and meta-analysis.
    Int J Clin Oncol. 2017 Jul 27. doi: 10.1007/s10147-017-1171.
    Abstract     Related articles   

  867. HE X, Hou J, Ping J, Wen D, et al
    Opa interacting protein 5 acts as an oncogene in bladder cancer.
    J Cancer Res Clin Oncol. 2017 Jul 27. doi: 10.1007/s00432-017-2485.
    Abstract     Related articles   

  868. DZOMBETA T, Kruslin B
    High Grade T1 Papillary Urothelial Bladder Cancer Shows Prominent Peritumoral Retraction Clefting.
    Pathol Oncol Res. 2017 Jul 27. doi: 10.1007/s12253-017-0279.
    Abstract     Related articles   

  869. TESSMANN JW, Buss J, Begnini KR, Berneira LM, et al
    Antitumor potential of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-1H-pyrazoles in human bladder cancer cells.
    Biomed Pharmacother. 2017;94:37-46.
    Abstract     Related articles   

  870. LI H, Xu Y, Li H
    CD147 as a novel biomarker for predicting the prognosis and clinicopathological features of bladder cancer: a meta-analysis.
    Oncotarget. 2017 Jul 15. doi: 10.18632/oncotarget.19257.
    Abstract     Related articles   

  871. WANG X, Cui MM, Xu Y, Liu L, et al
    Decreased mean platelet volume predicts poor prognosis in invasive bladder cancer.
    Oncotarget. 2017 Jul 12. doi: 10.18632/oncotarget.19242.
    Abstract     Related articles   

  872. CAO JY, Yin HS, Li HS, Yu XQ, et al
    Interleukin-27 augments the inhibitory effects of sorafenib on bladder cancer cells.
    Braz J Med Biol Res. 2017;50:e6207.
    Abstract     Related articles   

  873. WEN W, Li J, Wang L, Xing Y, et al
    Inhibition of NEDD4 inhibits cell growth and invasion and induces cell apoptosis in bladder cancer cells.
    Cell Cycle. 2017 Jul 26:1-6. doi: 10.1080/15384101.2017.1338220.
    Abstract     Related articles   

  874. ZHANG GH, Yuan JM, Qian G, Gu CX, et al
    Phthalazino[1,2-b]quinazolinones as p53 Activators: Cell Cycle Arrest, Apoptotic Response and Bak-Bcl-xl Complex Reorganization in Bladder Cancer Cells.
    J Med Chem. 2017 Jul 26. doi: 10.1021/acs.jmedchem.6b01769.
    Abstract     Related articles   

  875. ZUIVERLOON TC, Theodorescu D
    Pharmacogenomic considerations in the treatment of muscle-invasive bladder cancer.
    Pharmacogenomics. 2017 Jul 26. doi: 10.2217/pgs-2017-0055.
    Abstract     Related articles   

  876. LI MZ, Lai DH, Zhao HB, Chen Z, et al
    SOCS3 overexpression enhances ADM resistance in bladder cancer T24 cells.
    Eur Rev Med Pharmacol Sci. 2017;21:3005-3011.
    Abstract     Related articles   

  877. KORPAL M, Puyang X, Jeremy Wu Z, Seiler R, et al
    Evasion of immunosurveillance by genomic alterations of PPARgamma/RXRalpha in bladder cancer.
    Nat Commun. 2017;8:103.
    Abstract     Related articles   

  878. HAKENBERG OW
    Nivolumab for the treatment of bladder cancer.
    Expert Opin Biol Ther. 2017 Jul 24:1-7. doi: 10.1080/14712598.2017.1353076.
    Abstract     Related articles   

  879. WANG CY, Nie QW, Zhou X, Huang DX, et al
    [S100A4, a potential therapeutic target on bladder cancer stem cells].
    Nan Fang Yi Ke Da Xue Xue Bao. 2017;37:869-874.
    Abstract     Related articles   

  880. MARTINEZ RODRIGUEZ RH, Buisan Rueda O, Ibarz L
    Bladder cancer: Present and future.
    Med Clin (Barc). 2017 Jul 20. pii: S0025-7753(17)30478.
    Abstract     Related articles   

  881. CHARGARI C, Haie-Meder C, Guerin F, Minard-Colin V, et al
    Brachytherapy Combined With Surgery for Conservative Treatment of Children With Bladder Neck and/or Prostate Rhabdomyosarcoma.
    Int J Radiat Oncol Biol Phys. 2017;98:352-359.
    Abstract     Related articles   

  882. PAN ZJ, Deng N, Zou ZH, Chen GX, et al
    The effect of curcumin on bladder tumor in rat model.
    Eur Rev Med Pharmacol Sci. 2017;21:884-889.
    Abstract     Related articles   

  883. WEWERING F, Jouy F, Caliskan S, Kalkhof S, et al
    Hepatic co-cultures in vitro reveal suitable to detect Nrf2-mediated oxidative stress responses on the bladder carcinogen o-anisidine.
    Toxicol In Vitro. 2017;40:153-160.
    Abstract     Related articles   

  884. MA Y, Luo W, Bunch BL, Pratt RN, et al
    1,25D3 differentially suppresses bladder cancer cell migration and invasion through the induction of miR-101-3p.
    Oncotarget. 2017 Jul 27. doi: 10.18632/oncotarget.19629.
    Abstract     Related articles   

  885. SHI HB, Yu JX, Yu JX, Feng Z, et al
    Diagnostic significance of microRNAs as novel biomarkers for bladder cancer: a meta-analysis of ten articles.
    World J Surg Oncol. 2017;15:147.
    Abstract     Related articles   

  886. ZHU J, Li Y, Chen C, Ma J, et al
    NF-kappaB p65 Overexpression Promotes Bladder Cancer Cell Migration via FBW7-Mediated Degradation of RhoGDIalpha Protein.
    Neoplasia. 2017;19:672-683.
    Abstract     Related articles   

  887. LIU H, Chang JK, Hou JQ, Zhao ZH, et al
    Inhibition of miR-221 influences bladder cancer cell proliferation and apoptosis.
    Eur Rev Med Pharmacol Sci. 2017;21:3193-3199.
    Abstract     Related articles   

  888. GERACE C, Montorsi F, Tambaro R, Carteni G, et al
    Cost of illness of urothelial bladder cancer in Italy.
    Clinicoecon Outcomes Res. 2017;9:433-442.
    Abstract     Related articles   

  889. LOFTFIELD E, Freedman ND, Inoue-Choi M, Graubard BI, et al
    A Prospective Investigation of Coffee Drinking and Bladder Cancer Incidence in the United States.
    Epidemiology. 2017;28:685-693.
    Abstract     Related articles   

  890. AZEVEDO R, Peixoto A, Gaiteiro C, Fernandes E, et al
    Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?
    Oncotarget. 2017 Jul 21. doi: 10.18632/oncotarget.19433.
    Abstract     Related articles   

  891. CHENG TC, Din ZH, Su JH, Wu YJ, et al
    Sinulariolide Suppresses Cell Migration and Invasion by Inhibiting Matrix Metalloproteinase-2/-9 and Urokinase through the PI3K/AKT/mTOR Signaling Pathway in Human Bladder Cancer Cells.
    Mar Drugs. 2017;15.
    Abstract     Related articles   

  892. SAHU D, Lotan Y, Wittmann B, Neri B, et al
    Metabolomics analysis reveals distinct profiles of nonmuscle-invasive and muscle-invasive bladder cancer.
    Cancer Med. 2017 Aug 1. doi: 10.1002/cam4.1109.
    Abstract     Related articles   

  893. RACHAKONDA T, Kendall B, Spivak AM, Boltax J, et al
    Pleural Effusion Caused by Bacillus Calmette-Guerin Immunotherapy for Bladder Cancer.
    Open Forum Infect Dis. 2017;4:ofx126.
    Abstract     Related articles   

  894. YOON HJ, Yoo J, Kim Y, Lee DH, et al
    Enhanced Application of 18F-FDG PET/CT in Bladder Cancer by Adding Early Dynamic Acquisition to a Standard Delayed PET Protocol.
    Clin Nucl Med. 2017 Jul 29. doi: 10.1097/RLU.0000000000001780.
    Abstract     Related articles   

  895. HU R, Zhong P, Xiong L, Duan L, et al
    Long Noncoding RNA Cancer Susceptibility Candidate 8 Suppresses the Proliferation of Bladder Cancer Cells via Regulating Glycolysis.
    DNA Cell Biol. 2017 Jul 31. doi: 10.1089/dna.2017.3785.
    Abstract     Related articles   

  896. HUANG SY, Chang SF, Liao KF, Chiu SC, et al
    Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling.
    Int J Mol Sci. 2017;18.
    Abstract     Related articles   

  897. PAVAN GRANDHI TS, Potta T, Nitiyanandan R, Deshpande I, et al
    Chemomechanically engineered 3D organotypic platforms of bladder cancer dormancy and reactivation.
    Biomaterials. 2017;142:171-185.
    Abstract     Related articles   

  898. PACKIAM VT, Lamm DL, Barocas DA, Trainer A, et al
    An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non-muscle-invasive bladder cancer: Interim results.
    Urol Oncol. 2017 Jul 26. pii: S1078-1439(17)30350.
    Abstract     Related articles   

  899. NECCHI A, Mariani L, Lo Vullo S, Yu EY, et al
    Lack of Effectiveness of Postchemotherapy Lymphadenectomy in Bladder Cancer Patients with Clinical Evidence of Metastatic Pelvic or Retroperitoneal Lymph Nodes Only: A Propensity Score-based Analysis.
    Eur Urol Focus. 2017 Jun 3. pii: S2405-4569(17)30125.
    Abstract     Related articles   

  900. NECCHI A, Pond GR, Smaldone MC, Pal SK, et al
    Robot-assisted Versus Open Radical Cystectomy in Patients Receiving Perioperative Chemotherapy for Muscle-invasive Bladder Cancer: The Oncologist's Perspective from a Multicentre Study.
    Eur Urol Focus. 2017 Mar 31. pii: S2405-4569(17)30079.
    Abstract     Related articles   

  901. NASELLI A, Hurle R, Paparella S, Buffi NM, et al
    Role of Restaging Transurethral Resection for T1 Non-muscle invasive Bladder Cancer: A Systematic Review and Meta-analysis.
    Eur Urol Focus. 2017 Jan 13. pii: S2405-4569(17)30006.
    Abstract     Related articles   

  902. KUKREJA JB, Porten S, Golla V, Ho PL, et al
    Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy.
    Eur Urol Focus. 2017 Jan 18. pii: S2405-4569(16)30181.
    Abstract     Related articles   

  903. KRAMER MW, Altieri V, Hurle R, Lusuardi L, et al
    Current Evidence of Transurethral En-bloc Resection of Nonmuscle Invasive Bladder Cancer: Update 2016.
    Eur Urol Focus. 2017 Jan 11. pii: S2405-4569(16)30180.
    Abstract     Related articles   

  904. VIND-KEZUNOVIC S, Bouchelouche K, Ipsen P, Hoyer S, et al
    Detection of Lymph Node Metastasis in Patients with Bladder Cancer using Maximum Standardised Uptake Value and 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Results from a High-volume Centre Including Long-term Follow-up.
    Eur Urol Focus. 2017 Jun 23. pii: S2405-4569(17)30156.
    Abstract     Related articles   

  905. DRAY EV, Cameron AP
    Identifying Patients with High-Risk Neurogenic Bladder: Beyond Detrusor Leak Point Pressure.
    Urol Clin North Am. 2017;44:441-452.
    Abstract     Related articles   

  906. KRISHNAMURTHY A, Jimeno A
    Atezolizumab: A novel PD-L1 inhibitor in cancer therapy with a focus in bladder and non-small cell lung cancers.
    Drugs Today (Barc). 2017;53:217-237.
    Abstract     Related articles   

  907. MUSAYEV T
    [ORTHOTOPIC URINE DERIVATION AFTER RADICAL CYSTECTOMY (REVIEW)].
    Georgian Med News. 2017;:29-35.
    Abstract     Related articles   

  908. XING NZ, Kang N, Song LM, Niu YN, et al
    Laparoscopic radical cystectomy with novel orthotopic neobladder with bilateral isoperistaltic afferent limbs: initial experience.
    Int Braz J Urol. 2017;43:57-66.
    Abstract     Related articles   

  909. SEDAGHAT S, Gheytanchi E, Asgari M, Roudi R, et al
    Expression of Cancer Stem Cell Markers OCT4 and CD133 in Transitional Cell Carcinomas.
    Appl Immunohistochem Mol Morphol. 2017;25:196-202.
    Abstract     Related articles   

  910. YAN L, Li Q, Yang J, Qiao B, et al
    TPX2-p53-GLIPR1 regulatory circuitry in cell proliferation, invasion and tumor growth of bladder cancer.
    J Cell Biochem. 2017 Aug 11. doi: 10.1002/jcb.26340.
    Abstract     Related articles   

  911. FAIREY AS, Jacobsen NE
    Taking it to the HILT: High-intensity local treatment with radical cystectomy for metastatic bladder cancer.
    Can Urol Assoc J. 2017;11:249-250.
    Abstract     Related articles   

  912. CHANG SS, Bochner BH, Chou R, Dreicer R, et al
    Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer: American Urological Association/American Society of Clinical Oncology/American Society for Radiation Oncology/Society of Urologic Oncology Clinical Practice Guideline Summary.
    J Oncol Pract. 2017 Aug 10:JOP2017024919. doi: 10.1200/JOP.2017.024919.
    Abstract     Related articles   

  913. CHEN Z, Zhou L, Wang L, Kazobinka G, et al
    HBO1 promotes cell proliferation in bladder cancer via activation of Wnt/beta-catenin signaling.
    Mol Carcinog. 2017 Aug 10. doi: 10.1002/mc.22715.
    Abstract     Related articles   

  914. LI Y, Zheng F, Xiao X, Xie F, et al
    CircHIPK3 sponges miR-558 to suppress heparanase expression in bladder cancer cells.
    EMBO Rep. 2017 Aug 9. pii: e201643581. doi: 10.15252/embr.201643581.
    Abstract     Related articles   

  915. JIN H, Xie Q, Guo X, Xu J, et al
    p63alpha protein upregulates heat shock protein 70 expression via E2F1 transcription factor 1, promoting Wasf3/Wave3/MMP9 signaling and bladder cancer invasion.
    J Biol Chem. 2017 Aug 9. pii: jbc.M117.792010. doi: 10.1074/jbc.M117.792010.
    Abstract     Related articles   

  916. ZHU F, Qian W, Zhang H, Liang Y, et al
    SOX2 Is a Marker for Stem-like Tumor Cells in Bladder Cancer.
    Stem Cell Reports. 2017;9:429-437.
    Abstract     Related articles   

  917. GAO L, Li SH, Tian YX, Zhu QQ, et al
    Role of downregulated miR-133a-3p expression in bladder cancer: a bioinformatics study.
    Onco Targets Ther. 2017;10:3667-3683.
    Abstract     Related articles   

  918. CAO W, Tian J, Li C, Gao Y, et al
    A novel bladder cancer - specific oncolytic adenovirus by CD46 and its effect combined with cisplatin against cancer cells of CAR negative expression.
    Virol J. 2017;14:149.
    Abstract     Related articles   

  919. COLLARILE P, Bidoli E, Barbone F, Zanier L, et al
    Residence in Proximity of a Coal-Oil-Fired Thermal Power Plant and Risk of Lung and Bladder Cancer in North-Eastern Italy. A Population-Based Study: 1995-2009.
    Int J Environ Res Public Health. 2017;14.
    Abstract     Related articles   

  920. GARAPATI SS, Hadjiiski L, Cha KH, Chan HP, et al
    Urinary Bladder Cancer Staging in CT Urography using Machine Learning.
    Med Phys. 2017 Aug 8. doi: 10.1002/mp.12510.
    Abstract     Related articles   

  921. SIDAWAY P
    Bladder cancer: PPARgamma-RXRalpha alterations promote immune evasion.
    Nat Rev Urol. 2017 Aug 8. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  922. GUHANIYOGI R
    Bayesian nonparametric areal wombling for small-scale maps with an application to urinary bladder cancer data from Connecticut.
    Stat Med. 2017 Aug 7. doi: 10.1002/sim.7408.
    Abstract     Related articles   

  923. XIA J, Zeng M, Zhu H, Chen X, et al
    Emerging role of Hippo signalling pathway in bladder cancer.
    J Cell Mol Med. 2017 Aug 7. doi: 10.1111/jcmm.13293.
    Abstract     Related articles   

  924. AVIRMED S, Wang BS, Selenge B, Sanjaajamts A, et al
    Association between MDM2-SNP309 and p53R72P polymorphisms and the risk of bladder cancer in the Mongolian population.
    Mol Clin Oncol. 2017;7:412-420.
    Abstract     Related articles   

  925. KANG HW, Seo SP, Jeong P, Ha YS, et al
    Long-term validation of a molecular progression-associated gene classifier for prediction of muscle invasion in primary non-muscle-invasive bladder cancer.
    Oncol Lett. 2017;14:2468-2474.
    Abstract     Related articles   

  926. WU H, Hao A, Cui H, Wu W, et al
    TRAF6 expression is associated with poorer prognosis and high recurrence in urothelial bladder cancer.
    Oncol Lett. 2017;14:2432-2438.
    Abstract     Related articles   

  927. LI S, Wang F, Zhai Z, Fu S, et al
    Synergistic effect of bladder cancer-specific oncolytic adenovirus in combination with chemotherapy.
    Oncol Lett. 2017;14:2081-2088.
    Abstract     Related articles   

  928. TRUTA A, Popon TAH, Saraci G, Ghervan L, et al
    Health Related Quality of life in bladder cancer. Current approach and future perspectives.
    Clujul Med. 2017;90:262-267.
    Abstract     Related articles   

  929. HADKHALE K, MacLeod J, Demers PA, Martinsen JI, et al
    Occupational variation in incidence of bladder cancer: a comparison of population-representative cohorts from Nordic countries and Canada.
    BMJ Open. 2017;7:e016538.
    Abstract     Related articles   

  930. MIAO X, Gao H, Liu S, Chen M, et al
    Down-regulation of microRNA-224 -inhibites growth and epithelial-to-mesenchymal transition phenotype -via modulating SUFU expression in bladder cancer cells.
    Int J Biol Macromol. 2017 Aug 2. pii: S0141-8130(17)30303.
    Abstract     Related articles   

  931. LV M, Zhong Z, Huang M, Tian Q, et al
    lncRNA H19 regulates epithelial-mesenchymal transition and metastasis of bladder cancer by miR-29b-3p as competing endogenous RNA.
    Biochim Biophys Acta. 2017;1864:1887-1899.
    Abstract     Related articles   

  932. SIDDIQUI MR, Grant C, Sanford T, Agarwal PK, et al
    Current clinical trials in non-muscle invasive bladder cancer.
    Urol Oncol. 2017;35:516-527.
    Abstract     Related articles   

  933. STAPF M, Teichgraber U, Hilger I
    Methotrexate-coupled nanoparticles and magnetic nanochemothermia for the relapse-free treatment of T24 bladder tumors.
    Int J Nanomedicine. 2017;12:2793-2811.
    Abstract     Related articles   

  934. D'ANDREA D, Moschini M, Gust KM, Abufaraj M, et al
    Lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio as biomarkers for predicting lymph node metastasis and survival in patients treated with radical cystectomy.
    J Surg Oncol. 2017;115:455-461.
    Abstract     Related articles   

  935. PARK S, Kang SY, Kwon GY, Kwon JE, et al
    Clinicopathologic Characteristics and Mutational Status of Succinate Dehydrogenase Genes in Paraganglioma of the Urinary Bladder: A Multi-Institutional Korean Study.
    Arch Pathol Lab Med. 2017;141:671-677.
    Abstract     Related articles   

  936. WANG F, Wu LM, Hua XL, Zhao ZZ, et al
    Intravoxel incoherent motion diffusion-weighted imaging in assessing bladder cancer invasiveness and cell proliferation.
    J Magn Reson Imaging. 2017 Aug 17. doi: 10.1002/jmri.25839.
    Abstract     Related articles   

  937. WANG Y, Zhang H, Li X, Chen W, et al
    Differential expression profile analysis of lncRNA UCA1alpha regulated mRNAs in bladder cancer.
    J Cell Biochem. 2017 Aug 16. doi: 10.1002/jcb.26345.
    Abstract     Related articles   

  938. GECIT I, Eryilmaz R, Kavak S, Meral I, et al
    The Prolidase Activity, Oxidative Stress, and Nitric Oxide Levels of Bladder Tissues with or Without Tumor in Patients with Bladder Cancer.
    J Membr Biol. 2017 Aug 16. doi: 10.1007/s00232-017-9971.
    Abstract     Related articles   

  939. LOPEZ-BELTRAN A, Cheng L, Montorsi F, Scarpelli M, et al
    Concomitant bladder cancer and prostate cancer: challenges and controversies.
    Nat Rev Urol. 2017 Aug 16. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  940. THOMA C
    Bladder cancer: The promise of liquid biopsy ctDNA analysis.
    Nat Rev Urol. 2017 Aug 16. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  941. AVITAN O, Bahouth Z, Halachmi S, Shprits S, et al
    Histopathologic Differences between Jewish and Arab Population in Israel at First-Time Presentation with Bladder Cancer.
    Biomed Res Int. 2017;2017:8239601.
    Abstract     Related articles   

  942. VERMA A, Kapoor R, Mittal RD
    Genetic Variation in CD166 Gene and Its Association with Bladder Cancer Risk in North Indian Population.
    Indian J Clin Biochem. 2017;32:292-300.
    Abstract     Related articles   

  943. HUSSEIN S, Mosaad H, Rashed HE, Ahmed S, et al
    Molecular factors regulating E-cadherin expression in urothelial bladder cancer and their correlations with the clinicopathological features.
    Mol Biol Rep. 2017 Aug 14. doi: 10.1007/s11033-017-4118.
    Abstract     Related articles   

  944. CORMIO A, Sanguedolce F, Musicco C, Pesce V, et al
    Mitochondrial dysfunctions in bladder cancer: Exploring their role as disease markers and potential therapeutic targets.
    Crit Rev Oncol Hematol. 2017;117:67-72.
    Abstract     Related articles   

  945. MASTRANGELO G, Carta A, Arici C, Pavanello S, et al
    An etiologic prediction model incorporating biomarkers to predict the bladder cancer risk associated with occupational exposure to aromatic amines: a pilot study.
    J Occup Med Toxicol. 2017;12:23.
    Abstract     Related articles   

  946. FEKI-TOUNSI M, Khlifi R, Louati I, Fourati M, et al
    Polymorphisms in XRCC1, ERCC2, and ERCC3 DNA repair genes, CYP1A1 xenobiotic metabolism gene, and tobacco are associated with bladder cancer susceptibility in Tunisian population.
    Environ Sci Pollut Res Int. 2017 Aug 12. doi: 10.1007/s11356-017-9767.
    Abstract     Related articles   

  947. OUGHTON JB, Poad H, Twiddy M, Collinson M, et al
    Radical cystectomy (bladder removal) against intravesical BCG immunotherapy for high-risk non-muscle invasive bladder cancer (BRAVO): a protocol for a randomised controlled feasibility study.
    BMJ Open. 2017;7:e017913.
    Abstract     Related articles   

  948. STEINBERG RL, Nepple KG, Velaer KN, Thomas LJ, et al
    Quadruple immunotherapy of Bacillus Calmette-Guerin, interferon, interleukin-2, and granulocyte-macrophage colony-stimulating factor as salvage therapy for non-muscle-invasive bladder cancer.
    Urol Oncol. 2017 Aug 8. pii: S1078-1439(17)30386.
    Abstract     Related articles   

  949. LEE Y, Kischuk E, Crist S, Ratliff TL, et al
    Targeting and Internalization of Liposomes by Bladder Tumor Cells Using a Fibronectin Attachment Protein-Derived Peptide-Lipopolymer Conjugate.
    Bioconjug Chem. 2017;28:1481-1490.
    Abstract     Related articles   

  950. GERULLIS H, Ecke TH, Barski D, Bantel C, et al
    Retrospective analysis of a surgical innovation using the IDEAL framework: radical cystectomy with epidural anaesthesia.
    J Int Med Res. 2017;45:714-722.
    Abstract     Related articles   

  951. SHIGETA K, Kikuchi E, Hagiwara M, Ando T, et al
    Prolonged pneumoperitoneum time is an independent risk factor for intravesical recurrence after laparoscopic radical nephroureterectomy in upper tract urothelial carcinoma.
    Surg Oncol. 2017;26:73-79.
    Abstract     Related articles   

  952. NISHIOKA K, Shimizu S, Shinohara N, Ito YM, et al
    Analysis of inter- and intra fractional partial bladder wall movement using implanted fiducial markers.
    Radiat Oncol. 2017;12:44.
    Abstract     Related articles   

  953. KRENGLI M, Pisani C, Deantonio L, Surico D, et al
    Intraoperative radiotherapy in gynaecological and genito-urinary malignancies: focus on endometrial, cervical, renal, bladder and prostate cancers.
    Radiat Oncol. 2017;12:18.
    Abstract     Related articles   

  954. ROIFE D, Kang Y, Wang L, Fang B, et al
    Generation of patient-derived xenografts from fine needle aspirates or core needle biopsy.
    Surgery. 2017;161:1246-1254.
    Abstract     Related articles   

  955. SMEDINGA H, Steyerberg EW, Beukers W, van Klaveren D, et al
    Prediction of Multiple Recurrent Events: A Comparison of Extended Cox Models in Bladder Cancer.
    Am J Epidemiol. 2017 May 19. doi: 10.1093.
    Abstract     Related articles   

  956. HAHN AW, Giri S, Pathak R, Bhatt VR, et al
    Effect of Adjuvant Radiotherapy on Survival in Patients with Locoregional Urothelial Malignancies of the Upper Urinary Tract.
    Anticancer Res. 2016;36:4051-5.
    Abstract     Related articles   

  957. MANIG L, Kasmann L, Janssen S, Rades D, et al
    Predicting Survival After Irradiation of Metastases from Transitional Carcinoma of the Bladder.
    Anticancer Res. 2016;36:6663-6665.
    Abstract     Related articles   

  958. HANCOCK BM, McGuire KL, Tsuji S, Reil K, et al
    A Single Intravesical Instillation of VAX014 Inhibits Orthotopic Superficial Bladder Tumor Implantation to Increase Survival.
    Anticancer Res. 2016;36:6243-6248.
    Abstract     Related articles   

  959. WIECZOREK E, Jablonowski Z, Tomasik B, Gromadzinska J, et al
    Different Gene Expression and Activity Pattern of Antioxidant Enzymes in Bladder Cancer.
    Anticancer Res. 2017;37:841-848.
    Abstract     Related articles   

  960. IWAMOTO H, Izumi K, Shimura Y, Natsagdorj A, et al
    Metastasectomy Improves Survival in Patients with Metastatic Urothelial Carcinoma.
    Anticancer Res. 2016;36:5557-5561.
    Abstract     Related articles   

  961. FRIEDMAN P, Lai JP
    Liver Metastasis of Urothelial Carcinoma with Hepatoid Features: An Unusual Morphological Finding.
    Anticancer Res. 2017;37:801-804.
    Abstract     Related articles   

  962. RADES D, Manig L, Janssen S, Schild SE, et al
    Concurrent Chemotherapy Improves the Overall Survival of Patients Irradiated for Locally Recurrent Bladder Cancer.
    Anticancer Res. 2017;37:1485-1488.
    Abstract     Related articles   

  963. RADES D, Manig L, Janssen S, Schild SE, et al
    A Survival Score for Patients Assigned to Palliative Radiotherapy for Metastatic Bladder Cancer.
    Anticancer Res. 2017;37:1481-1484.
    Abstract     Related articles   

  964. SILVA J, Arantes-Rodrigues R, Pinto-Leite R, Faustino-Rocha AI, et al
    Synergistic Effect of Carboplatin and Piroxicam on Two Bladder Cancer Cell Lines.
    Anticancer Res. 2017;37:1737-1745.
    Abstract     Related articles   

  965. HUDOLIN T, Mengus C, Coulot J, Kastelan Z, et al
    Expression of Indoleamine 2,3-Dioxygenase Gene Is a Feature of Poorly Differentiated Non-muscle-invasive Urothelial Cell Bladder Carcinomas.
    Anticancer Res. 2017;37:1375-1380.
    Abstract     Related articles   

  966. SHI CS, Li JM, Chin CC, Kuo YH, et al
    Evodiamine Induces Cell Growth Arrest, Apoptosis and Suppresses Tumorigenesis in Human Urothelial Cell Carcinoma Cells.
    Anticancer Res. 2017;37:1149-1159.
    Abstract     Related articles   

  967. MANIG L, Kasmann L, Janssen S, Schild SE, et al
    Simplified Comorbidity Score and Eastern Cooperative Oncology Group Performance Score Predicts Survival in Patients Receiving Organ-preserving Treatment for Bladder Cancer.
    Anticancer Res. 2017;37:2693-2696.
    Abstract     Related articles   

  968. KHANAL A, Budhathoki N, Singh VP, Shah BK, et al
    Second Primary Malignancy in Bladder Carcinoma - A Population-based Study.
    Anticancer Res. 2017;37:2033-2036.
    Abstract     Related articles   

  969. JANSSEN S, Manig L, Schild SE, Rades D, et al
    Radiotherapy of Primary or Recurrent Bladder Cancer in the Very Elderly.
    Anticancer Res. 2017;37:3287-3290.
    Abstract     Related articles   

  970. ORYWAL K, Jelski W, Werel T, Szmitkowski M, et al
    The Diagnostic Significance of Serum Alcohol Dehydrogenase Isoenzymes and Aldehyde Dehydrogenase Activity in Urinary Bladder Cancer Patients.
    Anticancer Res. 2017;37:3537-3541.
    Abstract     Related articles   

  971. TANG X, Wang S, An C, DU P, et al
    Preoperative High Neutrophil-to-Lymphocyte Ratio Is Associated with High-grade Bladder Cancer.
    Anticancer Res. 2017;37:4659-4663.
    Abstract     Related articles   

  972. ZHOU HH, Liu LY, Yu GH, Qu GM, et al
    Analysis of Clinicopathological Features and Prognostic Factors in 39 Cases of Bladder Neuroendocrine Carcinoma.
    Anticancer Res. 2017;37:4529-4537.
    Abstract     Related articles   

  973. DU P, Wang S, Tang X, An C, et al
    Reduced Expression of Metastasis Suppressor-1 (MTSS1) Accelerates Progression of Human Bladder Uroepithelium Cell Carcinoma.
    Anticancer Res. 2017;37:4499-4505.
    Abstract     Related articles   

  974. HUSSEIN AA, Hinata N, Dibaj S, May PR, et al
    Development, Validation and Clinical Application of Pelvic Lymphadenectomy Assessment and Completion Evaluation (PLACE): Intraoperative Assessment of Lymph Node Dissection after Robot-Assisted Radical Cystectomy for Bladder Cancer.
    BJU Int. 2016 Dec 17. doi: 10.1111/bju.13748.
    Abstract     Related articles   

  975. WOLDU SL, Bagrodia A, Lotan Y
    Guideline of Guidelines - Non-Muscle Invasive Bladder Cancer.
    BJU Int. 2017 Jan 6. doi: 10.1111/bju.13760.
    Abstract     Related articles   

  976. VESKIMAE E, Neuzillet Y, Rouanne M, MacLennan S, et al
    Systematic review of the oncological and functional outcomes of pelvic organ-preserving cystectomy compared with standard radical cystectomy in women who undergo curative surgery and orthotopic neobladder substitution for bladder cancer.
    BJU Int. 2017 Feb 20. doi: 10.1111/bju.13819.
    Abstract     Related articles   

  977. HAYNE D, Stockler M, McCombie SP, Lawrence N, et al
    The BCG + Mitomycin trial for high risk non-muscle-invasive bladder cancer: Progress report and lessons learned.
    BJU Int. 2017 Apr 9. doi: 10.1111/bju.13873.
    Abstract     Related articles   

  978. MATARAZA JM, Gotwals P
    Recent advances in immuno-oncology and its application to urological cancers.
    BJU Int. 2016;118:506-14.
    Abstract     Related articles   

  979. LONGO N, Imbimbo C, Fusco F, Ficarra V, et al
    Complications and quality of life in elderly patients with several comorbidities undergoing cutaneous ureterostomy with single stoma or ileal conduit after radical cystectomy.
    BJU Int. 2016;118:521-6.
    Abstract     Related articles   

  980. ZHANG C, Ma X, Du J, Yao Z, et al
    MicroRNA-30a as a prognostic factor in urothelial carcinoma of bladder inhibits cellular malignancy by antagonising Notch1.
    BJU Int. 2016;118:578-89.
    Abstract     Related articles   

  981. MEYER CP, Rios Diaz AJ, Dalela D, Hanske J, et al
    Wound dehiscence in a sample of 1 776 cystectomies: identification of predictors and implications for outcomes.
    BJU Int. 2016;117.
    Abstract     Related articles   

  982. NGO B, Papa N, Perera M, Bolton D, et al
    Bladder cancer diagnosis during haematuria investigation - implications for practice guidelines.
    BJU Int. 2017;119 Suppl 5:53-54.
    Abstract     Related articles   

  983. HAYNE D
    Bladder cancer - Old lessons yet to be learned.
    BJU Int. 2017;119 Suppl 5:7.
    Abstract     Related articles   

  984. NGO B, Perera M, Papa N, Bolton D, et al
    Factors affecting the timeliness and adequacy of haematuria assessment in bladder cancer: a systematic review.
    BJU Int. 2017;119 Suppl 5:10-18.
    Abstract     Related articles   

  985. LAWRENTSCHUK N
    Bladder cancer- time for a higher profile in our region.
    BJU Int. 2017;119 Suppl 5:5.
    Abstract     Related articles   

  986. GOLOMBOS DM, O'Malley P, Lewicki P, Stone BV, et al
    Robot-assisted partial cystectomy: perioperative outcomes and early oncological efficacy.
    BJU Int. 2017;119:128-134.
    Abstract     Related articles   

  987. AFSHAR M, Goodfellow H, Jackson-Spence F, Evison F, et al
    Centralisation of radical cystectomies for bladder cancer in England, a decade on from the 'Improving Outcomes Guidance': The case for super centralisation.
    BJU Int. 2017 Jun 8. doi: 10.1111/bju.13929.
    Abstract     Related articles   

  988. NGO B, Papa N, Perera M, Bolton D, et al
    Predictors of delay to cystoscopy and adequacy of investigations in patients with haematuria.
    BJU Int. 2017;119 Suppl 5:19-25.
    Abstract     Related articles   

  989. MCCOMBIE SP, Bangash HK, Kuan M, Thyer I, et al
    Delays in the diagnosis and initial treatment of bladder cancer in Western Australia.
    BJU Int. 2017 Jun 29. doi: 10.1111/bju.13939.
    Abstract     Related articles   

  990. SOAVE A, Riethdorf S, Dahlem R, Minner S, et al
    Detection and oncological effect of circulating tumour cells in patients with variant urothelial carcinoma histology treated with radical cystectomy.
    BJU Int. 2017;119:854-861.
    Abstract     Related articles   

  991. WAINGANKAR N, Mallin K, Smaldone M, Egleston BL, et al
    Assessing the relative influence of hospital and surgeon volume on short-term mortality after radical cystectomy.
    BJU Int. 2017;120:239-245.
    Abstract     Related articles   

  992. MILLER C, Campain NJ, Dbeis R, Daugherty M, et al
    Introduction of robot-assisted radical cystectomy within an established enhanced recovery programme.
    BJU Int. 2017;120:265-272.
    Abstract     Related articles   

  993. DUDDERIDGE T
    Positive messages for bladder cancer management in negative sentinel lymph node study.
    BJU Int. 2017;120:302-303.
    Abstract     Related articles   

  994. CHOUDHURY A, West CM, Porta N, Hall E, et al
    The predictive and prognostic value of tumour necrosis in muscle invasive bladder cancer patients receiving radiotherapy with or without chemotherapy in the BC2001 trial (CRUK/01/004).
    Br J Cancer. 2017 Jan 26. doi: 10.1038/bjc.2017.
    Abstract     Related articles   

  995. SAKAGUCHI T, Yoshino H, Yonemori M, Miyamoto K, et al
    Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer.
    Br J Cancer. 2017 Mar 21. doi: 10.1038/bjc.2017.
    Abstract     Related articles   

  996. DESCOTES F, Kara N, Decaussin-Petrucci M, Piaton E, et al
    Non-invasive prediction of recurrence in bladder cancer by detecting somatic TERT promoter mutations in urine.
    Br J Cancer. 2017 Jul 6. doi: 10.1038/bjc.2017.
    Abstract     Related articles   

  997. PACKIAM VT, Johnson SC, Steinberg GD
    Non-muscle-invasive bladder cancer: Intravesical treatments beyond Bacille Calmette-Guerin.
    Cancer. 2017;123:390-400.
    Abstract     Related articles   

  998. WANG H, Hoda RS, Faquin W, Rossi ED, et al
    FNA biopsy of secondary nonlymphomatous malignancies in salivary glands: A multi-institutional study of 184 cases.
    Cancer. 2017;125:91-103.
    Abstract     Related articles   

  999. MACLEOD LC, Pham KN, Agoff SN, Dahl KL, et al
    Cytologic persistence of malignant cells after transurethral resection of bladder tumors: Implications for concomitant manipulation of the urinary tract at the time of endoscopic resection.
    Cancer. 2017;125:114-119.
    Abstract     Related articles   

  1000. KORPICS MC, Block AM, Martin B, Hentz C, et al
    Concurrent chemotherapy is associated with improved survival in elderly patients with bladder cancer undergoing radiotherapy.
    Cancer. 2017 Jun 5. doi: 10.1002/cncr.30719.
    Abstract     Related articles   

  1001. OJERHOLM E, Smith A, Hwang WT, Christodouleas JP, et al
    Reply to Neutrophil-to-lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710.
    Cancer. 2017 Jun 30. doi: 10.1002/cncr.30871.
    Abstract     Related articles   

  1002. DOLAN RD, McMillan DC
    Neutrophil-to-lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710.
    Cancer. 2017 Jun 30. doi: 10.1002/cncr.30872.
    Abstract     Related articles   

  1003. CAHN DB, Handorf EA, Ghiraldi EM, Ristau BT, et al
    Contemporary use trends and survival outcomes in patients undergoing radical cystectomy or bladder-preservation therapy for muscle-invasive bladder cancer.
    Cancer. 2017 Jul 25. doi: 10.1002/cncr.30900.
    Abstract     Related articles   

  1004. VETTERLEIN MW, Wankowicz SAM, Seisen T, Lander R, et al
    Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology.
    Cancer. 2017 Jul 25. doi: 10.1002/cncr.30907.
    Abstract     Related articles   

  1005. OWCZAREK TB, Kobayashi T, Ramirez R, Rong L, et al
    ARF confers a context-dependent response to chemotherapy in muscle invasive bladder cancer.
    Cancer Res. 2017 Jan 12. pii: canres.2621.2016.
    Abstract     Related articles   

  1006. NICHOLSON J, Jevons S, Groselj B, Ellermann S, et al
    E3 ligase cIAP2 mediates downregulation of MRE11 and radiosensitization in response to HDAC inhibition in bladder cancer.
    Cancer Res. 2017 Mar 31. pii: canres.3232.2016.
    Abstract     Related articles   

  1007. VAN KAMPEN JGM, van Hooij O, Jansen CF, Smit FP, et al
    miRNA-520f Reverses Epithelial-to-Mesenchymal Transition by Targeting ADAM9 and TGFBR2.
    Cancer Res. 2017;77:2008-2017.
    Abstract     Related articles   

  1008. MIAO L, Liu Q, Lin CM, Luo C, et al
    Targeting Tumor-Associated Fibroblasts for Therapeutic Delivery in Desmoplastic Tumors.
    Cancer Res. 2017;77:719-731.
    Abstract     Related articles   

  1009. GUIN S, Ru Y, Agarwal N, Lew CR, et al
    Loss of Glycogen Debranching Enzyme AGL Drives Bladder Tumor Growth via Induction of Hyaluronic Acid Synthesis.
    Clin Cancer Res. 2016;22:1274-83.
    Abstract     Related articles   

  1010. SIN ML, Mach KE, Sinha R, Wu F, et al
    Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics.
    Clin Cancer Res. 2017 Feb 13. pii: clincanres.2610.2016.
    Abstract     Related articles   

  1011. YANG L, Taylor J, Eustace A, Irlam J, et al
    A Gene Signature for Selecting Benefit from Hypoxia Modification of Radiotherapy for High Risk Bladder Cancer Patients.
    Clin Cancer Res. 2017 Apr 11. pii: clincanres.0038.2017.
    Abstract     Related articles   

  1012. WEN T, Yang Z, He L, Lin K, et al
    The KMT1A-GATA3-STAT3 circuit is a novel self-renewal signaling of human bladder cancer stem cells.
    Clin Cancer Res. 2017 Aug 1. pii: clincanres.0882.2017.
    Abstract     Related articles   

  1013. VANDEKERKHOVE GR, Todenhofer T, Annala M, Struss WJ, et al
    <span style="font-weight: 400;">Circulating tumor DNA reveals clinically-actionable somatic genome of metastatic bladder cancer</span>.
    Clin Cancer Res. 2017 Jul 31. pii: clincanres.1140.2017.
    Abstract     Related articles   

  1014. KATES M, Date A, Yoshida T, Afzal U, et al
    Preclincial Evaluation of Intravesical Cisplatin Nanoparticles for Non-Muscle-Invasive Bladder Cancer.
    Clin Cancer Res. 2017 Aug 14. pii: clincanres.1082.2017.
    Abstract     Related articles   

  1015. ZENG S, Zhu Y, Ma AH, Yu W, et al
    The Phosphatidylinositol 3-kinase Pathway as a Potential Therapeutic Target in Bladder Cancer.
    Clin Cancer Res. 2017 Aug 14. pii: clincanres.0033.2017.
    Abstract     Related articles   

  1016. HERRMANN TR, Wolters M, Kramer MW
    Transurethral en bloc resection of nonmuscle invasive bladder cancer: trend or hype.
    Curr Opin Urol. 2016 Dec 28. doi: 10.1097/MOU.0000000000000377.
    Abstract     Related articles   

  1017. SELTZ LM, Herrell SD
    Applications of spectroscopy in diagnosis, staging, and treatment of urologic malignancies.
    Curr Opin Urol. 2016;26:259-63.
    Abstract     Related articles   

  1018. GILD P, Ehdaie B, Kluth LA
    Effect of obesity on bladder cancer and renal cell carcinoma incidence and survival.
    Curr Opin Urol. 2017 Jun 24. doi: 10.1097/MOU.0000000000000425.
    Abstract     Related articles   

  1019. KAWADA T
    Bladder cancer and smoking with special reference to education.
    Eur J Cancer. 2017;75:1-2.
    Abstract     Related articles   

  1020. KHAN MS, Gan C, Ahmed K, Ismail AF, et al
    A Single-centre Early Phase Randomised Controlled Three-arm Trial of Open, Robotic, and Laparoscopic Radical Cystectomy (CORAL).
    Eur Urol. 2016;69:613-21.
    Abstract     Related articles   

  1021. SELINSKI S, Gerullis H, Otto T, Roth E, et al
    Ultra-slow N-Acetyltransferase 2 Is Associated with Recurrence-free Time in Bladder Cancer Patients.
    Eur Urol. 2016 Dec 28. pii: S0302-2838(16)30904.
    Abstract     Related articles   

  1022. GIACALONE NJ, Shipley WU, Clayman RH, Niemierko A, et al
    Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience.
    Eur Urol. 2017 Jan 9. pii: S0302-2838(16)30924.
    Abstract     Related articles   

  1023. DE VERE WHITE R
    Re: Management of Nonmuscle Invasive Bladder Cancer: A Comprehensive Analysis of Guidelines from the Unites States, Europe, and Asia.
    Eur Urol. 2017 Jan 7. pii: S0302-2838(16)30921.
    Abstract     Related articles   

  1024. CHRISTENSEN E, Birkenkamp-Demtroder K, Nordentoft I, Hoyer S, et al
    Liquid Biopsy Analysis of FGFR3 and PIK3CA Hotspot Mutations for Disease Surveillance in Bladder Cancer.
    Eur Urol. 2017 Jan 6. pii: S0302-2838(16)30920.
    Abstract     Related articles   

  1025. ROTH B
    Re: Prediction of Lymph Node Metastasis in Patients with Bladder Cancer Using Whole Transcriptome Gene Expression Signatures.
    Eur Urol. 2017 Jan 13. pii: S0302-2838(17)30012.
    Abstract     Related articles   

  1026. MARQUES M, Real FX
    PIcKing on Fibroblast Growth Factor Receptors as Bladder Cancer Therapeutic Targets.
    Eur Urol. 2017 Feb 14. pii: S0302-2838(17)30087.
    Abstract     Related articles   

  1027. COTTE J, Roupret M
    Re: Long-term Oncological Outcomes of an Active Surveillance Program in Recurrent Low Grade Ta Bladder Cancer.
    Eur Urol. 2017 Feb 18. pii: S0302-2838(17)30106.
    Abstract     Related articles   

  1028. MAY M, Lebentrau S, Brookman-May SD
    Re: Decreased Overall and Bladder Cancer-specific Mortality with Adjuvant Chemotherapy After Radical Cystectomy: Multivariable Competing Risk Analysis.
    Eur Urol. 2017 Feb 20. pii: S0302-2838(17)30107.
    Abstract     Related articles   

  1029. BOKARICA P, Hrkac A, Gilja I
    Re: J. Alfred Witjes, Thierry Lebret, Eva M. Comperat, et al. Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer. Eur Urol 2017;71:462-75.
    Eur Urol. 2017 Mar 6. pii: S0302-2838(17)30126.
    Abstract     Related articles   

  1030. CHOI W, Ochoa A, McConkey DJ, Aine M, et al
    Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset.
    Eur Urol. 2017 Mar 29. pii: S0302-2838(17)30175.
    Abstract     Related articles   

  1031. SEILER R, Oo HZ, Tortora D, Clausen TM, et al
    An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder Cancer.
    Eur Urol. 2017 Apr 10. pii: S0302-2838(17)30232.
    Abstract     Related articles   

  1032. SEILER R, Ashab HA, Erho N, van Rhijn BW, et al
    Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy.
    Eur Urol. 2017 Apr 5. pii: S0302-2838(17)30251.
    Abstract     Related articles   

  1033. BLACK PC
    Seeking the Molecular Truth in Bladder Cancer: Biology=Genomex(Transcriptome)2.
    Eur Urol. 2017 Apr 17. pii: S0302-2838(17)30286.
    Abstract     Related articles   

  1034. GALSKY MD, Sfakianos JP, Ferket BS
    Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer: Are Things Now Getting Personal?
    Eur Urol. 2017 Apr 19. pii: S0302-2838(17)30292.
    Abstract     Related articles   

  1035. SOUKUP V, Capoun O, Cohen D, Hernandez V, et al
    Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel
    Eur Urol. 2017 Apr 27. pii: S0302-2838(17)30323.
    Abstract     Related articles   

  1036. KULKARNI GS, Klaassen Z
    Trimodal Therapy is Inferior to Radical Cystectomy for Muscle-invasive Bladder Cancer using Population-level Data: Is There Evidence in the (Lack of) Details?
    Eur Urol. 2017 May 5. pii: S0302-2838(17)30338.
    Abstract     Related articles   

  1037. BABJUK M
    Bladder Cancer in the Elderly.
    Eur Urol. 2017 May 3. pii: S0302-2838(17)30326.
    Abstract     Related articles   

  1038. FONTEYNE V, Ost P, Bellmunt J, Droz JP, et al
    Curative Treatment for Muscle Invasive Bladder Cancer in Elderly Patients: A Systematic Review.
    Eur Urol. 2017 May 3. pii: S0302-2838(17)30230.
    Abstract     Related articles   

  1039. ERIKSSON P, Sjodahl G, Liedberg F
    Re: Thomas Powles, Robert A. Huddart, Tony Elliott, et al. Phase III, Double-blind, Randomized Trial that Compared Maintenance Lapatinib versus Placebo after First-line Chemotherapy in Patients with Human Epidermal Growth Factor Receptor 1/2-positive
    Eur Urol. 2017 May 29. pii: S0302-2838(17)30455.
    Abstract     Related articles   

  1040. SEISEN T, Cole AP, Trinh QD
    Reply from Authors re: Girish S. Kulkarni, Zachary Klaassen. Trimodal Therapy is Inferior to Radical Cystectomy for Muscle-invasive Bladder Cancer using Population-level Data: Is There Evidence in the (Lack of) Details? Eur Urol. In press. http://doi.
    Eur Urol. 2017 May 29. pii: S0302-2838(17)30411.
    Abstract     Related articles   

  1041. D'ANDREA D, Shariat SF
    Re: Comparative Effectiveness of Treatment Strategies for Bladder Cancer with Clinical Evidence of Regional Lymph Node Involvement.
    Eur Urol. 2017 Jun 6. pii: S0302-2838(17)30481.
    Abstract     Related articles   

  1042. DYRSKJOT L, Reinert T, Algaba F, Christensen E, et al
    Prognostic Impact of a 12-gene Progression Score in Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Validation Study.
    Eur Urol. 2017 Jun 2. pii: S0302-2838(17)30475.
    Abstract     Related articles   

  1043. PIETZAK EJ, Bagrodia A, Cha EK, Drill EN, et al
    Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets.
    Eur Urol. 2017 Jun 2. pii: S0302-2838(17)30466.
    Abstract     Related articles   

  1044. POWLES T, Gomez de Liano A, Ackerman C
    Reply to Pontus Eriksson, Gottfrid Sjodahl, and Fredrik Liedberg's Letter to the Editor re: Thomas Powles, Robert A. Huddart, Tony Elliott, et al. Phase III, Double-blind, Randomized Trial that Compared Maintenance Lapatinib versus Placebo after First
    Eur Urol. 2017 Jun 9. pii: S0302-2838(17)30453.
    Abstract     Related articles   

  1045. GIACALONE NJ, Niemierko A, Shipley WU, Efstathiou JA, et al
    Reply to Saeid Safiri and Erfan Ayubi's Letter to the Editor re: Nicholas J. Giacalone, William U. Shipley, Rebecca H. Clayman, et al. Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: A
    Eur Urol. 2017 Jun 19. pii: S0302-2838(17)30502.
    Abstract     Related articles   

  1046. BOSSCHIETER J, Vis AN, van der Poel HG, Moonen LM, et al
    Robot-assisted Laparoscopic Implantation of Brachytherapy Catheters in Bladder Cancer.
    Eur Urol. 2017 Jun 12. pii: S0302-2838(17)30494.
    Abstract     Related articles   

  1047. SAFIRI S, Ayubi E
    Re: Nicholas J. Giacalone, William U. Shipley, Rebecca H. Clayman, et al. Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Expe
    Eur Urol. 2017 Jun 22. pii: S0302-2838(17)30503.
    Abstract     Related articles   

  1048. BOSSCHIETER J, Nieuwenhuijzen JA, van Ginkel T, Vis AN, et al
    Value of an Immediate Intravesical Instillation of Mitomycin C in Patients with Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Randomised Study in 2243 patients.
    Eur Urol. 2017 Jul 10. pii: S0302-2838(17)30538.
    Abstract     Related articles   

  1049. LEOW JJ, Cole AP, Seisen T, Bellmunt J, et al
    Variations in the Costs of Radical Cystectomy for Bladder Cancer in the USA.
    Eur Urol. 2017 Aug 9. pii: S0302-2838(17)30640.
    Abstract     Related articles   

  1050. HADKHALE K, Martinsen JI, Weiderpass E, Kjaerheim K, et al
    Occupational exposure to solvents and bladder cancer: A population-based case control study in Nordic countries.
    Int J Cancer. 2016 Dec 29. doi: 10.1002/ijc.30593.
    Abstract     Related articles   

  1051. SOAVE A, Riethdorf S, Dahlem R, von Amsberg G, et al
    A nonrandomized, prospective, clinical study on the impact of circulating tumor cells on outcomes of urothelial carcinoma of the bladder patients treated with radical cystectomy with or without adjuvant chemotherapy.
    Int J Cancer. 2017;140:381-389.
    Abstract     Related articles   

  1052. BOTTERI E, Ferrari P, Roswall N, Tjonneland A, et al
    Alcohol consumption and risk of urothelial cell bladder cancer in the European Prospective Investigation into Cancer and Nutrition cohort.
    Int J Cancer. 2017 Jul 19. doi: 10.1002/ijc.30894.
    Abstract     Related articles   

  1053. HUSSAIN SA, Palmer DH, Syn WK, Sacco JJ, et al
    Gene expression profiling in bladder cancer identifies potential therapeutic targets.
    Int J Oncol. 2017 Mar 2. doi: 10.3892/ijo.2017.3893.
    Abstract     Related articles   

  1054. FENG C, Sun P, Hu J, Feng H, et al
    miRNA-556-3p promotes human bladder cancer proliferation, migration and invasion by negatively regulating DAB2IP expression.
    Int J Oncol. 2017 Apr 20. doi: 10.3892/ijo.2017.3969.
    Abstract     Related articles   

  1055. KIM WT, Seo SP, Byun YJ, Kang HW, et al
    Garlic extract in bladder cancer prevention: Evidence from T24 bladder cancer cell xenograft model, tissue microarray, and gene network analysis.
    Int J Oncol. 2017 May 11. doi: 10.3892/ijo.2017.3993.
    Abstract     Related articles   

  1056. XIONG Y, Huang F, Li X, Chen Z, et al
    CCL21/CCR7 interaction promotes cellular migration and invasion via modulation of the MEK/ERK1/2 signaling pathway and correlates with lymphatic metastatic spread and poor prognosis in urinary bladder cancer.
    Int J Oncol. 2017 May 17. doi: 10.3892/ijo.2017.4003.
    Abstract     Related articles   

  1057. CHEN M, Lv JM, Ye JQ, Cui XG, et al
    Disruption of serine/threonine protein phosphatase 5 inhibits tumorigenesis of urinary bladder cancer cells.
    Int J Oncol. 2017 May 16. doi: 10.3892/ijo.2017.3997.
    Abstract     Related articles   

  1058. HUSSAIN SA, Ansari J, Huddart R, Power DG, et al
    VICTOR: Vinflunine in advanced metastatic transitional cell carcinoma of the urothelium: A retrospective analysis of the use of vinflunine in multi-centre real life setting as second line chemotherapy through Free of Charge Programme for patients in t
    Int J Oncol. 2017;50:768-772.
    Abstract     Related articles   

  1059. YAMASHITA T, Higashi M, Momose S, Morozumi M, et al
    Nuclear expression of Y box binding-1 is important for resistance to chemotherapy including gemcitabine in TP53-mutated bladder cancer.
    Int J Oncol. 2017;51:579-586.
    Abstract     Related articles   

  1060. WANG CY, Xu ZB, Wang JP, Jiao Y, et al
    Rb deficiency accelerates progression of carcinoma of the urinary bladder in vivo and in vitro through inhibiting autophagy and apoptosis.
    Int J Oncol. 2017;50:1221-1232.
    Abstract     Related articles   

  1061. LIU Z, Liu J, Zhao L, Geng H, et al
    Curcumin reverses benzidine-induced epithelial-mesenchymal transition via suppression of ERK5/AP-1 in SV-40 immortalized human urothelial cells.
    Int J Oncol. 2017;50:1321-1329.
    Abstract     Related articles   

  1062. SUN Y, Guan Z, Zhao W, Jiang Y, et al
    Silibinin suppresses bladder cancer cell malignancy and chemoresistance in an NF-kappaB signal-dependent and signal-independent manner.
    Int J Oncol. 2017 Aug 2. doi: 10.3892/ijo.2017.4089.
    Abstract     Related articles   

  1063. ALEVIZOPOULOS A, Tyritzis S, Leotsakos I, Anastasopoulou I, et al
    Role of coagulation factors in urological malignancy: A prospective, controlled study on prostate, renal and bladder cancer.
    Int J Urol. 2016 Dec 22. doi: 10.1111/iju.13271.
    Abstract     Related articles   

  1064. DAL MORO F, Zattoni F
    Lighting from the urethral cystoscope side: A novel technique to safely manage bowel division during intracorporeal robotic urinary diversion.
    Int J Urol. 2016;23:344-5.
    Abstract     Related articles   

  1065. JINZAKI M, Kikuchi E, Akita H, Sugiura H, et al
    Role of computed tomography urography in the clinical evaluation of upper tract urothelial carcinoma.
    Int J Urol. 2016;23:284-98.
    Abstract     Related articles   

  1066. MATSUMURA N, Nakamura Y, Kohjimoto Y, Nishizawa S, et al
    Overexpression of ribonucleotide reductase subunit M1 protein predicts shorter survival in metastatic bladder cancer patients treated with gemcitabine-containing combination chemotherapy.
    Int J Urol. 2017 Jan 9. doi: 10.1111/iju.13274.
    Abstract     Related articles   

  1067. ALIMI Q, Verhoest G, Kammerer-Jacquet SF, Mathieu R, et al
    Response to Re: Role of routine computed tomography scan in the oncological follow up of patients treated by radical cystectomy for bladder cancer.
    Int J Urol. 2017 Jan 13. doi: 10.1111/iju.13290.
    Abstract     Related articles   

  1068. INOUE K
    5-Aminolevulinic acid-mediated photodynamic therapy for bladder cancer.
    Int J Urol. 2017;24:97-101.
    Abstract     Related articles   

  1069. SHIMIZU F, Muto S, Taguri M, Ieda T, et al
    Effectiveness of platinum-based adjuvant chemotherapy for muscle-invasive bladder cancer: A weighted propensity score analysis.
    Int J Urol. 2017 Mar 9. doi: 10.1111/iju.13324.
    Abstract     Related articles   

  1070. SALUJA M, Gilling P
    Intravesical bacillus Calmette-Guerin instillation in non-muscle-invasive bladder cancer: A review.
    Int J Urol. 2017 Jul 25. doi: 10.1111/iju.13410.
    Abstract     Related articles   

  1071. NASELLI A
    Editorial Comment to Chronic kidney disease as a risk factor for recurrence and progression in patients with primary non-muscle-invasive bladder cancer.
    Int J Urol. 2017 Jul 21. doi: 10.1111/iju.13402.
    Abstract     Related articles   

  1072. KOBATAKE K, Hayashi T, Black PC, Goto K, et al
    Chronic kidney disease as a risk factor for recurrence and progression in patients with primary non-muscle-invasive bladder cancer.
    Int J Urol. 2017 Jul 22. doi: 10.1111/iju.13389.
    Abstract     Related articles   

  1073. OTTO W, Breyer J, Herdegen S, Eder F, et al
    WHO 1973 grade 3 and infiltrative growth pattern proved, aberrant E-cadherin expression tends to be of predictive value for progression in a series of stage T1 high-grade bladder cancer after organ-sparing approach.
    Int Urol Nephrol. 2016 Dec 29. doi: 10.1007/s11255-016-1491.
    Abstract     Related articles   

  1074. JO JK, Jeong SJ, Hong SK, Byun SS, et al
    The impact of preoperative anemia on oncologic outcome in patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
    Int Urol Nephrol. 2016;48:489-94.
    Abstract     Related articles   

  1075. ROBINSON R, Tait CD, Somov P, Lau MW, et al
    Estimated glomerular filtration rate is unreliable in detecting renal function loss during follow-up after cystectomy and urinary diversion.
    Int Urol Nephrol. 2016;48:511-5.
    Abstract     Related articles   

  1076. TONYALI S, Yazici S
    Does solitary- and organ-confined metastasectomy really improve survival in advanced urologic malignancies?
    Int Urol Nephrol. 2016;48:671-80.
    Abstract     Related articles   

  1077. BOTHIG R, Kurze I, Fiebag K, Kaufmann A, et al
    Clinical characteristics of bladder cancer in patients with spinal cord injury: the experience from a single centre.
    Int Urol Nephrol. 2017 Mar 22. doi: 10.1007/s11255-017-1570.
    Abstract     Related articles   

  1078. VAN DE PUTTE EEF, Vegt E, Mertens LS, Bruining A, et al
    FDG-PET/CT for response evaluation of invasive bladder cancer following neoadjuvant chemotherapy.
    Int Urol Nephrol. 2017 Jul 3. doi: 10.1007/s11255-017-1637.
    Abstract     Related articles   

  1079. MAHMOUD O, El-Assmy A, Kamal M, Ashamallah A, et al
    Is chronic alkali therapy in orthotopic ileal neobladders necessary? A prospective controlled study.
    Int Urol Nephrol. 2017;49:49-53.
    Abstract     Related articles   

  1080. SONG W, Jeon HG, Jeong BC, Seo SI, et al
    Clinical significance of incidentally detected bladder wall thickening on computed tomography.
    Int Urol Nephrol. 2017;49:191-196.
    Abstract     Related articles   

  1081. GONDO T, Ohno Y, Nakashima J, Hashimoto T, et al
    Preoperative determinant of early postoperative renal function following radical cystectomy and intestinal urinary diversion.
    Int Urol Nephrol. 2017;49:233-238.
    Abstract     Related articles   

  1082. POWLES T, Huddart RA, Elliott T, Sarker SJ, et al
    Phase III, Double-Blind, Randomized Trial That Compared Maintenance Lapatinib Versus Placebo After First-Line Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 1/2-Positive Metastatic Bladder Cancer.
    J Clin Oncol. 2017;35:48-55.
    Abstract     Related articles   

  1083. KUSHI LH, Quinn VP, Ghai NR, Roh JM, et al
    Identifying lifestyle and genetic factors to prevent recurrence of non-muscle invasive bladder cancer in a prospective cohort study at Kaiser Permanente (the Be-Well study).
    J Clin Oncol. 2016;34.
    Abstract     Related articles   

  1084. DANFORTH KN, Kwan ML, Bulkley JE, O'Keeffe-Rosetti MC, et al
    Recovery challenges faced by bladder cancer survivors after recent cystectomy and urinary diversion.
    J Clin Oncol. 2016;34.
    Abstract     Related articles   

  1085. KULKARNI GS, Hermanns T, Wei Y, Bhindi B, et al
    Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic.
    J Clin Oncol. 2017 Apr 14:JCO2016692327. doi: 10.1200/JCO.2016.69.2327.
    Abstract     Related articles   

  1086. CHOU R, Selph S, Buckley DI, Fu R, et al
    Intravesical Therapy for the Treatment of Non-Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-analysis.
    J Urol. 2016 Dec 24. pii: S0022-5347(16)32091-2. doi: 10.1016/j.juro.2016.
    Abstract     Related articles   

  1087. PATEL S, Cookson MS
    Radical Cystectomy-The Waiting is the Hardest Part...or is it?
    J Urol. 2016;195.
    Abstract     Related articles   

  1088. HUSSEIN AA, Hashmi Z, Dibaj S, Altartir T, et al
    Reoperations following Robot-Assisted Radical Cystectomy: A Decade of Experience.
    J Urol. 2016;195:1368-76.
    Abstract     Related articles   

  1089. BEUKERS W, van der Keur KA, Kandimalla R, Vergouwe Y, et al
    FGFR3, TERT and OTX1 as urinary biomarker combination for surveillance of bladder cancer patients in a large prospective multicenter study.
    J Urol. 2016 Dec 31. pii: S0022-5347(16)32099-7. doi: 10.1016/j.juro.2016.
    Abstract     Related articles   

  1090. SHENOY SP, Marla PK, Sharma P, Batchu CK, et al
    Re: Sequential bacillus Calmette-Guerin/Electromotive Drug Administration of Mitomycin C as the Standard Intravesical Regimen in High Risk Nonmuscle Invasive Bladder Cancer: 2-Year Outcomes: C. Gan, S. Amery, K. Chatterton, M. S. Khan, K. Thomas and T
    J Urol. 2016 Dec 28. pii: S0022-5347(16)31927-9. doi: 10.1016/j.juro.2016.
    Abstract     Related articles   

  1091. STEINBERG GD
    Re: Comparative Effectiveness of Fluorescent versus White Light Cystoscopy for Initial Diagnosis or Surveillance of Bladder Cancer on Clinical Outcomes: Systematic Review and Meta-Analysis: R. Chou, S. Selph, D. I. Buckley, R. Fu, J. C. Griffin, S. Gr
    J Urol. 2017 Feb 6. pii: S0022-5347(16)32070-5. doi: 10.1016/j.juro.2016.
    Abstract     Related articles   

  1092. CHANG SS
    Re: Benefits of Adjuvant Chemotherapy for Bladder Cancer.
    J Urol. 2017;197.
    Abstract     Related articles   

  1093. BOEHM BE, Cornell JE, Wang H, Mukherjee N, et al
    Efficacy of Bacillus Calmette-guerin Strains for the Treatment of non-muscle Invasive Bladder Cancer: a Systematic Review and Network Meta-analysis.
    J Urol. 2017 Mar 9. pii: S0022-5347(17)39246-7. doi: 10.1016/j.juro.2017.
    Abstract     Related articles   

  1094. TOBERT CM, Hamilton-Reeves JM, Norian LA, Hung C, et al
    The Emerging Impact of Malnutrition on Surgical Patients: Literature Review and Potential Implications on Cystectomy for Bladder Cancer.
    J Urol. 2017 Mar 9. pii: S0022-5347(17)39247-9. doi: 10.1016/j.juro.2017.
    Abstract     Related articles   

  1095. KIM JH, Chung BI
    Re: Suppressed Recurrent Bladder Cancer after Androgen Suppression with Androgen Deprivation Therapy or 5alpha-Reductase Inhibitor: M. Shiota, K. Kiyoshima, A. Yokomizo, A. Takeuchi, E. Kashiwagi, T. Dejima, R. Takahashi, J. Inokuchi, K. Tatsugami and
    J Urol. 2017 Mar 29. pii: S0022-5347(17)30226-4. doi: 10.1016/j.juro.2017.
    Abstract     Related articles   

  1096. RAVVAZ K, Walz ME, Weissert JA, Downs TM, et al
    Predicting non-muscle invasive bladder cancer recurrence and progression in a US population.
    J Urol. 2017 Apr 19. pii: S0022-5347(17)54785-0. doi: 10.1016/j.juro.2017.
    Abstract     Related articles   

  1097. CHANG SS, Bochner BH, Chou R, Dreicer R, et al
    Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline.
    J Urol. 2017 Apr 26. pii: S0022-5347(17)57836-2. doi: 10.1016/j.juro.2017.
    Abstract     Related articles   

  1098. LAGUNA MP
    Re: Oncologic Outcomes of Kidney-Sparing Surgery versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-Muscle Invasive Bladder Cancer Guidelines Panel.
    J Urol. 2017;197:1437-1438.
    Abstract     Related articles   

  1099. CHANG SS
    Re: Phase II Drug-Metabolizing Polymorphisms and Smoking Predict Recurrence of Non-Muscle-Invasive Bladder Cancer: A Gene-Smoking Interaction.
    J Urol. 2017;198:40.
    Abstract     Related articles   

  1100. CHANG SS
    Re: EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-Specific and Overall Survival in Non-Muscle-Invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guerin.
    J Urol. 2017;198:39-41.
    Abstract     Related articles   

  1101. ARK JT, Alvarez JR, Koyama T, Bassett JC, et al
    Variation in the diagnostic evaluation among persons with hematuria: influence of gender, race, and risk factors for bladder cancer.
    J Urol. 2017 Jun 24. pii: S0022-5347(17)76746-8. doi: 10.1016/j.juro.2017.
    Abstract     Related articles   

  1102. WAN W, Peng K, Li M, Qin L, et al
    Histone demethylase JMJD1A promotes urinary bladder cancer progression by enhancing glycolysis through coactivation of hypoxia inducible factor 1alpha.
    Oncogene. 2017 Mar 6. doi: 10.1038/onc.2017.
    Abstract     Related articles   

  1103. HAN AL, Veeneman BA, El-Sawy L, Day KC, et al
    Fibulin-3 promotes muscle-invasive bladder cancer.
    Oncogene. 2017 May 15. doi: 10.1038/onc.2017.
    Abstract     Related articles   

  1104. YU G, Jia Z, Dou Z
    miR-24-3p regulates bladder cancer cell proliferation, migration, invasion and autophagy by targeting DEDD.
    Oncol Rep. 2016 Dec 16. doi: 10.3892/or.2016.5326.
    Abstract     Related articles   

  1105. DENG QF, Sun X, Liang ZF, Zhang ZQ, et al
    Cigarette smoke extract induces the proliferation of normal human urothelial cells through the NF-kappaB pathway.
    Oncol Rep. 2016;35:2665-72.
    Abstract     Related articles   

  1106. CHEN JF, Yu BX, Yu R, Ma L, et al
    Monoclonal antibody Zt/g4 targeting RON receptor tyrosine kinase enhances chemosensitivity of bladder cancer cells to Epirubicin by promoting G1/S arrest and apoptosis.
    Oncol Rep. 2017 Jan 5. doi: 10.3892/or.2017.5356.
    Abstract     Related articles   

  1107. LI W, Liu J, Zou D, Cai X, et al
    Exploration of bladder cancer molecular mechanisms based on miRNA-mRNA regulatory network.
    Oncol Rep. 2017;37:1461-1468.
    Abstract     Related articles   

  1108. HORI S, Miyake M, Onishi S, Tatsumi Y, et al
    Clinical significance of alpha and betaKlotho in urothelial carcinoma of the bladder.
    Oncol Rep. 2016;36:2117-25.
    Abstract     Related articles   

  1109. ZHANG Y, Zhang Z, Li Z, Gong D, et al
    MicroRNA-497 inhibits the proliferation, migration and invasion of human bladder transitional cell carcinoma cells by targeting E2F3.
    Oncol Rep. 2016;36:1293-300.
    Abstract     Related articles   

  1110. ZHANG N, Bi X, Zeng Y, Zhu Y, et al
    TGF-beta1 promotes the migration and invasion of bladder carcinoma cells by increasing fascin1 expression.
    Oncol Rep. 2016;36:977-83.
    Abstract     Related articles   

  1111. YANG X, Zhang F, Luo J, Pang J, et al
    A new non-muscle-invasive bladder tumor-homing peptide identified by phage display in vivo.
    Oncol Rep. 2016;36:79-89.
    Abstract     Related articles   

  1112. BA M, Cui S, Wang B, Long H, et al
    Bladder intracavitary hyperthermic perfusion chemotherapy for the prevention of recurrence of non-muscle invasive bladder cancer after transurethral resection.
    Oncol Rep. 2017;37:2761-2770.
    Abstract     Related articles   

  1113. YUAN SY, Shiau MY, Ou YC, Huang YC, et al
    Miconazole induces apoptosis via the death receptor 5-dependent and mitochondrial-mediated pathways in human bladder cancer cells.
    Oncol Rep. 2017 Apr 27. doi: 10.3892/or.2017.5608.
    Abstract     Related articles   

  1114. WU D, Niu X, Tao J, Li P, et al
    MicroRNA-379-5p plays a tumor-suppressive role in human bladder cancer growth and metastasis by directly targeting MDM2.
    Oncol Rep. 2017 Apr 27. doi: 10.3892/or.2017.5607.
    Abstract     Related articles   

  1115. RADY M, Mostageer M, Rohde J, Zaghloul A, et al
    Therapy-relevant aberrant expression of MRP3 and BCRP mRNA in TCC-/SCC-bladder cancer tissue of untreated patients.
    Oncol Rep. 2017 Jun 2. doi: 10.3892/or.2017.5695.
    Abstract     Related articles   

  1116. WANG H, Zhong J, Wu C, Liu Y, et al
    Stromal antigen 2 functions as a tumor suppressor in bladder cancer cells.
    Oncol Rep. 2017 Jun 12. doi: 10.3892/or.2017.5711.
    Abstract     Related articles   

  1117. WANG S, Liu B, Zhang J, Sun W, et al
    Centromere protein U is a potential target for gene therapy of human bladder cancer.
    Oncol Rep. 2017 Jun 30. doi: 10.3892/or.2017.5769.
    Abstract     Related articles   

  1118. WANG SC, Wang ST, Liu HT, Wang XY, et al
    Trichostatin A induces bladder cancer cell death via intrinsic apoptosis at the early phase and Sp1survivin downregulation at the late phase of treatment.
    Oncol Rep. 2017 Jul 6. doi: 10.3892/or.2017.5795.
    Abstract     Related articles   

  1119. GAO SL, Kong CZ, Zhang Z, Li ZL, et al
    TRPM7 is overexpressed in bladder cancer and promotes proliferation, migration, invasion and tumor growth.
    Oncol Rep. 2017 Aug 7. doi: 10.3892/or.2017.5883.
    Abstract     Related articles   

  1120. CHANU T, Neuzillet Y, Butreau M, Bach C, et al
    [Predictive factors and prognostic consequences of perioperative complications of radical cystectomies for urothelial carcinoma in patients of 80 years or more].
    Prog Urol. 2016;26:331-8.
    Abstract     Related articles   

  1121. BELOT PY, Fassi-Fehri H, Colombel M, Matillon X, et al
    [The W-shaped ileal neobladder: Long term functional outcomes and health-related quality of life].
    Prog Urol. 2016;26:367-74.
    Abstract     Related articles   

  1122. ALIMI Q, Peyronnet B, Kammerer-Jacquet SF, Lefevre M, et al
    [Oncologic and perioperative outcomes of robot-assisted radical cystectomy: A single-center prospective series].
    Prog Urol. 2016;26:538-46.
    Abstract     Related articles   

  1123. RIOUX-LECLERCQ N, Comperat E, Kammerer-Jacquet SF, Camparo P, et al
    [Pathological advances in renal, prostatic, bladder and testis neoplasia].
    Prog Urol. 2016 Jul 26. pii: S1166-7087(16)30070.
    Abstract     Related articles   

  1124. BREYER J, Otto W, Wirtz RM, Wullich B, et al
    ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ.
    Urol Int. 2016.
    Abstract     Related articles   

  1125. SOORIAKUMARAN P, Chiocchia V, Dutton S, Pai A, et al
    Predictive Factors for Time to Progression after Hyperthermic Mitomycin C Treatment for High-Risk Non-Muscle Invasive Urothelial Carcinoma of the Bladder: An Observational Cohort Study of 97 Patients.
    Urol Int. 2016;96:83-90.
    Abstract     Related articles   

  1126. SERRETTA V, Scalici Gesolfo C, Alonge V, Cicero G, et al
    Does the Compliance to Intravesical BCG Differ between Common Clinical Practice and International Multicentric Trials?
    Urol Int. 2016;96:20-4.
    Abstract     Related articles   

  1127. MARTINI T, Aziz A, Roghmann F, Rink M, et al
    Prediction of Locally Advanced Urothelial Carcinoma of the Bladder Using Clinical Parameters before Radical Cystectomy--A Prospective Multicenter Study.
    Urol Int. 2016;96:57-64.
    Abstract     Related articles   

  1128. MILLER K, Morant R, Stenzl A, Zuna I, et al
    A Phase II Study of the Central European Society of Anticancer-Drug Research (CESAR) Group: Results of an Open-Label Study of Gemcitabine plus Cisplatin with or without Concomitant or Sequential Gefitinib in Patients with Advanced or Metastatic Transi
    Urol Int. 2016;96:5-13.
    Abstract     Related articles   

  1129. TANAKA H, Yoshida S, Komai Y, Sakai Y, et al
    Clinical Value of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Upper Tract Urothelial Carcinoma: Impact on Detection of Metastases and Patient Management.
    Urol Int. 2016;96:65-72.
    Abstract     Related articles   

  1130. MOSCHINI M, Shariat SF, Freschi M, Soria F, et al
    Impact of Prostate Involvement on Outcomes in Patients Treated with Radical Cystoprostatectomy for Bladder Cancer.
    Urol Int. 2017 Feb 1. doi: 10.1159/000454736.
    Abstract     Related articles   

  1131. NAKAMURA Y, Yoshida S, Tanaka H, Inoue M, et al
    Potential Utility of Diffusion-Weighted Magnetic Resonance Imaging in Diagnosis of Residual Bladder Cancer before Second Transurethral Resection.
    Urol Int. 2017 Mar 1. doi: 10.1159/000456722.
    Abstract     Related articles   

  1132. BALCI M, Tuncel A, Keten T, Guzel O, et al
    Comparison of Monopolar and Bipolar Transurethral Resection of Non-Muscle Invasive Bladder Cancer.
    Urol Int. 2017 Apr 6. doi: 10.1159/000467397.
    Abstract     Related articles   

  1133. GAKIS G, Efstathiou JA, Daneshmand S, Keegan KA, et al
    Oncological Outcomes of Patients with Concomitant Bladder and Urethral Carcinoma.
    Urol Int. 2016;97:134-41.
    Abstract     Related articles   

  1134. D''AGOSTINO D, Racioppi M, Pugliese D, Ragonese M, et al
    Postoperative Quality of Life in Patients with Ileal Neobladder at Short-, Intermediate- and Long-Term Follow-Up.
    Urol Int. 2016;97:54-60.
    Abstract     Related articles   

  1135. POLETAJEW S, Zapala P, Radziszewski P
    Safety and Efficacy of Intravesical Bacillus Calmette-Guerin Immunotherapy in Patients with Non-Muscle-Invasive Bladder Cancer Presenting with Asymptomatic Bacteriuria: A Systematic Review.
    Urol Int. 2017 Jun 10. doi: 10.1159/000477673.
    Abstract     Related articles   

  1136. NAGAO K, Hara T, Nishijima J, Shimizu K, et al
    The Efficacy of Trimodal Chemoradiotherapy with Cisplatin as a Bladder-Preserving Strategy for the Treatment of Muscle-Invasive Bladder Cancer.
    Urol Int. 2017 Jun 21. doi: 10.1159/000477912.
    Abstract     Related articles   

  1137. SHINTANI T, Kusuhara Y, Daizumoto K, Dondoo TO, et al
    The Involvement of HGF-MET-MMP1 Signaling in Bladder Cancer Invasiveness and Proliferation. Effect of the MET Inhibitor, Cabozantinib (XL184), on Bladder Cancer Cells.
    Urology. 2016 Dec 21. pii: S0090-4295(16)30945.
    Abstract     Related articles   

  1138. CHAPPIDI MR, Kates M, Brant A, Baras AS, et al
    Assessing Cancer Progression and Stable Disease after Neoadjuvant Chemotherapy for Organ-Confined Muscle-Invasive Bladder Cancer.
    Urology. 2017 Jan 16. pii: S0090-4295(17)30031.
    Abstract     Related articles   

  1139. ROBINS DJ, Sui W, Matulay JT, Ghandour R, et al
    Long-Term Survival Outcomes with Intravesical Nanoparticle Albumin-Bound Paclitaxel for Recurrent Nonmuscle Invasive Bladder Cancer after Previous Bacillus Calmette-Guerin Therapy.
    Urology. 2017 Feb 2. pii: S0090-4295(17)30046.
    Abstract     Related articles   

  1140. PAK JS, Lee JJ, Bilal K, Finkelstein M, et al
    Utilization Trends and Short-Term Outcomes of Robotic Versus Open Radical Cystectomy for Bladder Cancer.
    Urology. 2017 Feb 8. pii: S0090-4295(17)30124.
    Abstract     Related articles   

  1141. KLAASSEN Z, Soloway MS
    EAU and AUA/SUO Guidelines on Risk Categories for Non-Muscle Invasive Bladder Cancer May Lead to Overtreatment for Low Grade Ta Bladder Tumors.
    Urology. 2017 Mar 30. pii: S0090-4295(17)30297.
    Abstract     Related articles   

  1142. LAVOIE JM, Bidnur S, Black PC, Eigl BJ, et al
    Expanding Immunotherapy Options for Bladder Cancer.
    Urology. 2017 Apr 25. pii: S0090-4295(17)30344.
    Abstract     Related articles   

  1143. SORIA F, Moschini M, Wirth GJ, Gust KM, et al
    Characterization of Late Recurrence after Radical Cystectomy in a Large Multicenter Cohort of Bladder Cancer Patients.
    Urology. 2017 May 12. pii: S0090-4295(17)30487.
    Abstract     Related articles   

  1144. DUNPHY KM, Garino MC, Shaw NM, Carvalho FL, et al
    When the Gold Standard Proves to be Fool's Gold - Blue Light Cystoscopy in a Case of High Risk Non-Muscle Invasive Bladder Cancer.
    Urology. 2017 May 31. pii: S0090-4295(17)30581.
    Abstract     Related articles   

  1145. SIHRA N, Diasuke N, Thurairaja R, Khan MS, et al
    Renal Tuberculosis Following Intravesical BCG for High-Grade Non-Muscle-Invasive Bladder Cancer.
    Urology. 2017 May 31. pii: S0090-4295(17)30587.
    Abstract     Related articles   

  1146. MONCRIEF TJ, Balaji P, Lindgren B, Weight CJ, et al
    Comparative Evaluation of Bladder Specific Health Related Quality of Life (HRQOL) Instruments for Bladder Cancer.
    Urology. 2017 Jul 10. pii: S0090-4295(17)30698.
    Abstract     Related articles   

  1147. KOO K, Zubkoff L, Sirovich BE, Goodney PP, et al
    The Burden of Cystoscopic Bladder Cancer Surveillance: Anxiety, Discomfort, and Patient Preferences for Decision Making.
    Urology. 2017 Jul 21. pii: S0090-4295(17)30754.
    Abstract     Related articles   

  1148. BAI Y, Wang X, Yang Y, Tang Y, et al
    Parity and bladder cancer risk: a dose-response meta-analysis.
    BMC Cancer. 2017;17:31.
    Abstract     Related articles   

  1149. LAVERY HJ, Zaharieva B, McFaddin A, Heerema N, et al
    A prospective comparison of UroVysion FISH and urine cytology in bladder cancer detection.
    BMC Cancer. 2017;17:247.
    Abstract     Related articles   

  1150. KAO YT, Wu CH, Wu SY, Lan SH, et al
    Arsenic treatment increase Aurora-A overexpression through E2F1 activation in bladder cells.
    BMC Cancer. 2017;17:277.
    Abstract     Related articles   

  1151. FONTEYNE V, Dirix P, Junius S, Rammant E, et al
    Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer: a phase II trial.
    BMC Cancer. 2017;17:308.
    Abstract     Related articles   

  1152. TEYSSONNEAU D, Daste A, Dousset V, Hoepffner JL, et al
    Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: case report of an unexpected response.
    BMC Cancer. 2017;17:323.
    Abstract     Related articles   

  1153. PENG D, Gong YQ, Hao H, He ZS, et al
    Preoperative Prognostic Nutritional Index is a Significant Predictor of Survival with Bladder Cancer after Radical Cystectomy: a retrospective study.
    BMC Cancer. 2017;17:391.
    Abstract     Related articles   

  1154. DYSHLOVOY SA, Madanchi R, Hauschild J, Otte K, et al
    The marine triterpene glycoside frondoside A induces p53-independent apoptosis and inhibits autophagy in urothelial carcinoma cells.
    BMC Cancer. 2017;17:93.
    Abstract     Related articles   

  1155. MATSUO T, Miyata Y, Asai A, Sagara Y, et al
    Green Tea Polyphenol Induces Changes in Cancer-Related Factors in an Animal Model of Bladder Cancer.
    PLoS One. 2017;12:e0171091.
    Abstract     Related articles   

  1156. XIONG Y, Li J, Ma S, Ge J, et al
    A meta-analysis of narrow band imaging for the diagnosis and therapeutic outcome of non-muscle invasive bladder cancer.
    PLoS One. 2017;12:e0170819.
    Abstract     Related articles   

  1157. SHIN SS, Song JH, Hwang B, Noh DH, et al
    HSPA6 augments garlic extract-induced inhibition of proliferation, migration, and invasion of bladder cancer EJ cells; Implication for cell cycle dysregulation, signaling pathway alteration, and transcription factor-associated MMP-9 regulation.
    PLoS One. 2017;12:e0171860.
    Abstract     Related articles   

  1158. VAN KESSEL KE, van de Werken HJ, Lurkin I, Ziel-van der Made AC, et al
    A reported 20-gene expression signature to predict lymph node-positive disease at radical cystectomy for muscle-invasive bladder cancer is clinically not applicable.
    PLoS One. 2017;12:e0174039.
    Abstract     Related articles   

  1159. IDE H, Inoue S, Miyamoto H
    Histopathological and prognostic significance of the expression of sex hormone receptors in bladder cancer: A meta-analysis of immunohistochemical studies.
    PLoS One. 2017;12:e0174746.
    Abstract     Related articles   

  1160. XIE JY, Chen PC, Zhang JL, Gao ZS, et al
    The prognostic significance of DAPK1 in bladder cancer.
    PLoS One. 2017;12:e0175290.
    Abstract     Related articles   

  1161. ORRE M, Latorzeff I, Flechon A, Roubaud G, et al
    Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer: A retrospective multicenter study.
    PLoS One. 2017;12:e0174978.
    Abstract     Related articles   

  1162. HORI S, Miyake M, Tatsumi Y, Onishi S, et al
    Topical and systemic immunoreaction triggered by intravesical chemotherapy in an N-butyl-N-(4-hydroxybutyl) nitorosamine induced bladder cancer mouse model.
    PLoS One. 2017;12:e0175494.
    Abstract     Related articles   

  1163. LI M, Wang L
    The Associations of Psychological Stress with Depressive and Anxiety Symptoms among Chinese Bladder and Renal Cancer Patients: The Mediating Role of Resilience.
    PLoS One. 2016;11:e0154729.
    Abstract     Related articles   

  1164. REULEN RC, de Vogel S, Zhong W, Zhong Z, et al
    Physical activity and risk of prostate and bladder cancer in China: The South and East China case-control study on prostate and bladder cancer.
    PLoS One. 2017;12:e0178613.
    Abstract     Related articles   

  1165. AFSHARI M, Janbabaei G, Bahrami MA, Moosazadeh M, et al
    Opium and bladder cancer: A systematic review and meta-analysis of the odds ratios for opium use and the risk of bladder cancer.
    PLoS One. 2017;12:e0178527.
    Abstract     Related articles   

  1166. MASOOMPOUR SM, Lankarani KB, Honarvar B, Tabatabaee SH, et al
    Changing Epidemiology of Common Cancers in Southern Iran, 2007-2010: A Cross Sectional Study.
    PLoS One. 2016;11:e0155669.
    Abstract     Related articles   

  1167. SU YL, Hsieh MC, Chiang PH, Sung MT, et al
    Novel Inflammation-Based Prognostic Score for Predicting Survival in Patients with Metastatic Urothelial Carcinoma.
    PLoS One. 2017;12:e0169657.
    Abstract     Related articles   


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;